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SUMMARY
Cholera is an acute diarrheal disease that is characterized by massive 
loss of fluids and electrolytes. If it remains untreated, in its most severe 
form it may result in death .The causative agent is Vibrio cholerae, which 
was first described by Robert Koch (1884).The disease is contracted by the 
ingestion of water or food contaminated by the excreta of persons 
harbouring the bacilli. Since it is exquisitely sensitive to gastric acid, at least 
100 million vibrios are required for infection in a reasonably healthy person, 
but in a malnourished victim or someone with no gastric acidity, 10,000 to 
1 million vibrios can produce disease. The human is the only host of 
V.cholerae (Smith, 1985).
The species V.cholerae is divided into several serotypes on the 
basis of O antigens, and the strains belonging to serogroup Ol are the most 
common causative agents of cholera in man. Serotype Ol is further divided 
into two main serotypes, Ogawa and Inaba on the basis of type-specific 
antigens (Gardner and Venkatraman 1935; Kauffmann, 1950; Gustafson et 
al, 1982).
Diagnosis of cholera caused by V.cholerae alone is made by 
immobilizing the organism with Ol antiserum. This phenomenon is 
observed under the dark field or phase contrast microscope. Culture of the 
sample on selective media and indirect immunofluorescence techniques are 
also used (Chatteijee, 1986). However, the techniques for identification of 
V.cholerae are time consuming and need trained personnel.
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The objective of this study was to investigate the feasibility of the 
construction of a diagnostic system for a rapid detection of V.cholerae for 
use in the field by untrained personnel.
The optimal conditions for growth of two cell lines producing 
monoclonal antibodies were determined in different Foetal Calf Serum 
(FCS) concentrations. The results indicated that high levels of FCS increase 
cell growth and immunoglobulin secretion in the culture medium, while low 
levels increase the amount of immunoglobulin expressed on the cell surface. 
The cells were found to be specific for their homologous serotype antigen, 
but excess of either serotype antigen can dislodge the other.
I1A1 and 04A6 were purified from cell culture supernatant 
contaminating proteins by using QAE-Sephadex A50. The method was 
satisfactory for 04A6, while IIA1 required further purification in FPLC gel 
filtration on Superose 12 to remove the high molecular weight contaminants 
and bovine serum albumin.
The most commonly employed enzymes for labelling, horse radish 
peroxidase and alkaline phosphatase, were tested with two different 
attachment methods, glutaraldehyde and periodate. The best method for 
conjugation of both I1A1 and 04A6 without loss of either antibody and 
enzyme activity was the glutaraldehyde method. Different assay systems 
were compared with the conjugated antibody; the Enzyme Linked 
ImmunoSorbent Assay (ELISA) and a nitrocellulose paper based "blotting" 
type assay. The results showed that antibody conjugated directly to alkaline 
phosphatase has better antigen binding capacity than the biotin-avidin 
system which is 10 fold less sensitive than the conjugated antibody and
XVII
more time consuming.The conjugate was separated from the free enzyme 
and antibody by FPLC gel filtration on Superose 12 which gave a high titre 
reading in ELISA and strong colour intensity on nitrocellulose paper from 
the first peak and no activity in the other peaks.
The antigen binding of the conjugate increased with 
increasedF.c/zo/erae concentration in both ELISA and the nitrocellulose 
paper assay (kit). Binding also increased with increasing conjugate 
concentration in the ELISA assay while increase of the conjugate 
concentration in the kit gave non specific binding to other components.
Among the blocking agents tested to block the nitrocellulose paper, 
skimmed dried milk (Blotto) was found to produce the clearest background 
and optimal signal/noise ratio. Prolonging the blocking time did not affect 
the background staining. The other blocking agents tested resulted either in 
a high background staining (as with gelatin and normal goat serum) or 
inhibition of the binding of the proteins to nitrocellulose and removal of the 
bound protein from the paper.
Two types of solid support were investigated for kit construction. 
The nitrocellulose paper showed better results while the colour intensity 
from plastic wands was very faint and irregular. When the kit was 
constructed using commercially available plastic sticks (Clearblue kit) an 
unsatisfactory result was obtained.
The sensitivity of the nitrocellulose kit for the detection of 
V.cholerae was 10^ organisms/ml. The sensitivity in ELISA was lO^/ml* 
These values are well below the level required to cause infection in healthy 
individuals even if a comparatively large volume of infected water was
XVIII
consumed.
The specificity of the IIA1 and 04A6 conjugates was demonstrated 
by testing cross reactions with a number of gram negative and gram positive
bacteria in both ELISA assay and the kit. The results from both Ogawa and 
Inaba kits were quite similar to the negative control of the assay, while in 
ELISA, using microtitre plates, a very weak reaction was detected between 
the conjugates and Escherichia.coli, Brucella  species and 
Bacillus.anthracis, the level being slightly above the background control.
Among the optimal conditions tested for the construction of both 
Inaba and Ogawa kits, nitrocellulose paper was chosen as a support, milk as 
a blocking reagent, antibody conjugated to alkaline phosphatase rather than 
biotinylated antibody with a molar ratio of 1:1 of antibody-enzyme for the 
detecting system, and tap water as the washing agent.
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CHAPTER 1 
INTRODUCTION
1.1.  Enzyme-Immunoassay
1.1 .1 .  Background
Enzyme-immunoassay (EIA) evolved as a result of the finding by 
Nakane and Pierce (1967) that antibodies could be labelled with enzymes for 
use in histochemical staining procedures; (Herrmann,1986). Since the first 
report on enzyme immunoassay appeared in 1971 (Engvall and 
Perlman, 1971) a wide variety of applications have been found utilising the 
same basic principles (Miyai,1985). Enzyme immunoassay (EIA) has led to 
the expansion of many of the traditional techniques in diagnostic medicine 
and biological research, (Kurstak,1985). The procedures involved, which 
are simple to perform and give excellent results take advantages both of the 
powerful amplification of chemical reactions achieved with enzymes and of 
the potentially very high specificity of antibodies for a given antigen.
1.1.2.  Classification of EIA
Enzyme immunoassays may be classified into Heterogeneous 
and Homogeneous.The former was introduced by Miles and Hales, who 
also suggested that enzymes or coenzymes could replace the isotopic label.
All heterogenous EIAs have at least one separation step to 
distinguish the reactant from unreacted materials, in this EIA system the 
enzyme and the labelled antigen or antibodies retain the enzymatic activities 
even after the reaction with antibody or antigen (Nakamura et a/, 1986).
Enzyme-Linked Immunosorbent Assay (ELISA), first used by 
Engvall and Perlmann (Engvall and Perlman, 1971), is capable of the 
detection of extremely small quantities of immune reactant. The enzymatic 
detection in the bound or free fractions is made quantitative by the enzyme
1
catalysed conversion of the relatively colourless or non-fluorescent substrate 
to a highly coloured or fluorescent prouduct. ELISA methods may be 
competitive or non-competitive by variations on the basic technique 
(Nakamura et al,1986).
Homogeneous EIA tests have also been developed. This assay is 
based on the reaction of antigen with an antibody-enzyme complex causing 
a decrease in product after reaction with enzyme substrate. The major 
advantage of the homogeneous assays are that they do not require the 
separation steps necessary in the heterogeneous assays, and the major 
disadvantage of this type of EIA is that it has been difficult to apply it to the 
detection of high-molecular weight antigens with the degree of sensitivity 
required (Hermann, 1986). Homogeneous EIAs have been used for the assay 
of drugs and hormones, but are at the present time generally less sensitive 
than heterogeneous EIAs, which have equalled the sensitivity of RIA in most 
applications (Nakamura et al, 1986). There are many types of homogeneous 
EIA including antigen analyte labelled immunoassay and enzymatic substrate 
labelled immunoassay (Tijssen,1985).
1.1.3 .  Enzymes for EIA
There are several important criteria in the selection of a particular 
enzyme label including turnover number, purity, sensitivity, ease and speed 
of detection, absence of interfering factors in the test fluid, potential reactive 
groups, and stability (Schuurs and Van Weemen,1977). The most common 
enzymes used for heterogeneous EIA are horse radish peroxidase, 
glucoamylase, carbonic anhydrase and acetyl cholinesterase. For 
homogeneous they are lysozyme, malate dehydrogenase, glucose-6- 
phosphate dehydrogenase and p-galactosidase.
2
1.1 .4 .  Application of EIA in the detection of microbial
antigens
The application of the of EIA assay method to the detection of 
microbial antigens provides an alternative to culture as a mean for direct 
identification of a specific microbial agent, and is also an extension of 
previously employed serological tests for the detection of antibody and 
antigen (Herrmann, 1986) . EIA assays have been developed for the 
sensitive detection of many bacteria and viruses such as Bacillus anthracis, 
Brucella abortus, Vibrio cholerae (toxin) and Rabies viruses.
>
1.2.  Radioimmunoassay
In 1960 Yalow and Berson introduced radioimmunoassay 
(RIA), to determine circulating insulin levels, using 1 ^ 1  labelled insulin 
and the appropriate antiserum . The success of the technique can be 
attributed to the fact that it offers a general system for the measurement of a 
wide range of materials of clinical and biological interest (Chard, 1987).
The classical radioimmunological system was originally based 
upon the ability of an antibody to bind to antigen labelled with radioactive 
isotope. The antibody-bound labelled antigen is then separated from the 
unbound and the radioactivity is measured (Wide, 1971).
Many variations on the basic techniques of RIA have been 
developed including solid phase radio binding immunoassay, competitive 
binding radioimmunoassay and immunoradiometric assay (IRMA) 
(Johnstone and Thorpe, 1987).
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1.3.  Other immunological techniques employed in
bacteriology
Immunological techniques have been used for many years in the 
diagnosis of infectious diseases. Among the major ones are
Agglutination of suspensions of bacteria by specific antibodies. 
This is a classical method for the diagnosis of infections and for serological 
typing of bacteria (Winstanley and Blackwell, 1986 ), it is not a sensitive 
technique but it is still widely used as it is simple and quick to perform and 
of low cost.
Complement fixation tests. These tests take advantage of the 
ability of antibody antigen complexes to fix exogenous complement. The 
usual test is effectively a competition assay where a second detection 
antibody-antigen system involving haemolysis and sheep red blood cells is 
employed. This competes with the bacterial bound antibody for complement 
components (Wasserman and Levine, 1960). Such assays are widely used in 
virology, but have limited application in bacteriology, the main application 
being in the diagnosis of syphilis and brucellosis.
Precipitation of soluble bacteria antigens by specific antibody. 
This is a classic assay which was originally used to distinguish toxicogenic 
strains of Coryn$bacterium diphtheriae (Ouchterlony,1948). Antibody - 
antigen complexes are detected by the precipitates they form after diffusing 
towards each other through a gel. The assay has the advantage of simplicity 
and low cost but is insensitive in comparison to most other techniques.
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Fluorometric immunoassay. This is similar to ELISA, with the 
probe being an enzyme with a fluorescent product. Fluorometric 
immunoassays of antibacterial antibodies have been developed to assist in 
the diagnosis of the infectious diseases including Legionellosis (Black et 
al, 1982). Fluoresence linked enzyme assays have considerable potential in 
terms of amplifying the signal sent out from the antibody antigen complex
However, until more portable -possibly electronic- fluorimetric 
instruments can be developed, they are restricted to laboratory use.
1.4. The advantages of EIA over other assays
Enzyme labelling has been the subject of most recent active 
research and provides a feasible altamative to radioimmunoassay. Several 
factors have had a major impact on the development of enzyme linked 
assays. Firstly, labelling of immunoreactant with enzyme has become highly 
( refined so that conjugates with high immunological and enzymatic activities
can be obtained (Kurstak,1985).Secondly, the colour reaction can be 
observed by eye, making it suitable for use in the field (e.g for scanning 
circulating antibodies to detect infection in third world countries) or use by 
untrained individuals in the developed world (e.g pregnancy kits) (Johnstone 
et al, 1987). In addition further advantages include the availability and 
relative cheapness of many enzymes and of manual and automated systems 
for their assay, the long shelf life of the labelling product (which can be 
measured in years), lack of hazards during labelling, and a sensitivity, 
specificity and applicability similar to radioimmunoassay without its 
attendant disadvantages. Such disadvantages include the health hazard 
associated with the production and application of radiolabelled antigens, and
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the limited shelf life imposed by the decay time of the attached radioisotope 
(L&ndon, 1977). While it may also be argued that chemical substitution of a 
radioactive probe may alter its subsequent potential to react with antibody, 
the same is also true of substitution to an enzyme probe. However, wider 
flexibility on attachment methods and sites is available in the case of EIA. 
Although all other immunological assays may be used at greater simplicity 
and lower cost, these (apart from biosensor based assays which have not yet 
been developed to their full potential) have limited sensitivity and require 
much greater concentrations of the immunological reagents involved.
1.5 Biosensors
A Biosensor is a multi-component system comprising a 
biological element to provide specificity of measurement, such as an 
antibody-antigen binding or an enzyme-substrate reaction, together with a 
base sensing device capable of transducing the biological events into a signal 
that can be converted into a suitable output (fig 1.1). The biological element 
must be in close proximity to the transducer and therefore, immobilization 
method and the union of its elements are important in biosensor design . 
Recent advances in silicon technology, polymer fabrication, optics and data 
processing techniques may greatly facilitate this union. Thus the biosensor 
field is developing at the interface between existing and emerging 
technologies, combining the physical and biological disciplines with 
electronics and possibly computer science (Cooper and Hall, 1988).
1.5.1. Amperometric sensors_______________________ _______
1 .5 .1 .1 .  Amperometric immunoassays based on the Clark
electrode
The use of the Clark oxygen electrode to detect either the loss or 
formation of oxygen as a consequence of an enzymic reaction was an
Figure 1.1 construction of a biosensor
A) A biosensor consist of a biological molecule such as an antibody or 
enzyme in close contact with a base tranducing device
B) The analyte to be measured binds to the sensing surface, i.e. 
antibody binds antigen or enzyme binds substrate, and the tranducer convert 
this into a suitable output.
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interesting progression for enzyme immunoassays. The two most 
commonly used enzyme labels were glucose oxidase and catalase.
Aizawa et al in 1979 constructed an enzyme linked 
immunoassay to monitor human chorionic gonadotropin (hCG) using 
catalase labelled hCG. They mobilized an antibody on to a pre-cast 
cellulose membrane, and the membrane was then placed over the teflon 
membrane of the oxygen electrode.
2H202 ______________ > 2H20 + 0 2
Both labelled and non-labelled hCG were allowed to compete for 
the antibody in the membranes. The membrane was washed to remove 
bound from free hCG, and the electrode then exposed to hydrogen peroxide 
solution. The hydrogen peroxide solution in the presence of catalase is 
broken down to yield oxygen and water and the rate of increase in oxygen 
tension is monitored. A calibration plot suggests that the sensor can monitor 
between 0.02 and 100 IU/ml of hCG. Unfortunately using one antibody, 
the assay was prone to cross reactivity due to lutenizing hormones. 
However the existence of good monoclonal antibodies against the a  and P 
subunits of hCG and the use of a sandwich type E1IS A assay using labelled 
second antibody rather than labelled hCG, could form the basis of an 
improved biosensor for hCG.
Renneberg et al (1983) have concentrated on the consumption of 
oxygen rather than its production, using a less than simple enzyme linked 
immunoassay for factor VIII related antigen. They have adapted a glucose 
oxidase (GOD) electrode (Updike and Hicks, 1967) to monitor glucose
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produced by an antibody labelled with alkaline phosphatase (AP).
AP
Glucose-6-phosphate + H2 O > Glucose + phosphate
GOD
Glucose + O2  ---------------- > Gluconolactone + H2 O2
The assay appears somewhat cumbersome to perform and 
requires reasonably expensive reagents.
1 .5 .1 .2 . Amperometric enzyme linked immunoassays
A more elegant use of alkaline phosphatase as a label has been 
demonstrated by Doyle et al (1982; 1984). For their model antigen they 
used human serum orosomucoid which is a small glycoprotein of 41 kDa, 
implicated in various malignant conditions (Doyle et al, 1984) and believed 
to be related to carcino-embryonic antigen. This protein was labelled with 
alkaline phosphatase. A competitive reaction was allowed to occur between 
antibody against the orosomucoid protein immobilized on the surface of a 
cuvette and the enzyme-labelled protein after a suitable time period the 
cuvette was washed and substrate solution was added.
1.5.1.3. Amperometric immunoassays utilizing antigens
labelled with electroactive species
In 1979 two groups published on novel homogenous 
electrochemical immunoassays using antigens labelled with an electroactive 
species. In both cases the model antigen used was small. Weber and 
Purdly (1979) labelled morphine with ferrocene. They described their assay 
as a voltammetric immunoassay and monitored the oxidation of their
9
ferrocene morphine conjugate in the presence and absence of the antibody 
against morphine. This formed the basis of a homogenous assay for 
morphine. In the presence of the antibody the oxidation current due to the 
ferrocene-morphine conjugate is reduced.
1.5.2. Potentiometric Sensors
1 .5 .2 .1 . Potentiometric electrode linked immunoassays
These were based on the premise that proteins in aqueous 
solutions were polyelectrolytes and hence, as an antibody is a protein, its 
electrical charge will be affected on binding an antigen. The potential 
difference between an electrode on to which antibody has been immobilized 
and a reference electrode will depend on the concentration of the free 
antigen, assuming that the antibody binding site is free to participate in the 
interaction with the antigen.. For example, levels of the hormone human 
chorionic gonadotrophin (hCG) can be measured in the urine of pregnant 
women using anti-human choriogonadotropin (anti hCG) attached to a 
cyanogen bromide treated titanium oxide electrode (Yamamoto et al, 1978). 
This antibody electrode is reported to respond to solution hCG with a 
positive shift in potential, which is presumbly due to changes in charge 
distribution at the electrode solution interface during the antibody-antigen 
interaction:
anti hCG + hCG < —~~~— ~~~~ > anti hCG - hCG
Riboflavin can be measured with an FAD-cellulose membrane 
(Yao and Rechnitz, 1987). Riboflavin binding protein (RBP) is bound to 
FAD, a riboflavin analogue, on the membrane causing the transmembrane 
potential to increase. Addition of samples of riboflavin displaced RBP from 
FAD due to the higher affinity of riboflavin for RBP. The displacement is
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measured as a decrease in transmembrane potential, proportional to the 
concentration of riboflavin. The method is less time consuming than 
conventional analysis employing high pressure liquid chromatography 
(HPLC).
The potentiometric membrane-based sensor system can be 
applied to the measurement of Candida albicans. Increased levels of the 
micro-organism have been noted when the immune system is suppressed by 
various antibiotics, so it may be a useful indicator of the state of the immune 
response. The standard method is to measure antibody-antigen agglutination 
visually. However, a device has been developed consisting of anti- 
Candida albicans immobilized on derivatized cellulose triacetate, the 
membrane potential changes on binding Candida albicans. This sensor is 
claimed to be more convenient for automated analysis (Cooper and Hall, 
1988).
1 .5 .2 .2 . Ion-selective electrodes (ISEs)
Ion selective electrodes can be adapted for use in immunoassays. 
Indeed a potentiometric ionophore modulation immunoassay (PIMIA) has 
been described by Keating and Rechnitz (1984) for the measurement of 
antibodies. In this assay the corresponding antigen is coupled to an 
ionophore for potassium e.g. cis-dibenzo-18-crown-6 or benzo-15 crown-5. 
The ionophore antigen conjugate is then immobilized in a polyvinyl-chloride 
film containing a plasticiser and mounted onto a conventional ion selective 
electrode. The electrode is then exposed to a constant concentration of 
potassium and a constant background potential is observed. Addition of 
antibody results in binding to the antigen portion of the conjugate present at 
the membrane solution interface and a potential change occurs which is
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proportional to the antibody concentration.
The most promising results in both , owferometric and 
potentiometric assays appear to be in the assays which have been specifically 
designed for electrochemical detection and not in the adaptation of existing 
enzyme immunoassays to electrochemical detection. Although it is possible 
to demonstrate immunosensors in the laboratory environment there may be 
considerable difficulties in commercialising novel immunosensors (Turner 
etal, 1987).
1 .5 .3 . Calorimetric sensors
Calorimetric sensors are based on a general detection principle, 
the measurement of the heat of reaction. Enzymatic reactions, in particular, 
are accompanied by a considerable heat evolution, generally in the range of 
25 to 100 KJ/mol, which makes enzyme calorimetry a highly versatile 
technique.
Although some applications of calorimetry in biochemical 
analysis have been reported (Johansson et al, 1976) Calorimetry has not 
gained widespread use in routine bio-analysis. This might be attributed to the 
high cost and complexity of available instruments and tedious, time- 
consuming operation. Several research groups have attempted to develop 
simple and less expensive calorimeters for routine use with immobilized 
enzymes. A "small volume calorimeter", in which the enzyme was attached 
to a thin aluminium foil placed on the surface of a peltier element as a 
temperature sensor (Pennington 1976), was one of the first instruments 
developed. A drop of the sample was applied on the enzyme layer with the 
amount of substrate detected as a very small temperature change. The
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sensitivity, however, was poor and continuous flow operation was not 
possible.
Calorimetric sensors have been used for determining glucose 
concentrations with either hexokinase or glucose oxidase (with catalase) 
being used. Soluble hexokinase was used in a direct injection a 
enthalpimetric assay for glucose samples in the range of 0.5 to 50 mmol/L 
(McGlothlin and Jordan, 1975). Immobilized hexokinase was used in a 
similar system in the range of 0.5 to 25 mmol/L (Bowers and Carr, 1976). 
The throughput of 40 samples/hour, the accuracy and precision, in addition 
to the long-term stability and reproducibility of the system gave it potential to 
be accepted as a routine clinical instrument for determining glucose 
concentrations.
1 .5 .3 .1 . Thermometric enzyme -linked immunosorbent assay
(TELISA)
The enzyme thermistor can also be applied to a growing area of 
immunochemical analysis. For this alternative procedure, the proponents 
have suggested the name "thermometric1 enzyme linked immunosorbent 
assay (TELISA) (Mattiasson et al, 1977). In principle, the column of the 
enzyme thermistor is filled with an immunosorbent, such as antibodies 
immobilized on Sepharose CL-4B. The antigen to be determined and an 
enzyme (e.g. catalase)-labelled antigen are introduced into the flow; the 
amount of catalase-bound antigen remaining bound to the column being a 
function of the antigen content. The less antigen that is present in the 
sample, the more catalase-labelled antigen will be found in the columns and 
thus evolve more heat after the subsequent introduction of hydrogen 
peroxide, the substrate of catalase, into the flow stream. Sensitivities as 
low as 10 -13mol/L have been obtained to date with the TELISA technique.
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After the determination, the immunosorbent is readily regenerated by a 
glycine wash at low pH and a complete measuring cycle will only take 10-15 
minutes to performed. The advantage of this technique is that occasional 
samples can be rapidly and sensitively analysed in a very simple procedure. 
The TELISA procedure was automated by Birmbaum et al (1986).
1 .5 .4 . Optical Sensors
Optical sensors are devices involving an immobilized reagent 
phase on the end of a single optical fibre or a fibre bundle. Interaction of 
the component being measured (i.e. the analyte) with the immobilized 
reagent phase causes a change in the optical properties of the reagent phase 
which is measured through the optical fibre.
These sensors involve the synthesis of two ideas. One is the use 
of optical fibres to bring light from a spectrometer to and from a sample. 
The other is then use of immobilization as a means of allowing a chemical 
reagent to be used on a continuous rather than a one time basis. While both 
ideas have been applied individually for many years, their combination is 
relatively new and presents exciting possibilities that are just beginning to be 
realized. The use of optical fibres effectively permits the scientist to "bring 
the spectrometer to the sample", while the use of immobilized reagent phases 
makes it possible to chemically analyse the sample for a variety of analytes 
simultaneously if different wavelength of detection are used.
Optical sensors offer advantages relative to electrodes. Among 
these are the fact that no reference electrode is required, they are not subject 
to electrical interference, the immobilized reagent phase does not have to be 
in physical contact with the optical fibre and optical devices are inherently
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safer than electrical devices because there is no chance of electrical shock. 
In general optical sensors have the disadvantage of being subject to 
background from ambient light and having limited dynamic ranges. The 
long-term stability of immobilized reagents subjected to incident light may 
also present a problem (Turner et al, 1987).
Probably the simplest of optical devices use a column change 
reaction linked to a biological analyte, for example, immobilized 
bromocresol green changes its absorption spectrum on binding albumin. As 
a pH indicator, bromocresol green co-immobilized with penicillinase or 
glucose oxidase (GOD) will respond to the decrease in pH that occurs during 
the enzyme reaction. Many other such indicator-dye linked enzyme or 
immuno systems would be suitable for development as simple optical 
sensors (Cooper and Hall, 1988).
1 .5 .4 .1 . Surface plasmon resonance (SPR)
(SPR) is a highly sensitive technique that can be used to follow 
antibody-antigen binding on the surface by monitoring the changes in 
incident light angle required to excite the surface plasmons. The 
manufacturing costs of disposable elements may be quite modest since cheap 
diffraction gratings may be employed (Cullen et al, 1988). The SPR 
approach has considerable commercial potential, having the advantages of 
lack of labels, fast response and simple protocols. Rapid advances are 
being made in reducing it to practice.
1 .5 .4 .2 . Fluorescence capillary fill device (FCFD)
Another highly innovative optical immunoassay method recently 
developed is the fluorescence capillary fill device (FCFD). Along with the
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SPR approach, this has considerable commercial potential lending itself to 
cheap, high volume manufacturing methods. A small glass chamber is used 
as an optical cell which fills with a defined volume of sample of capillary. 
The lower plate of the cell acts as an optical waveguide and fluorescent- 
labelled antigen is printed onto the top plate. This dissolves in the samples 
and competes with antigen in the sample for binding to antibody immobilised 
on the bottom plate. On illumination, the fluorescent light emitted by 
labelled antigen bound to the plate enters the waveguide at all angles whilst 
that from molecules in solution impinges at relatively large angles relative to 
the plane of the waveguide. By measuring light emerging at small angles 
and compensating for solution fluorescence, a rapid, sensitive, one step, 
competitive immunoassay is effected (Higgins, 1989).
1.5.5. Colorimetric sensors
This can be achieved by immobilizing antibody to the solid 
matrix. The immobilized antibody is dipped into a solution containing the 
antigen to be detected. This is followed by dipping the matrix into a 
antibody enzyme conjugate, the bound antibody enzyme conjugate is 
determined by adding a suitable substrate to the enzyme (fig 1.2). The 
biotin-avidin system can be employed in the colo rimetric immunoassay 
(fig 1.3).
The colorimetric sensor can be developed as a homogenous 
immunoassay, as in the case of the pregnancy kit developed by Unipath, 
which does not require washing between steps.
However, these kits are disposable and the reagents may not be 
re-used. The advantage of these sensors is the simplification of the 
analytical procedure.
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Figure 1.2 Schematic representation of colorimetric sensors
using conjugated antibody to enzyme
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Figurel.3  Schematic representation of colorimetric sensors
using biotin-avidin system
Ag Antigen
HRP Horse radish peroxidase
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‘ 1 .5 .6  Future developments
Whilst many new products are expected to be based on 
electrochemical methods, the recent substantial advances in optical 
technology will doubtless soon be expressed in the market place especially in 
the form of immunodiagnostic devices and for DNA probes and other 
nucleic acid-based systems. It is likely that these two transduction 
technologies will remain the most important for the foreseeable future. 
Much work continues on the difficult task of incorporating biosensor 
concepts into microfabricated semiconductor devices, especially with a view 
to developing multianalyte micro-chip biosensors. These are long-term 
development programmes and it is too early to predict whether they will 
eventually compete with or even displace the now more conventional 
printing and optical technologies. Over the next few years, biosensor 
principals developed for clinical purposes can be applied to a wide range of 
other fields, including food quality assessment, fermentation technology, 
process control, military and environmental uses. A particularly promising 
opportunity for biosensor technology, both because of technological 
developments and market needs, is rapid microbial number and type 
assessment in untreated 'field' samples.
A major challenge for the biosensor research and development 
scientist, is the incorporation of the rapid advances in other areas of 
biotechnology into biosensor programmes of special relevance are genetic 
engineering, nucleic acid chemistry, enzymes, catalytic antibodies, protein 
engineering, receptor proteins and developments in immobilisation and 
stabilisation technologies (Higgins, 1989).
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1 .6 . CHOLERA
1 .6 .1 . Epidemiology and extent
The classical form of cholera, Asiatic cholera, appears to have 
been endemic in India and China for many years. In 1966, a distinct biotype 
known as EL Tor began to spread from a new focus , Sulaweze (Celebes) in 
the Western Pacific to other parts of S.E.Asia, the Middle East, South 
European U.S.S.R, Southern Italy and Spain and Portugal (Howe, 1982), 
reaching the African Continent in about 1970, with subsequent annual 
epidemics occuring each summer in South Africa (Turnbull et al,1985).
The early 1970s and 1980s were also significant in terms of 
cholera in Bangladesh .In 1973, the EL Tor biotype was found to have 
completely replaced the classical biotype as the cause of endemic and 
pandemic cholera in the country . However in 1979 , 1980 and 1981, a few 
classical isolates were again detected, and since then the two biotypes have 
coexisted (Samadi et al, 1983). It is a matter of some concern that, should 
cholera reach any of the countries of south or central America, which are 
considered receptive , there would be another dramatic increase in the 
number of countries affected . The consequences of such a calamity are 
unpredictable.
1 .6 .2 . Morphology and laboratory characteristics
In respect of morphology and staining, the vibrios are allocated 
to the family Spirilaceae and characterized as gram-negative slender bacilli (2 
- 2.5pm), sometimes comma - shaped with a pointed end; often arranged in 
pairs or short chains giving a spiral appearance . The vibrios are made 
actively motile by one long polar flagellum and are non- capsulated and non- 
sporing . (Sleigh and Timbury 1986 ). Routine laboratory culture is under
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aerobic conditions and can be performed over a wide temperature range. The 
vibrio favours an alkaline growth medium (pH 8 -8 .2 ) under laboratory 
conditions. Routine laboratory identification is by agglutination. In 
biochemical analyses, fermentation of sucrose and mannose but not 
arabinose is typical of V.cholerae and a distinguishing feature with respect 
to other vibrios.
1 .6 .3 . Cholera toxin
In 1887, Koch proposed that the disease caused by cholera was 
toxin - mediated. However, it was not until 1957 that De and Dutta 
convincingly demonstrated the existence of a cholera toxin.
1 .6 .3 .1 . The molecular nature of the toxin.
Cholera toxin (molecular weight, 84 kDa) is composed of five B 
peptides each with a subunit size of of 1 lkDa, and one A peptide which is 
further divided into Al and A2 components with molecular weight of 24 
kDa and 5kDa respectively. Al and A2 are linked by a single disulfide 
bond. The B subunits bind the toxin to its GM1 ganglioside receptor present 
in mucosal enterocytes. The A2 subunit is believed to serve in holding the 
Al and B subunits together in the biologically active tertiary configuration 
(Levine et al, 1983).
1 .6 .3 .2 . The cholera toxin receptor
The biological action of cholera toxin is initiated by attachment to 
the ganglioside (GM1) receptor on the epithelial cell surface in the gut 
(Cuatrecasas 1973; Holmgren et al, 1973). Such receptors are, composed 
of a lipid portion (sphingosine plus a long chain fatty acid) and 
oligosaccharide portion through which B subunits attach to the cell surface 
(Vaughan, 1983 ). The number of binding sites per cell varies within a wide
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range according to the cell type but affinity of binding is comparatively 
invariant suggesting that the receptor is the same for various cell types.
1 .6 .3 .3 . Membrane penetration and adenyl cyclase activation
Concomitant on B subunit binding to the GM1 receptor, a 
conformational change is believed to occur Moss et.al (1976) showed that 
cholera toxin has ADP- ribosyltransferase activity, that is, it catalyses the 
reaction:
NAD+ acceptorprotein >ADP ribose acceptorprotein+nicotinamide+H+
The specific substrate protein which is ADP ribosylated has
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been identified as the guanyl nucleotide.^, Cassel and Selinger0977 ) have 
shown that adenyl cyclase is active while GTP is bound to GTP- binding 
component but reverts to an inactive state as GTP is hydrolysed to GDP by 
GTPase; cholera toxin blocks the GTPase action which stabilizes adenyl 
cyclase in an active conformation. Another way stimulation of adenyl cyclase 
is that inhibitory GDP is replaced by stimulatory GTP at a rate higher than 
that of hydrolysis of GTP to GDP. Elevated levels of cyclic AMP modify 
the nature of the cell membrane, resulting in outward secretion by crypt cells 
and cells of the sides of villi and decreased absorption by villus tip cells 
(Levine et al, 1983), the secretion fluid is low in protein and rich in 
electrolytes, including Na+ , K+ , CL' and HCO"3 .
1 .6 .4 . Pathogenesis
Man is the only natural host of the cholera vibrio and the spread 
of the infection is from person to person, contaminated water, uncooked 
seafoods or vegetables are the most common vehicles. (McIntyre et al,
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1979).The sequence of events leading to cholera are basically simple and 
confined to the gut. After passing the acid barrier of the stomach juices, the 
organisms begin to multiply in the alkaline medium of the enterocytes of the 
small intestine. As they multiply, they produce the potent exotoxin 
(enterotoxin) which stimulates a persistent outpouring of isotonic fluid by 
the gut mucosal cells.The low pH of the stomach mucus membrane and the 
peristalsis of the small intestine serve as a natural barriers to the infection 
(Staniner et al, 1986).
It has been suggested that proteolytic enzymes produced by the 
vibrio might be involved in the establishment of cholera infection, by 
causing erosion of the normal intestinal mucus barrier (Crowther et al, 
1987).
1 .6 .4 .1 . Clinical infection
Cholera is typically characterised by the sudden onset of 
effortless vomiting and profuse watery diarrhoea . Vomiting which may 
cause death in 12 to 24 hours are related mainly to the profuse " rice water " 
stools - watery and colourless, with flecks of mucus and a distinctive sweet, 
fishy odour and containing little (0.1%) protein (Mackie and McCartney
1980).
1 .6 .5 . Treatment of cholera
On the basis of present understanding of the biochemical events 
initiated by cholera toxin possibilities for specific intervention include
(i) Prevention of entry of the A subunit - a strategy usually regarded 
as impracticable as this event occurs before the onset of symptoms.
(ii) The use of purines and their analogues to alter the NADase action
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of cholera toxin.
(iii) The use of alternative acceptors, such as arginine or imidazoles, 
for the ADP-ribose generated by the toxin.
Several drugs have been found to inhibit the secretion induced by 
cholera toxin in experimental animals example, chloropromazine, nicotinic 
acid and aspirin (Holmgren,1981). Although some antibiotics are used for 
cholera vibrios (Chatterjee, 1986), sulphonamides, penicillin, and 
streptomycin have no value in cholera therapy (Schuhardt, 1978). 
Bacteriophage or serum treatment have not proved to be of any therapeutic 
value (Chauduri,1971).
1 .6 .5 .1 . Rehydration therapy
In 1964 Phillips reported that the oral administration of a glucose 
containing solution could reduce net stool output of patients with cholera. 
Oral glucose electrolyte solution therapy is of value in the treatment of 
cholera and the requirement for expensive and scarce intravenous fluids can 
be reduced (Hirschhom et al 1968). It has been shown that with the use of 
orally administered glucose containing electrolyte solutions it has been 
possible to maintain satisfactory water, electrolyte and acid-base balance in 
most patients with severe cholera during stool output of up to 800 ml/hour 
for a period of 12 hr by replacing stool losses only with such a solution . 
However in severely affected patients hypovalemia usually occurs and this 
cannot be maintained by oral fluid so that correction by rapid administration 
of intravenous fluid is essential for survival. (Pierce et al, 1969).
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1 .6 .6 . Prevention of cholera
It is possible to prevent cholera by taking sensible precautions the 
risk can be reduced. As most infections are contracted from food or drink 
care should taken with these and in particular with salad and fruits. Good 
sanitation and personal hygiene is required for the control of the disease, and 
clean water supplies and safe disposal of human sewage can reduce the 
number of affected patients. However in endemic and epidemic areas in the 
world control of the disease is currently practically impossible.
1 .6 .7 . Antigen stimulated immunity to cholera
Studies in volunteers support the notion that antibacterial 
mechanisms play a role in immunity to cholera (Levine et al, 1979) . 
Antibody is presumed to interfere with the mucosal association of the 
V.cholerae cell wall lipopolysaccharide. Outer-membrane proteins and other 
antigens have been implicated, but the important protective antigens have not 
yet been defined. The identification of such antigens and the assessment of 
establishment and experimental vaccines require the use of in vivo methods 
.V. cholerae infection in rabbit ileal loops (Freter, 1964) and infant mice 
(Ujiiye and Kobari 1970 ) have yielded a wealth of information on 
pathogenesis and immunity in cholera, but have not been used extensively in 
studies on actively induced antibacterial immunity (Gay et al, 1983).
1 .6 .8 . Vibrio cholerae cell envelope components and
immunity
1.6.8.1. Outer membrane proteins
The outer membrane contains a major protein (OMP) of 
molecular weight 48 kDa , present in all biotypes (Classical and EL T or) 
and serotypes (Ogawa and Inaba) of V.cholerae. It has been suggested that
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the 48kDa protein is the common outer membrane antigen of V.cholerae 
(Kelly and Parker, 1981) . Kabir has suggested that the outer membrane 
48kDa protein is immunologically important and possibly a protective 
antigen (Kabir 1983). The outer membrane is strongly immunogenic and 
antibodies to it are readily detected in convalescent sera (Manning, 1987). 
However the role of these proteins in pathogenesis and the extent to which 
they represent protective antigens has not been determined. The study of 
Sears et al,(1984 ) indicates that there is a human IgG response to OMP 
during clinical cholera infection, that this response is constant among bio- 
and serotypes, and that at least 50% of volunteers who experienced clinical 
illness exhibit significant antibody rises. The search for these proteins is 
likely to continue since antibodies to the protective proteins are believed to be 
more protective on a weight basis than antibodies to LPS (Neoh and 
Rowley,1970).
1 .6 .8 .2 . Flagellum
Antibodies to the flagellum are also considered to be important. 
Yancey et al (1979) and Eubanks et al (1977) have described non LPS 
protective antigens associated with the flagellum Hamitsky et al (1980) 
characterised a flagellum sheath protein and demonstrated that antibodies to 
this protein could react with a variety of strains. They suggest that this 
protein may represent the common vibrio H antigen, present on both the 
flagellum and the outer membrane. The sheath is identical to and continuous 
with the outer membrane and this may be the flagellar protective antigen . 
Evidence for adhesion by means of the flagellum comes from electron 
microscopic observation showing vibrios attaching to the epithelium 
terminally with the flagellum directed towards the mucus (Nelson et al, 
1976).
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1 .6 .8 .3 . Fimbriae
Tweedy et al (1969) reported the presence of fimbriae on some 
vibrio species and correlated haemagglutinating capacity with the possession 
of fimbriae. A direct relationship between possession of fimbriae, 
haemagglutination and adherence to brush-borders has not, however, been 
shown for V.cholerae (AL-Kaissi and Mostratos,1985). Ehara et a\ (1987) 
have purified fimbriae and shown them to have a subunit molecular weight 
of 16kDa By analogy with Escherichia &oli it could be expected that 
antibodies to fimbriae would be protective (Tramont and Boslego,1985). 
No evidence for this is at present available.
1 .6 .8 .4 . Lipopolysaccharide (LPS)
Purified LPS induces significant protection against cholera in 
humans and experimental animals (Holmgren and Svennerholm,1977). 
Cooper and Narendranthan (1986) suggested that resistance to mucosal 
association induced by LPS depends on continued output of anti-LPS 
antibodies into the intestine via the mucosal surface. Anti LPS antibodies in 
saliva and breast milk samples may be useful in monitoring gut mucosal 
responses to naturally acquired cholera or enterotoxigenic E. coli where 
they are endemic (Jertbom et al, 1986). Failure to detect anti LPS antibodies 
does not exclude their involvement in induction of immunity to mucosal 
colonisation (Narendranthan et al, 1988 ).
1 .6 .8 .5 . Haemagglutinins (HA)
There is some evidence that the cell-bound haemagglutinins on 
V.cholerae are also responsible for adherence of cholera vibrios to 
intestinal epithelium. The nature of V. cholerae haemagglutinins is still 
incompletely understood (Holmgren et al, 1983). Little direct information
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is available on the significance of the haemagglutinins as protective 
antigens, but it has been demonstrated that pre-treatement of rabbit gut with 
soluble haemagglutinin prevents adherence of vibrios (Finkelstein and 
Hanne,1982). However Sevennerholm et al (1984) observed a poor local as 
well as systemic immune response to soluble HA in both North American 
volunteers and Bangladeshi cholera patients.
1 .6 .8 .6 . Antitoxin antibodies
Animals studies have demonstrated that anti-toxin immunity can 
be effective in preventing disease. The effectiveness of toxoid vaccine has 
been shown in man in a field trial in Bangladesh, where it stimulated high 
titres of circulating antitoxin but resulted in low- grade immunity lasting 
only three months (La Brooy and Rowley, 1983). Approximately 60% of 
volunteers who participated in experimental cholera studies manifested 
increased levels of secretory IgA antitoxin in intestinal fluid measured before 
and a few days after challenge (Levine et al, 1981). Isolated antibodies to the 
B subunit have considerably higher cholera toxin neutralizing activity than 
antibodies to the A subunit (Peterson et al,1979).
1 .6 .9 . Local organisation of the intestinal immune system.
Intestinal colonisation with virulent V. cholerae 01 stimulates 
substantial lasting immunity against reinfection to the heterologous as well as 
the homologous serotype (Cash et al, 1974). In addition, naturally acquired 
immunity to cholera among persons living in endemic areas increases with 
age , due to repeated accidental ingestions of viable V.cholerae and the 
incidence of disease decreases rapidly with age (Gangarosa et a/,1975 ).
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Antigens in the gut appear to make initial contact with the gut 
immune system after being absorbed by pinocytosis through the modified 
epithelium overlying Peyer’s patches. Lymphoblasts triggered by the antigen 
migrate through the gut lymphatics, mesenteric nodes and thoracic duct to 
enter the systemic circulation (Parrott and Furguson, 1974). They then 
move preferentially to the lamina propia of the gut where, as mature plasma 
cells , they secrete immunoglobulins, particularly dimeric IgA . This enters 
the gut lumen to interact with the antigen.
The protection against V. cholerae is mediated by intestinal 
secretory IgA antibodies (Cray et al, 1983) . Pre-existing secretory 
antibodies may prevent mucosal colonisation by binding to superficial 
colonisation factor antigen (Finkelstein and Hanne,1982) or by immobilising 
or agglutinating bacteria so that they cannot migrate efficiently to the 
epithelial surface. A second possibility, is that secretory antibodies have a 
bacteriocidal effect, directly inhibiting bacterial multiplication (Schrank and 
Verway 1976) . Vibrocidal antibodies are detectable in about 35% of 
children during their first decade and persist throughout life. Consequently 
in adults, the infections are often asymptomatic or cause only mild diarrhoea, 
as a consequence of the development of an adequate immune response from 
prior exposure (Glass et al, 1985).
1 .6 .1 0 . Secretory immunity to cholera after infection.
An attack of cholera confers short lived immunity to reinfection. 
Within a few weeks after onset of the disease, there is a rise of both serum 
antibodies (agglutinins [IgM], vibriocidal antibody [IgM], antitoxin [IgG] 
and coproantibody PgA]), which persist for three months, but fall to low 
titer thereafter (Chatteijee, 1981). Levine and his colleagues (1981) found
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that immunity of volunteers to re-infection with 10^ cholera vibrios persisted 
for 33-36 months. Little is known, however, about the factors responsible 
for immunity (Wilson, 1984). In man, studies in East Pakistan have revealed 
good correlation between the titre of vibriocidal antibodies and a fall in the 
attack rate from cholera (Mosley 1969; Neoh and Rowley, 1970) but further 
observations seemed to show that the degree of protection could not be 
related to the vibrocidal titer of the serum (Mosley et al, 1972). Levine et 
al (1979) subsequently showed that an initial clinical infection due to 
classical vibrios of either serotype led to complete protection upon 
subsequent challenge with classical vibrios of the heterologous as well as 
the homologous serotypes.
Further studies by the same group on the immunity conferrred 
by clinical infection with EL Tor vibrios, showed that initial infection with 
V.cholerae EL Tor also provided protection against rechallenge with EL Tor 
vibrios of either homologous or heterologous serotype.
1 .6 .1 1 . Vaccines against cholera
1.6.11.1. Killed whole cell vaccines
The whole cell cholera vaccines give only partial immunity for 
less than six months and offers only marginal protection. The whole cell 
vaccines probably fail because they lack any toxin derived antigen.
1.6.11.2.ParenteraI whole cell vaccines.
Parenterally administered whole cell vaccines currently in use 
have been found to afford only short term protection in controlled field trials 
(Azurin et al, 1967). The precise reason (s) for poor vaccine efficiency 
remain unknown. However possible explanations include poor vaccine 
immunogenicity, and the limited ability of parenterally administered vaccines
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to evoke a protective gut immunity (Cryz et al, 1982). In addition, 
parenteral immunisation is followed predominantly by the synthesis of 
systemic IgG Abs. The major function of these IgG Abs is neutralisation of 
antigens in blood and extravascular fluids. Only a small fraction of IgG is 
excreted in mucosal secretions (Pierre etal, 1988). However there is some 
evidence to suggest that parenteral whole cell Inaba vaccine provides good 
short term protection against Ogawa as well as Inaba (Mosley et at, 1973), 
whereas Ogawa vaccine is effective only against Ogawa (Philippines cholera 
committee, 1973).
1.6.11.3.Oral whole cell vaccine
Oral vaccines consisting of killed cholera whole cells (wc), have 
yielded promising results in stimulating intestinal antibody formation in 
Bangladeshi volunteers and in protecting North American volunteers against 
a challenge with virulent vibrio cholera 01 (Clemens et al, 1986). The 
protective efficiency of oral vaccines is attributed to the fact that only enteric 
immunization elicits the production of IgA antibodies (Abs) which are 
actively transported on mucosal surfaces and into exocrine secretions, where 
they are well suited for active function being more resistant to denaturation 
(Kobayashi et al, 1974) and proteolytic breakdown (Lind, 1975) than IgG 
antibodies.
1.6.11.4.Combination vaccines
Vaccines consisting of a combination of antigens are intended to 
stimulate both antibacterial and antitoxic immunity giving protection 
additional to that provided by either antigen alone (Holmgren and 
Svennerholm, 1977). Recently Jertbom (1988) has developed an oral 
vaccine consisting of the purified B subunit from cholera toxin and killed
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cholera vibrios. This B subunit -whole-cell cholera vaccine (B+Wcv) was 
found to stimulate mucosal IgA antibody responses to cholera toxin and 
bacteria (lipopolysaccaride) in the intestine which closely resembled the 
antibody responses seen in convalescents from the disease. The vaccine gave 
rise to serum IgG subclasses as well as IgA antitoxin . The study of Jertbom 
indicates the presence of immunological memory for immunity to cholera 
toxin and possibly also cholera bacteria in Swedish adult volunteers who 
were immunized with an oral cholera vaccine five years earlier. Such 
memory is obviously important for long lasting protective immunity against 
cholera.
1.6.11.5.Toxoid vaccines
Toxoid vaccines protecting against cholera by stimulating 
antitoxic immunity include, formaldehyde or glutaraldehyde-treated cholera 
toxin and purified B subunit (with or without formaldehyde). A large-scale 
field trial with this toxoid was carried out in the Phillipines and Bangladesh 
but the vaccine showed limited efficiency . Pierce (1978) showed that the B 
subunit is particulary well suited to oral immunization because it retains the 
ability to bind to the intestinal epithelium, which has been shown to be 
important for stimulating mucosal immunity in animals.
1.6.11.6 .A tten u a ted  V .C h o le ra e  vaccines
The immunological control of cholera may also be achieved by 
means of attenuated non-enterotoxigenicV.Cholerae strains as an oral 
vaccine, has been shown by in North American studies demonstrating that 
classical and EL Tor infection stimulate protection for at least 3 years (Cash 
et al, 1974; Levine et al, 1981). As a result of these observation, the most 
promising approach would seem to be toward immunological control of
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*cholera by means of attenuated non-enterotoxigenic V.Cholerae strains used 
as oral vaccines.
1.6.11.7.Naturally occuring strains.
Non toxinogenic V. cholerae 01 strains isolated from 
environmental sources in India and Brazil have been evaluated in volunteers 
as potential vaccines with disappointing results (Levine et al ,1982). They 
failed to provide protection in experimental challenge studies.
1.6.11.8.Chemically mutagenised attenuated strains
Finkelstein et al (1974) mutagenised classical Inaba 569 B with 
nitrosoguanidine, leading to isolation of a hypotoxinogenic mutant. In 1979 
Honda and Finkelstein mutagenised EL Tor Ogawa 3083 with 
nitrosoguanidine and produced the Texas Star-SR strain. This strain 
produces normal or increased amounts of B subunit but is negative in assays 
for holotoxin activity or A subunit activity . Texas Star-SR has been 
extensively evaluated in human volunteers as a live oral vaccine (Levine et 
al, 1984 ) . One or two doses of vaccine provides a moderate degree of 
protection (61% vaccine efficiency) against experimental challenge with 
inocula of V. cholerae EL Tor of either serotype causing cholera in 70-80% 
of control volunteers . However, the Texas Star strain suffers from certain 
drawbacks. Firstly, the method of attenuation, mutagenesis with 
nitrosoguanidine , induces multiple mutations, not all of which are 
recognised . Secondly, the precise lesion presumed to be responsible for 
the attenuation of Texas Star is not known and consequently, until this is 
clarified there remains the theoretical possibility of reversion to virulence.
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1.6.11.9.Vibriophage-induced mutants.
Mekelanos et al (1982) used mutagenic bacteriophages to detect 
DNA sequences encoding cholera toxin . Deletion of such sizable amounts 
of DNA eliminates the possibility of reversion and yields stable, 
nontoxinogenic strains of V. cholerae. So far, no mutants derived by this 
method have been evaluated in volunteers , nor have reports of efficency 
studies in animal models been published.
1 .6 .1 2 . Antigenic structure 
1.6.12.1.SeroIogy
Two serotypes of V.cholerae, Ogawa and Inaba have long been 
recognised. These share a common, heat stable, somatic A antigen . Ogawa 
possesses an additional somatic antigen B (AB), whereas Inaba has an 
additional somatic antigen C (AC) (Gustafson et al, 1982). Vibrios have a 
single heat-labile flagellar H antigen which is the same in many cholera 
vibrios.
Burrows et al (1946) reported a third serotype, Hikojima, 
with somatic antigens A , B and C . Thus by using three monospecific 
antisera for the somatic antigens (anti A , anti B , anti C) a cholera isolate 
may be identified as to serotype by three single agglutination tests . 
Occasional vibrios may possess only the somatic antigen A .
Gardner and Venkatraman (1935) divided vibrios into six 
serologically defined groups based on differences in the heat-stable cell wall 
(O) antigens. The cholera vibrios including the haemolytic EL Tor strains , 
were included in O subgroup I , and non-cholera or non-agglutinable vibrios 
(NCV or NAG) were placed into O subgroups II to VI . Sakazaki et al
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(1970) extended the number of serologically distinguishable O subgroups to 
39 . They suggested that the O groups be referred to as serovars (Serological 
variety of a single serotype), and that the Inaba form was derived from 
Ogawa by the loss of somatic antigen B (Sakazaki and Tamura, 1971). By 
1977 they had reported the existence of 60 serovars of V.cholerae. In 1979, 
Smith reviewed the updated status of serotyping system and reported the 
existence of 72 serotypes. He found that 2% of vibrio strains tested either 
did not agglutinate or spontaneously agglutinated in the vibrio reference 
laboratory system (VRL).
Both in vivo and in vitro serotype variations have been reported. 
Moreover vibrios have been isolated from the human enteric tract that do not 
agglutinate in any of the antisera . The serotype antigenic structure may 
therefore change within the human gut (Sleigh and Timbury, 1986).
1.6.12.2.The structure of V.cholerae LPS
Jackson and Redmond (1971) performed immunochemical 
studies on the LPS from strain Inaba 569B. The major components 
identified in the LPS were heptose, glucose, glucosamine, mannose and 
glycerol. Lipid A accounted for 30% of the weight of LPS . Galactose and
2-keto-3-deoxyoctonate (KDO) which typically links lipid A and the 
polysaccharide moieties were not detectable and it was suggested that the 
structure of the "core" LPS of V.cholerae may be fundamentally different 
from that of the Salmonella species.
Jann et al ( 1973 ) also reported the absence of KDO in 
V.cholerae LPS and extended their study to confirm that KDO is not present 
in any of the V.cholerae strains they tested namely , the S-forms of Inaba
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and Ogawa, EL Tor and Hikojima, and the R-forms of Inaba and Ogawa. 
However, they detected fructose in all these LPS molecules and suggested 
that KDO may be replaced by fructose . They were also successful in 
isolating 2-amino-2,6-dideoxyglucose (quinovosamine). The role of this 
amino sugar in the serological specificity was defined.
Redmond (1975) detected an oligosaccharide in addition to 
monosaccharides in the hydrolysed product of Inaba 569B LPS. This 
oligosaccharide required harsher conditions of hydrolysis to yield 
monosaccharide and was identified as 4-amino-4,6-dideoxy-D-mannose 
(perosamine) by NMR studies.The perosaminyl oligomer was thought 
to represent the main sugar component of V.cholerae LPS . On further 
analysis of vibrio LPS the presence of another highly unstable sugar, 4- 
amino-4-deoxy-L-arabinose was detected (Redmond, 1978). The sugar was 
present only in Ogawa LPS and not in Inaba LPS .
Raziuddin and Kawasaki ( 1976 ) analysed LPS extracted from 
cell walls of Inaba 569B and EL Tor Inaba . They found that among the 
characteristic components of gram-negative bacterial LPS , heptose 
phosphate was present but galactose and KDO were not detected . On the 
other hand, fructose was present.
<5 :hiosh and Campbell (1985) demonstrated that unlike E .coli and 
Salmonella typhimurium LPS, V.cholerae LPS has a highly restricted 
preferred range of repeating units , starting well above the one repeat shown 
by these other molecules and that the size of the repeating unit is very small.
Recently Fuerst and Perry (1988 ) used monoclonal antibodies 
against the LPS of V.cholerae 0:1 with protein A-gold particles as a
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markers and demonstrated that the LPS determinants were specifically 
associated with the flagellar sheath. The LPS antigenic pattern of the sheath 
flagellum corresponded to that of the of the outer membrane of the cell wall
1.6.12.3.The composition of lipid A of V.cholerae LPS .
In enterobacterial LPS , glucosamine represents the backbone of 
lipid A, carrying the long chain hydroxy acids in ester or amide linkage 
(Hammond et al, 1984) .The lipid A part of V .cholerae Ogawa 395 LPS 
contained only D-glucosamine residues . No other sugar residues were 
detected in i t . There is similarity in the distribution of fatty acids among the 
members of genus vibrios . The presence of ester-linked 0 2 ^ - 0  as a major 
hydroxy fatty acid is a unique feature for the lipid A part of the vibrio family 
(Kabir,1982). Further characterisation of the lipid A by Raziuddin (1977) 
indicated that approximately equal amounts of fatty acids C ^ .q  , Cqg.i and
3-hydroxy lauric acid were involved in ester linkages , but 3-hydroxy 
myristic acid was the only amide-linked fatty acid.
1.6.12.4.Immunological properties of V. cholerae lipid A .
The LPS and lipid A moieties prepared from V.cholerae EL Tor 
exibited almost equal endotoxic and anti-complementary activities 
(Raziuddin, 1978). It was demonstrated that the lipid A represented the toxic 
centre of V.cholerae LPS as had been observed with other gram-negative 
bacterial LPS molecules (Peavy et al, 1973; Rietschel et al, 1975 ; 
Mansheim et al, 1978). The toxicity of lipid A from V.cholerae EL Tor 
decreased following alkaline digestion which primarily hydrolyses the ester 
linked fatty acids of the lipid A portion of LPS . These results indicated that 
ester linked fatty acids play a crucial role in toxicity. Luderitz et a l, (1973) 
^ suggested that the presence of acylated hydroxy fatty acid esters may
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determine the endotoxicity of the LPS .
1.6.12.5.The polysaccharide content of LPS of V.cholerae
Kenne et al,(1979) hydrolysed V.cholerae into the lipid A and 
polysaccharide ( PS ) portions. The (PS) was isolate from the hydrolysate 
by gel filtration and hadd molecular weigt of 9 kD a. After hydrolysis with 
acid, glucose and heptose were obtained which account for only a small part 
of the PS . Acid hydrolysis also released an acid that was identified as 3- 
deoxy-L-glycero-tetronic acid ( 5-2,4-dihydroxybutanoic acid). He also 
proposed that the O-antigen of V.cholerae serogroup Inaba LPS contains a 
homopolysaccharide composed of monomer residues of 4-amino-4,6- 
dideoxy-D-manno-pyranosides.
Raziuddin (1980) characterised the water soluble polysaccarides 
by fractionating them on a column of Sephadex G-50. The eluates were 
monitored for phosphorus and carbohydrate.Two main peak differing in 
molecular size were obtained from all different strains of V.cholerae LPS 
tested. When each of these peaks were rerun separately on the same column, 
both were observed to move in their original positions. Detailed analysis of 
the two peaks showed that high molecular weight protein fractions did not 
contain phosphorus and heptose whereas phosphorus and heptose were 
detected in the low molecular weight fractions. On(; the basis of 
haemagglutination asssays the high molecular weigh heptose-free fractions 
were identified as O-specific side chain and low molecular weigh heptose- 
contai ning fractions as core polysaccaride region of the LPS. Glucose, 
heptose, fructose, phosphate and ethanolamine-phosphate were found to be 
concentrated in core polysaccaride, whereas mannose, rhamanose, 
glucosamine, D-quinovosamine and D-perosamine were concentrated in O-
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specific side chain.
Hisatsune and Kondo (1980) showed in their comparative 
studies between the rough (R) and smooth (S) form of V.cholerae that S-R 
mutation of cholera vibrios involves the total elimination of the amino sugar 
component quinovosamine and perosamine from the S-form 
lipopolysaccharides regardless of the serotype of their S parent strain , and 
that the perosamine present in S-form lipopolysaccharides is involved in the 
01 specifity of S-form lipopolysaccharide of cholera vibrios, thus 
supporting the above proposal of (Kenne et al ,1979) for the chemical 
structure of the O-antigenic polysaccharide of V.cholerae LPS .
Kenne et al (1982) demonstrated that O-antigen is composed of 
simple repeating-units, as observed for other gram-negative bacteria. 
However the part connecting lipid A with the O-antigen differs considerably 
from the cores observed in other Gram-negative bacteria , and is not well 
defined. The polymer with the repeating unit N-acetylated perosamine most 
probably represents the LPS antigen determinant A common to Inaba and 
Ogawa , a conclusion consistent with the results of haemagglutination - 
inhibition. The nature of the determinants B and C, specific for Ogawa and 
Inaba, respectively, are still obscure.
Kabir (1982) analysed V.cholerae 395 Ogawa LPS after 
splitting it into the polysaccharide and lipid moieties and detected glucose , 
heptose and fructose. It is possible that fructose maintains the necessary 
weak linkage between the lipid A and the polysaccharide component of LPS. 
He also detected an acid-labile amino sugar, 4-amino-arabinose. This sugar 
might chemically distinguish the Ogawa from the Inaba serotype. It is 
possible that any mutation which blocks the biosynthesis of 4-amino- 
arabinose results in a conversion from the Ogawa to the Inaba serotype .
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Sen et al, (1979), using methylation studies, obtained results 
which indicated that the nonreducing ends of LPS extracted from Inaba 
569B were occupied by glucopyranosyl and heptopyranosyl residues. They 
also observed the presence of two types of heptose residues, of which a 
large amount behaving like D-glycero-L-manno-heptose is located at the 
nonreducing end of the molecule. One or both heptose residues were thought 
to be located in the interior of the molecule. One of them had (1—>2) linkage 
and the other was branched. The 2-amino-2-deoxyglucose residue detected 
was also suggested to be present in the interior part of LPS as (l->4) linked 
residues.
Brade ( 1985 ) reinvestigated the presence of KDO in both 
Ogawa and Inaba serotypes of V.cholerae .KDO in V.cholerae LPS was 
identified by gas-liquid chromatography and mass spectrometry . In this 
study it was shown that KDO phosphate is a constituent of the LPS of both 
V.cholerae Ogawa and Inaba .This compound is liberated under harsh 
conditions and can be dephosphorylated subsequently by the action of 
alkaline phosphatase. The results indicated that at least two different KDO 
phosphates are present in the hydrolysate . One of them was identified as 
KDO-5-phosphate, other as 7-or 8 - phosphate. Thus the lack of KDO was 
shown not to be a taxonomical criterion for the members of Vibrionaceae.
Kenne etal (1988) investigated the structure of O-antigen from 
Vibrio cholerae  0:2 and showed that the PS was composed of a 
trisaccharide repeating unit containing 2-amino-2,6-dideoxy-p-D-glucose , 
p-D-galactose , and a third sugar . The last component should be a ketose 
with one carboxyl group , one methyl group , one methylene group , and
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two carbon atoms carrying nitrogen.
Kaca et al (1988) investigated the LPS of three serotypes of 
V.cholerae and detected the disaccharide moiety of methyl 7-0-( 2-amino-2- 
deoxy-a-D-glucopyranosyl )-L-glycero-D-manno-heptopyranoside.
It is clear from the data reviewed above that the structure of 
V.cholerae LPS is not yet fully understood and many features remain 
unresolved.
1.6.12.6.Antigenicity of core LPS
Anti-core antibodies have gained importance because of their 
potential to react with a broad spectrum of gram-negative bacteria , thus 
offering wide range protection for immunosuppressed patients (Marks et 
al, 1982 ; Teng et al, 1985; McCabe e t a l , 1977). Several research groups 
have now produced MCAbs against some components of core LPS (Nelles 
and Niswander , 1984 ; Mutharia et a l , 1984; Lind et a l , 1985). A new 
type of common antigen located in the inner core region of LPS has been 
detected in a variety of gram-negative bacteria (Brade and Galanos, 1983a). 
Immunochemical investigations have shown the new antigen to be an 
a - 2 —>4 interlinked 3-deoxy-D-manno-octulosonic acid (dOcIA) 
disaccharide (Brade and Galanos,1983b ;Brade and Rietschel ,1984) which 
has also been detected in the Ogawa and Inaba serotypes. Previous studies 
have indicated that production of antibodies against lipid A required 
immunisation of animals with bacteria coated with acid hydrolysed lipid A 
(Bruins et a l , 1977 ; Galanos et al, 1971 ; Johns et al, 1977 ) .  However , 
anti-lipid A MCAbs have been raised by (Mutharia et a/,1984) by using 
whole heat-killed E .coli J5 cells for priming mice before removal of their
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spleens for fusion.
Gustafsson et al (1982) have produced a MCAb directed against 
the core region of V.cholerae LPS.These antibodies were inhibited by LPS 
preparations of both serotypes of 0 1  group of vibrios and some non- 0 1  
group of vibrios as detected on ELISA. Unrelated bacterial LPS molecules 
were unable to inhibit the MCAb . Thus according to the authors that the 
MCAb was directed against an antigen present only in V.cholerae.
1 .2 .1 3 . Cross-reaction of antibodies to V .c h o le ra e  with
bacteria of other genera .
Many investigators have observed serologic cross-reactions 
between Brucella and V.cholerae (Mathur et al, 1960 ; Eisele et a/,1948). 
Eisele et a/,1946 and McCullough et al, 1948 attributed the cross-reaction 
to a flagellar H antigen of V.cholerae that is related to a somatic antigen in 
Brucella. Gallut (1953) ascribed the cross-reaction to heat-stable somatic O 
rather than H antigens of V.cholerae. Feeley (1969) examined the antigenic 
relationship between Brucella species and V.cholerae by agglutinin and 
agglutinin-absorption tests by using rabbit antisera . He observed that 
Brucella antisera agglutinated only the Inaba serotype of V.cholerae at low 
titers . The Inaba reactive antibodies were absorbed by either heat-stable 
Ogawa or Inaba O-antigens . Anti-cholera antisera from rabbits immunised 
with either O or HO antigens of either Ogawa or Inaba contained Brucella 
agglutinins . This activity was absorbed completely from Ogawa antiserum 
by either Ogawa or Inaba O antigens but only partially from Inaba antisera 
by the Ogawa O antigen . Thus the author concluded that the cross-reactive 
antigen is a heat-stable O antigen and is more dominant in the Inaba than in 
the Ogawa serotype of V.cholerae
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Barua and Watanabe (1972) described the production of 
vibriocidal antibodies against V.cholerae, particularly the Inaba serotype, in 
Yersinia enterocolitica immunized rabbits or infected humans. Y. 
enterocolitica serotype 0:9 has been regarded as strongly cross-reacting with 
the Brucella species (Ahvonen and Sievers, 1969).
The serological cross-reactivity between Y .enterocolitica 
serotype 0:9 and the LPS of V.cholerae and Brucella species have now 
been related to the presence of N-acylated 4-amino-4,6 dideoxy-a- 
mannopyranisyl residues in their respective O-antigenic chains (Caroff et al, 
1984a; Caroff et al, 1984b). Bundle et al (1984) confirmed the serological 
cross-reactions between Br. abortus and Y.enterocolitica with MCAbs . 
Since V.cholerae 01 shares a very similar O-chain structure with 
Br.abortus and Y. enterocolitica 0:9 differing only in N-acyl grouping, the 
anti-7, enterocolitica and anti-5, abortus MCAbs were tested with Ogawa 
and Inaba LPS on ELISA by the authors . Ascitic fluid from the MCAbs 
failed to reveal significant binding at dilutions of 1 in 1 0 0  , whereas the 
binding to Br. abortus and Y.enterocolitica was at dilutions in the order of 
1 to 10,000 . This contrasted with previous observations with polyclonal 
antisera (Barua and Watanabe, 1972 ; Sandulache and Marx, 1978) . The 
authors therefore concluded that although some vestige of recognition 
existed for the polysaccharide, the nature of the N-acyl group on the 
backbone sugar was crucial to the binding of these MCAbs.
Ghosh and Campbell (1986) studied the behaviour of six rat 
monoclonal antibodies to Inaba,and Ogawa in several assay systems. They 
reported three anti Inaba antibodies, specific to Inaba by ELISA, which 
cross reacted in some other assays not only with Ogawa but also with
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Br.abortus. In addition, while two of three anti-Ogawa antibodies, specific 
to Ogawa by ELISA, failed to agglutinate any bacteria while the third anti- 
Ogawa, 03D1, also totally specific to Ogawa on ELISA or 
immunofluorescence, failed to agglutinate Ogawa but agglutinated Inaba.
The electrophoretic analysis of V.cholerae LPS indicates that the 
size of the repeating O chain region is exceedingly small (Ghosh and 
Campbell, 1985). Consequently antibodies to the two serotypes might be 
expected to cross react extensively in their combination sites (Ghosh and 
Campbell, 1988).
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1.6.14 Objective of the study
Enteric bacterial infection, causing diarrhoea, dysentry, and enteric 
fever, are important health problems throughout theworld. Among the most 
important enteric bacterial pathogens is V.choleraethz etiologic agent of 
cholera disease which represent a notable burden, in particular for children 
living in less-developed regions of the world; it also pose a risk for 
travellers from industralized countries who visit less-developed areas.
To date, serological identification of V.cholerae 01 has primarily 
been performed by slide agglutination of bacteria suspended in polyclonal 
antisera. However, any technique used including culture of the bacteria 
requires laboratory equipments, trained people and time for the assay to be 
performed. Rapid identification of the agent can profoundly affect the 
subsequent course of a potential epidemic outbreak.
The study was undertaken in order to try to design a rapid and easy 
system for detection of V.cholerae using monoclonal antibodies, the 
system mew^to be used by untrained persons in the field without need of 
laboratory equipments.
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CHAPTER 2 
MATERIALS & METHODS
2.1. MATERIALS
The materials used during the course of this study are listed below 
with the name and the address of their supplier.
2.1.1. Cell culture materials
RPMI-1640 medium, Foetal calf serum and penicillin / streptomycin 
were obtained from Gibco L td P a is le y , Scotland
2.1.2. Disposable plasticware.
Tissue culture costar flasks ,were supplied by J . Bibby Ltd . , 
Stone , Staffordshire. U.K.
Micro ELISA plates were supplied by Dynatech laboratories Ltd'., 
Sussex, U.K.
Sterile universals Sterilin L td., Feltham, England, U.K.
2.1.3. Hybridoma cells
Rat hybridoma IIA 1 and 04A6 cell lines secreting IgG2b (Ghosh 
and Campbell, 1986) were used throughout this study.
2.1.4. Bacteria
V.cholerae serotype Ogawa ( NIH41 ) and Inaba ( 35 A3 ), 
Brucella, suis, abortus , and melitensis were obtained from David Bruce 
laboratories , Wiltshire , U.K. Bacillus Anthracis ames spores and 
vegetative forms were obtained from the Microbiological Research 
Establishment, Porton Down, Salisbury Wilts. Escherichia, coli K , K12 
and Bwere kindly provided by Dr .L.Fixter.
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2.1.5. Electrophoresis materials
Acrylamide, N,N-methylene bisacrylamide , N,N,N'N 
tetramethylene diamine ( TEMED), sodium dodecyl sulphate ( SDS ) and 
ammonium persulphate were obtained from BDH Chemicals Ltd., 
Pool,Dorset,U.K.
2-meracaptoethanol was obtained from Koch-light laboratories , 
England.U.K.
Low molecular weight markers were obtained from Pharmacia Fine 
Chemicals , Hounslow , Middlesex , U.K.
2.1.6. Stains
Coomassie blue ( G ) and coomassie blue ( R ) were obtained from 
Sigma Chem.Co .Ltd,Poole, Dorset .U.K.
Silver nitrate was obtained from Johnston Mathey Chemicals , U.K.
2.1.7. Serological reagents
Normal goat serum was obtained from Scotish Antibody Production 
Unit, Law Hospital Lanarkshire, Scotland . U.K .
Rabbit anti-rat IgG (H+L ) conjugated to HRP were supplied by 
Miles Laboratories L td, Slough , U.K.
Rabbit anti-rat IgG conjugated to FITC , goat anti-rat IgG and 
rabbit anti-goat IgG conjugated to FITC were supplied by Sigma 
Chem . Co . Ltd , Poole, Dorset. U.K .
2.1.8. Enzymes
Horse radish peroxidase was obtained from Sigma Chem .Co. Ltd., 
Poole, Dorset, U.K.
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Alkaline phosphatase was obtained from Boehringer Mannheim 
GmbH- Biochemica Mannheim, Germany.
2.1.9. Enzyme substrates
O-phenylenediamine, nitroblue tetrazolium, 5 - Bromo - 4- chloro - 
3 indolyl phosphate and P - nitrophenyl phosphate were obtained from 
Sigma Chem . Co . L td., Poole,Dorset. U.K.
2.1.10. Miscellaneous
Dialysis tubing was supplied by Visking Tubing Science Instrument 
Centre . Ltd , Hampshire, U.K.
Eppendorf tubes ( capacity 1.5 m l) were obtained from Anderman 
and Co ., Surrey U.K.
Multichannel micro - pipettes were obtained from Flow 
Laboratories, Ayrshire, U.K.
Micro - pipettes were obtained from Gilson Anachem L td ., Luton, 
U.K.
Membrane filter (nitrocellulose paper) was supplied by Schleicher 
and Schull, Surrey , U.K.
Isoelectric Focusing gel plates were obtained from Pharmacia LKB 
Biotechnology AB Bromma, Sweden.
Proteins isoelectric points (pi) calibration kit were obtained from 
Sigma Chem . Co . Ltd . Poole Dorset. U.K.
Dried skimmmed milk was obtained from Cadbury L td, Boumville, 
Birmingham. U.K.
Gelatine was obtained from DIFCO Laboratories, Detroit , 
Michigan , U.S.A.
ABC ( kit ) was supplied by Vector Laboratories , Bretton , 
Peterborough , U.K .
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Streptavidin was supplied by Amersham pic, Aylesbury , 
Buckinghamshire .U.K.
2.1.11 Chemicals
N'hydroxysuccinimide ester biotin was supplied by Pierce 
Chemicals . Co . Rochford U.S.A.
Bovine serum albumin , sorbitan monolaurate ( Tween 20 ) , 
dimethyl formamide and glutaraldehyde , were obtained from 
Sigma Chem . Co .Ltd . Poole, Dorset, U.K.
Dimethyl sulphoxide ( DMSO ) was supplied by Koch Light Ltd , 
Suffolk, U.K.
<Xw\» «Yo
Tris ( hydroxymethyl ) was supplied by Boehringer Mannheim 
GmbH-Biochemica Mannheim, Germany
Routine reagents , chemicals and solvents were supplied by BDH 
Chemicals L td , Dorset, U.K.
2.2. Standard solutions and buffers
2.2.1. Cell culture media
2.2.1.1. RPMI -1640 medium
This medium was supplied already prepared by Gibco Ltd . The 
medium, was warmed to 37 °C before use . The composition of RPMI - 
1640 medium is shown in Table 2.1.
2.2.1.2. Heat inactivation of foetal calf serum ( FCS)
Foetal calf serum was inactivated at 56 °C for 30 minutes oKiistored at 
4 0c.
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2.2.1.3. Antibiotics
Penicillin 10^ I.U./ L and streptomycin lOOmg / L were used in 
routine culture medium.
2.2.1.4. Complete medium
5 %, 1 0  % and 2 0  % complete medium were prepared by addition 
of either 5 %, 10 % or 20 % FCS (v/v) to RPMI-1640 and 2 % 
v/v) penicillin/streptomycin.
2.2.2. Immunoassay buffers
Mcllvaine's buffer
0.1 M citric acid 
0.2M Na2 HPO4
36.85 ml of citric acid and 63.15 ml of Na2 HP04  were mixed to 
give a solution of pH 6.0
2.2.3. Saline buffers
2.2.3.1. Phosphate buffer saline (PBS) pH 7.2 
NaCl (145 mM )
Na2 HP04  (9  m M )
NaH2 P04  ( 1.3mM)
2.2.3.2. PBS - Tween
0.5 ml of Tween 20 was added to every litre of PBS .
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2.2.3.3. Tris saline buffer pH 7.4
Tris-HCl(O. lM)
NaCl (0.2 M )
2.2.3.4. Sodium acetate buffer pH 4.4
Sodium acetate ( ImM)
2.2.3.5. Carbonate - bicarbonate buffer pH 9.5 
NaCO3 (0.1M )
NaHCO3 (0.1M )
2.2.3.6. Sodium phosphate buffer pH 7.5 
Na2 HPO4 (0 .1M )
NaHP04  (0.1 M )
2.2.3.7. Potassium phosphate buffer pH 7.5 
K2 HP04  (0.01 M )
KH2P 0 4  ( 0.01M)
KC1 (0.15 M )
2.2.3.8. Bicarbonate buffer pH 8.8
NaHC03  (0.2 M )
2.2.3.9. Ammonium chloride buffer pH 6.0
NH4 C1(1M )
2.2.3.10. Carbonate buffer pH 9.8 
NaCOs (0.1M)
MgCl ( I m M )
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Table 2.1 Composition of RPMI -1640 medium
Amino Acid mg/ml
L-Arginine 2 0 0 .0
L-Aspargine 65.0
L-Aspartic acid 2 0 .0
L-Cysteine (HC1) 65.0
L-Glutamic acid 2 0 .0
Glycine 1 0 .0
L-Histidine (free base) 15.0
L-Hydroxyproline 2 0 .0
L-Isoleucine (all free) 50.0
L-Leucine 50.0
(methionine free)
Vitamins
Biotin 0 .2
D-Calcium pantothenate 0.25
Choline chloride 3.0
Folic acid 1 .0
i-Inositol 35.0
Nicotinamide 1 .0
Para-aminobenzoic acid 1 .0
Pyridoxine hydrochloride, 1.0
Riboflavine 0 .2
Thiamine hydrochloride 1 .0
Vitamin B 12 0.005
Amino Acid mg/ml
L-Lysine HC1 40.0
L-Methionine 15.0
L-Phenylalanine 15
L-Proline 2 0 .0
(hydroxy-L-Prolinefree)
L-Serine 30.0
L-Threonine 2 0
(alio free)
L-Tryptophan 5.0
L-Tyrosine 15.0
L-Valine 2 0 .0
Inorganic salts
Ca(N03 )2 .4H20 1 0 0 .0
KC1 400.0
MgS04 48.84
NaCl 6000.0
Na2 HP04 800.0
NaHC0 3 2 0 0 0 .0
Other components
Glucose 2 0 0 .0
Phenol red 5.0
Reduced glutathione 1 .0
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2.3. METHODS
2.3.1. Freezing and thawing of cells
Cells were centrifuged at 400xg , resuspended in a growth medium 
and counted . Cells at a density of 2 - 5 x 1 0 ml were aliquoted in 90 % 
Foetal Calf Serum and 10 % DMSO in 1.5 ml capacity cryostate ampoules . 
The aliquots were placed in -70 °C freezer overnight then removed to liquid 
nitrogen storage.
Cells brought up from liquid nitrogen were thawed at 37 °C , 
washed with RPMI and centrifuged , at 400xg for 5 min. The supernatant 
was decanted and the pellets resuspended in complete medium containing 10  
% Foetal Calf Serum and incubated at 37 °C in a humidified CO2  incubator 
. Maintenance of cells was carried out in a Laminar-flow hood.
2.3.2. Routine culture of cells
Flasks at the appropiate cell density were incubated at 37 °C in a 
humidified CO2  incubator . Cells were expanded in a medium cell culture 
flask then into a large flasks . Cells were centrifuged at 400xg for 5 min and 
the supernatant was collected for further use.
2.3.3. Purification of immunoglobulins from cell culture supernatant
2.3.3.1. Fractionation of antibodies
Monoclonal antibodies were precipitated with ammonium sulphate . 
Culture supernatant was collected on ice 4 °C and 27 - 30 g/lOOml was 
added slowly with constant stirring . The mixture was left on ice for 30 min 
and then centrifuged at 500 x g for 20 mins . The pellets obtained were 
dissolved in PBS . The solution was dialysed against 100 volume of PBS at 
4 °C overnight, to remove traces of ammonium sulphate. The buffer was
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changed the next day and the dialysis continued for another 2hrs . The 
sample was collected and stored at - 2 0  ° C .
23.3.2. Purification of immunoglobulins on QAE-sephadex A 50
Materials
PBS pH 7.2
QAE - sephadex A 50
All purification procedures were performed at room temperature.
p H
QAE - sephadex A 50 was swollen in PBS^7.2 and degassed before pouring 
into the column. The 20 x 1.5 cm column was packed and calibrated with 
PBS buffer at a flow rate of 1ml / min . 8 ml of ten times concentrated 
immunoglubulin ( section 2.3.3.1 ) was applied gently to the top of the 
column and the column was washed with PBS buffer. 3ml fractions were 
collected at a flow rate of 1ml /min . The protein content of the fractions 
wou5  estimated by absorption at 280 nm, and the fractions were collected 
until the reading of their absorbance declined to zero .Each fraction was 
tested for its antigen binding activity on ELISA . The early fractions with 
low absorbance and high activity were pooled , the pooled fractions were 
concentrated with 50 % ammonium sulphate ( Section 2.3.3.1 ), and the 
pellet was dissolved in appropriate volume of PBS and dialysed against 100 
volumes of PBS overnight. The buffer was changed the second day and 
dialysis continued for 2 hrs , before further use .
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23 3 3 .  Purification of immunoglobulin and antibody conjugate on FPLC
Sample preparation
Method A
Immunoglobulins were first purified by QAE - sephadex A50 
and the pooled fractions were concentrated with PEG 600 in dialysis tubing 
for 30 minutes. The sample was transferred to fresh dialysis tubing and 
dialysed against PBS at 4°C overnight . After dialysis the sample was 
centrifuged at 5,000 x g or filtered through ; 0.22 pm filter before 
application to the Superose 12 column .
Method B
Method A was followed, but the pooled fractions were concentrated 
with 50 % ( W /V) ammonium sulphate . The pellet was dissolved in 1ml 
PBS and the sample was dialysed against PBS overnight at 4 °C . The 
dialysis sample was then centrifuged in a fixed angle rotor at 5,000 x g for 
15 min or filtered through a 0.22pm filter before application to the 
Superose 12 column.
Gel filtration on Superose 12
A Pharmacia Superose 12 column ( 1cm x 30 cm ) packed with a 
cross - linked , agarose - based medium was used both to separate IgG 
from contaminating cell culture materials , and to separate conjugated 
antibody from free enzyme and antibody. The Superose 12 was equilibrated 
with PBS ( 0.22pm filtered) at a flow rate of 0.5 ml / min.
500 pi ( method A ) 200 pi ( method B ) were injected into the 
equilibrated column and eluted with PBS pH 7.2 at a flow rate of 1ml / min 
.Fractions of 1ml were collected and their absorption profile at 280 nm was 
recorded along with the corresponding fraction number by the chart recorder
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(lcm / min ) . When the sample had eluted from the column , the 
equilibrated buffer was replaced by 24 % Ethanol ( 0.22pm filtered) under 
which the column material was stored . Individual fractions were analysed 
on SDS -PAGE ( Section 2.3.5 ) with the polyacrylamide gel being stained 
with coomassie blue ( Section 2.3.6.1 ) or silver stain ( Section 2.3.6.3 ) ,  
and tested in ELISA for the antigen binding activity ( Section 2.3.4).
The Superose 12 was also equilibrated with 0.05 M Tris - HC1 pH 
8 .0  so that this buffer could be used to purify the conjugated antibody from 
the free enzyme and antibody by injecting lOOpl of the conjugate after 
filtering or centrifugation as described above.
2.3.4. Immunoassay
23.4.1. Enzyme Linked Immunosorbent Assay ( ELISA)
Materials
i ) Blocking buffer
2% Bovine serum albumin 
3% Normal goat serum in PBS
i i ) Anti rat IgG (H+L)- conjugated to enzyme
iii) Dilution buffer
0.1% Tween 20 ,0.5% bovine serum albumin in PBS
iv ) Washing buffer 
0.05% PBS Tween 20
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v) Substrate
0.4mg/ml O-phenylene diamine dissolved in Mcllvaines buffer 
containing 0.33jil / ml hydrogen peroxide (0.01 % ) .
Routine screening ELISA
96 well microtitre plates ( Dynatech micro ELISA ) were first 
washed with distilled water and then coated with 10^ Vibrios / lOOpl / well 
in PBS . The plates were centrifuged at 800 x g for 5 min at room 
temperature , and washed three times with PBS-Tween . 250}il / well 
blocking buffer were added and incubated at room temperature for 2 hrs to 
block the unreacted sites in the wells and the plate was then washed three 
times with PBS-Tween . 100|il / well of the antibody or culture supernatant 
to be tested was added at the appropriate dilutions and the plate was 
incubated at room temperature for 2hrs , then washed 3 times with PBS - 
Tween. lOOjil / well of a 1:1000 dilution of anti rat IgG ( H+L ) horse 
radish peroxidase conjugate was added and incubated for lhr at room 
temperature , and the plate was then washed four times with PBS-Tween . 
lOOjil / well of the substrate were added and the plate was incubated at room 
temperature in the dark for 20 minutes. The reaction was stopped by the 
addition of 50fil of 4N H2 SO4  . The optical density of each well was 
measured with a Titretrek Multiskan spectrophotometer at 492 nm . Assays 
were performed in duplicate. Controls were wells with negative tissue 
culture supernatant to check for the non - specific binding of the second 
antibody to the vibrios.
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23.43. Direct ELISA for conjugated antibody
Materials
i) Alkaline phosphatase substrate
6 mg p-nitrophenyl phosphate
6ml 0.1M carbonate buffer pH 9.8
ii) Horse radish peroxidase substrate
( section 2.3.4.1 )
The direct ELISA was carried out to test the activity of the enzyme 
conjugated to antibody in direct binding to the vibrios.
ELISA plate was coated with 1 0^ Vibrios lOOjil / well and blocked 
as described in Section 2.3.4.1. A series of doubling dilutions of the 
conjugate were prepared and lOOjil / well were added to each well. The 
plate was incubated for two hours at room temperature and washed 4 times 
with 0.05 % PBS Tween 20. The appropriate substrate for the enzyme was 
added to each well (lOOjil / well), the plate was incubated in the dark for 
20 min at room temperature and the reaction was stopped with 4N H2 SO4  
for horse radish peroxidase or 3M NaOH for alkaline phophatase ( 50jil / 
w ell) . The optical density of each well was measured with a Titretrek 
Multiskan spectrophotometer at 492 nm ( horse radish peroxidase ) or 405 
nm ( alkaline phosphatase).
The negative control was PBS , and the assays were in duplicate .
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23.4.3. Direct ELISA for biotinylated antibody
Materials -
i) Biotinylated antibody
( Section 23.1 A  )
ii) ABC kit (avidin- biotinylated alkaline phosphatase)
1 drop of bottle A and 1 drop of bottle B (100{il) to 5 ml 0.1M Tris
buffered saline pH 7.4
iii) Alkaline phosphatase substrate
( Section 2.3.4.2)
iv) Streptavidin - alkaline phosphatase
10? Vibrios /lOOp.1 / well were coated onto the ELISA plate and 
blocked as described in Section 2.3.4.1. 100p.l / well dilution 1:50 of 
biotinylated antibody in 0.1 M carbonate buffer pH 9.5 were added and 
incubated at room temperature for 2hrs. The plate was washed 3 times with 
0.05% PBS Tween 20 and 100pl /well of avidin (ABC k it) or a dilution of 
1 : 1 0 0 0  of streptavidin were added and left at room temperature for lhour. 
The plate was washed again with 0.05% PBS Tween and 100|il / well of 
alkaline phosphatase substrate was added and incubated for 20 -30 minutes 
in the dark. The reaction was stopped by adding 50p.l / well of 3M NaOH, 
The colour reaction was measuredwith a Titretrek Multiskan 
spectrophotometer at 405 nm .
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2.3.5. Polyacrylamide Gel Electrophoresis ( SDS-PAGE)
Polyacrylamide gel electrophoresis was performed using the 
discontinous Tris -glycine buffer system ( Laemmli, 1970).
2.3.5.I. Stock solution
Solution A
45 % ( w/v) acrylamide
1.2 5% ( w/v) N^N'-methylenebisacrylamide
The solution was deionised with amberlite MB-2 ion exchange 
resin, filtered and stored at 4 in a dark bottle .
Solution B
1.5M Tris -HC1 pH8 .8  
0.13 % (v/v) TEMED 
The solution was filtered and stored at
Solution C
12 % ( w/v ) sodium dodecyl sulphate ( SDS ). The solution was 
filtered and stored at2 .o fc
Solution D
20 % (w/v) ammonium persulphate in H2 O. This solution was 
prepared immediately prior to use.
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Solution E
0.65 M Tris -HC1 pH 6 .8
The solution was filtered and stored at 4 °C
Electrophoresis buffer 
0.25 M Tris pH 8.3 
0.132 M glycine 
0.2% ( w/v) SDS
Reducing sample buffer ( x5 )
0.625 M Tris-HC1 pH 6 .8  
2% (w /v) SDS 
1 0  % ( w/v) glycerol 
0 .0 0 1  % bromophenol blue 
5% (v/v) 2-mercaptoethanol
2.3.5.2. Resolving gel preparation
12.5% , 10% and 7.5% polyacrylamide resolving gels were 
prepared from the stock solutions ( Section 2.3.5.1) as follows
Acrylamide gel 7,5% 1 0% 12t5%
Solution A 1 0ml 13.33ml 16.66ml
Solution B 15ml 15ml 15ml
Solution C 0.5ml 0.5ml 0.5ml
Dis H20 34ml 30.67ml 27.4ml
Solution D 0.5ml 0.5ml 0.5ml
The solution was then poured between the two plates of the casting
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apparatus till about 2/3 of the plate length had been filled. 1ml of butan -2- 
ol was then used to overlay the acrylamide solution. The acrylamide 
solution was then allowed to polymerise.
23.5.3. Stacking gel preparation
The stacking gel was prepared from the stock solution as follows:
2.64ml Solution A
2.40ml solution E
0.20ml solution C
18.67ml distilled water
0.20ml solution D
0.024ml TEMED
After polymerisation of the resolving gel, the butan-2-ol layer was 
poured off and the acrylamide surface rinsedwith distilled water . The 
stacking gel was then poured and allowed to polymerise around a 2 0  well 
teflon comb.
The final dimensions of the gel were 16.5 cm x 14.5 cm x 0.15 cm .
2.3.5.4. Electrophoresis conditions
Electrophoresis was was performed for 3-4 hr at room temperature 
at a constant current of 50mA per slab gel or overnight at a constant current 
of 10 mA per slab gel at room temperature.
23.5.5. Molecular weight markers
The molecular weight marker standards ( Pharmacia ) comprise of 
the following proteins.
62
Protein Mr Source
Phosphorylase b 94,000 Rabbit muscle
Albumin 67,000 Bovine Serum
Ovalbumirv 43,000 Egg white
Carbonic anhydrase 30,000 Bovine erythrocytes
Trypsin inhibitor 2 0 ,0 0 0 Soyabean
oc-Lactalbumin 14,000 Bovine milk
0 .1ml of sample buffer was added to the lyophilysed low molecular 
weight standards . The standards were then boiled at 100 °C for 5 minutes. 
A 5-10 microliter sample of molecular weight standards was loaded onto the 
well.
23.5.6. Sample preparation
To each protein sample an equal volume of sample buffer was added 
and the samples were then boiled at 100 °C for 5 minutes before loading 
onto the individual wells.
2.3.6. Staining techniques
2.3.6.1. Coomassie blue stain
0.25% ( w/v ) coomassie blue G 250 
45% ( w /v) ethanol 
10% glacial acetic acid
2.3.6.2. Destain for coomassie blue 
45% ( v/v) ethanol
1 0 % ( v/v ) glacial acetic acid
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After electrophoresis the gel was stained with coomassie blue for 
0 .5 -1  h r , the gel was then placed in destain to remove the backround colour 
and allowd the examination of the stained bands .
2.3.6.3. Silver stain
The silver stain method of Tsai and Frasch (1982 ) was used to 
detect low concentration protein bands . Double - deionised water was used 
in preparation of solutions and throughout the experimental procedure.
Solution for silver staining
Fixing solution
40% ( v/v) ethanol
5 % ( v/v) glacial acetic acid
55% ( v/v) water
Oxidising solution
0 .7 % ( w/v ) periodic acid in fixing solution 
Silver staining
28ml 0.1 N sodium hydroxide 
2ml 14.8 M ammonia 
5 ml 2 0 % ( w/v) silver nitrate 
115ml water
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Developer
0.005% ( v/v) citric acid 
0.1ml 37% ( v/v) formaldehyde
Stabilising solution
3% ( v/v) glacial acetic acid
After electrophoresis the gel was placed in the fixing solution 
overnight and then transferred to oxidising solution for 5 minutes with 
slow shaking. It was then washed three times with 500 ml water over 45 
minutes . During the last wash silver stain was prepared, then added to the 
gel and incubated for 10 minutes with vigorous shaking . The gel was 
washed as before but for 30 minutes with 3 changes of 500 ml water. The 
developer was added and incubated without shaking until the bands were 
observed after about 10-30 minutes. When the gel was sufficiently stained 
and before the background became too high, the gel was washed a few 
times with water and the developed gel was established by adding 2 0 0 ml of 
stabilising solution.
2.3.7. Conjugation of IgG to enzymes
2.3.7.1. Glutaradehyde method for conjugation of IgG to 
horse radish peroxidase
Materials
0.02% glutaraldehyde in PBS , freshly prepared 
Horse radish peroxidase ( Sigma)
Purified antibody
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Phosphate buffered saline ( PBS)
Sephadex G-25 column equilibrated with PBS
Antibody was purified from cell culture supernatant ( Section 2.3.3 
), concentrated by ammonium sulphate precipitation , redissolved in PBS 
and dialysed against PBS overnight at 4 . The antibody was adjusted to
a final concentration of lmg / 0.5ml. 5mg of peroxidase was dissolved in 
0.5 ml of phosphate buffer and added to the antibody solution , 1ml of 
glutaraldehyde solution was added and the solution was mixed at room 
temperature for lhr . Finally the mixture was applied to the Sephadex 
column and eluted with PBS . Fractions of 1ml were collected and the 
absorbance was monitored at 280nm until the absorbance reached zero . 
The coloured fractions were run in SDS - PAGE and stained with silver 
stain or coomassie blue stain to observed the conjugate. The fractions were 
also tested in ELISA to monitor the conjugate activity ( Section 2.3.4.2) .
2.3.7.2.Glutaraldehyde method for conjugation of IgG to alkaline 
phosphatase
Materials
Purified antibody
Alkaline phosphatase ( Boehringer)
Phosphate buffer saline ( PBS )
0.05 M Tris-HCl pH 8 
Glutaraldehyde (25 % v/v)
Antibody was adjusted to a final concentration of lmg / ml after 
being purified ( Section 2.3.3). An equal ratio of enzyme to antibody (lmg)
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was added to 0.8ml antibody and the mixture was dialysed against PBS at 
4 °C overnight to remove the ammonium sulphate present in the enzyme. 
The volume was made up to 1ml with PBS and 8 pl glutaraldehyde were 
added. The mixture was incubated at room temperature for 2hrs and the 
solution was then dialysed against PBS (2  changes of 500 m l) and then for 
24hrs against Tris buffer (3  changes of 500 m l) .
The conjugate was separated from unconjugated antibody and 
enzyme by FPLC gel filtration on Superose 12 ( Section 2.3.3.3 ) . The 
fractions were run in SDS - PAGE to identify the conjugate and tested in 
ELISA for the conjugate activity ( Section 2.3.4.2) .  The fractions which 
had activity in ELISA were pooled together for further use.
23.13. Periodate method of conjugation of IgG to alkaline phosphatase
This was based on the modification of method reported by Wilson 
and Nakane (1978 ).
Materials
lmg alkaline phosphatase
lmg purified antibody
0.1 M sodium periodate
ImM sodium acetate buffer pH 4.4
0.1 M carbonate -bicarbonate buffer pH 9.5
5mg sodium borohydrUt.
Phosphate buffer saline ( PBS )
lmg of the enzyme was added to 1ml distilled water . 0 .2  ml of 
sodium periodate was added to the solution and the solution was mixed at
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room temperature for 30 minutes then dialysed against sodium acetate buffer 
overnight at 4 °C . lmg purified antibody in 1ml of carbonate - bicarbonate 
buffer were mixed with the enzyme solution for 2hrs . After the addition of 
5mg sodium borohydr/de , the solution was left standing for lhr and 
dialysed against 2 changed of 2 litre of PBS . The conjugate was separated 
from free enzyme and antibody by FPLC gel filtration on Superose 12 and 
the fractions were run in SDS-PAGE , and tested in ELISA for conjugate 
activity.
2.3.7.4. Conjugation of IgG to biotin
Method A
Materials
lmg purified antibody
0.2mg biotin - N - hydroxy succintmide ester
0.1M bicarbonate buffer pH 9.5
Phosphate buffer saline ( PBS )
The method of Lake (1988) was followed with minor 
modifications. A linker N- hydroxysuccinamide ester was used to 
conjugate biotin to the monoclonal antibody .
0.2 mg biotin - ester was dissolved in lOjil of dimethyl sulphoxide 
and added to lmg antibody in 400jil bicarbonate buffer . The reaction was 
stopped after 2  hours at room temperature by dialysis against two changes 
of 1 litre of PBS overnight at 4 °C . The conjugate was stored at -20 °C 
until further use.
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Method B 
Material
lmg purified antibody
0.01M potassium phosphate buffer containing 0.15M KC1 (PBK) 
pH7.5
0.2 M sodium bicarbonate buffer, containing 0.15 M KC1 
pH 8 .8
30mg /ml biotin hydroxysuccinamide ester 
Dimethyl formamide 
1M ammonium chloride, PH 6.0
lmg of purified monoclonal antibody in 400jil of potassium 
phosphate buffer were mixed with lOOpl of sodium bicarbonate buffer. 5pl 
of biotinyl - hydroxysuccinimide ester in dimethlformamide were added to 
the antibody solution. The reaction was allowed to proceed under gentle 
stirring for lhr at room temperature and then 50 p.1 of the ammonium 
chloride buffer were added to the mixture in order to terminate the reaction. 
The conjugate was dialysed against two changes of PBK at 4 °C and the 
dialysed material was stored at -20 °C until further use .
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2.3.8. Construction of Vibrio cholerae kit
23.8.1. Construction ofVibrio cholerae kit using conjugated antibody
Materials
Nitrocellulose paper strips size 1 cm x 2 cm
Blocker: 1.25% skimmed dried milk ( Blotto) in PBS
Purified antibody
Antibody - enzyme conjugate
Enzyme substrate
30mg nitroblue tetrazolium in 1ml dimethylformamide , 15 mg 5- 
bromo- 4 - chloro - 3- indolyl phosphate in 1ml dimethylformamide in to 
100ml 0.1M carbonate buffer, ImM MgCl pH 9.8.
200|il of 20jig/ml of Purified antibody was added to each strip; and 
incubated at room temperature for lhr. The strips were removed and 
incubated with 1ml blocker/strip for 3 hrs at room temperature and then 
dipped in 10^ Vibrios / ml/strip for 10 minutes . They were then removed 
and washed under tap water for 40 seconds (20 second each side) . 200|il 
/ strip of 1 :1 0 0  dilution of conjugated antibody were added and incubated 
for 20 minutes . Finally the strips were washed under the tap for 40 seconds 
and developed with 300|J.l/strip enzyme substrate for 5-10 minutes then 
washed with water to stop the reaction and air dried.
Controls for this experiment were, firstly, strips which had not 
been dipped in antigen ( vibrios) ,  secondly strips without first antibody 
but with blocker, and thirdly strips without conjugated antibody .
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2J.8.2. Construction of the kit using biotinylated antibody
Materials
Nitrocellulose paper strips size 1 cm x 2 cm 
Purified antibody
50mM tris buffer saline containing 200mM NaCl pH7.4 
Biotinylated antibody 
( ABC kit) biotinylated - AP -avidin 
Blocker 1.25 % dried skimmed milk ( Blotto) in PBS 
Enzyme substrate 
( Section 2.3.8.1 )
2 0 0  pi of 2 0 pg/ml pure monoclonal antibody were added to each 
strip and incubated at room temperature for lhr . The strips were removed 
and incubated in 1ml blocker/strip for 3 hrs .10^ Vibrios / ml were added to 
each strip and left for about 5-10 minutes. The strips were washed under the 
tap for 40 seconds . 200|il / strip of 1:50 dilution of biotinylated antibody 
was incubated for 2 0  minutes at room temperature and the strips were 
washed again with tap water. ( ABC k it) was added (2drops / strip) and 
incubated for another 20 minutes at room temperature . Finally the strips 
were washed under the tap for 40 seconds and developed with 300pl/strip 
enzyme substrate for 5-10 minutes then washed with tap water to stop the 
reaction and air dried.
Three controls were set. The first was strips without Vibrios , the 
second was strips with no first antibody and the third was strips without 
biotinylated antibody.
71
2.3.9. Flow cytomertry
23.9.1. Labelling of Ogawa and Inaba with fluorescein isothiocyanate
(FTTC)
Materials
0.5 mg/ml fluorescein isothiocyanate ( FITC)
Inaba and Ogawa vibrios
Sephadex column G 25
0.25 M carbonate buffer, containing 0.1 M NaCl pH9
The; concentrations of Ogawa and Inaba were adjusted to lOmg / 
0.5 ml and dialysed overnight against carbonate buffer at 4 °C . 10|il of 
FITC were added to both Ogawa and Inaba and kept overnight at 4 ° C . The 
sample were applied to^ephadex column and eluted with PBS. Fractions of 
0.5 ml were collected . The first coloured fractions were collected and 
stored in dark at 4 ° C .
2.3.9.2. Preparations of cells for flow cytometry
To analyse cells by flow cytometry aliquot of approximately 1 xlO^ 
cells were removed from culture , centrifuged and then washed twice in ice 
cold PBS . The cells were resuspended in 1ml PBS and 50 |il were 
added/tube . The appropriate antibody or labelled vibrios then added as 
specified in the text and figure legends . Samples where antibody or antigen 
conjugated directly to FITC were used were incubated for 20 minutes on ice 
. After incubation they were centrifuged, washed twice in ice cold PBS and 
finally resuspended in 0.5 ml of PBS for analysis by flow cytometry . In 
cases where a two step reaction was required the first antibody was added to 
the cells incubated for 20 minutes as before . The cells were then
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centrifuged and washed twice in ice cold PBS and the second antibody or 
antigen was added. The second incubation was again for 20 minutes on ice 
. After the incubation the cells were washed in PBS and then resuspended in 
0.5 ml of PBS for analysis by flow cytometery .
In each samplelOjil of propidium iodide ( P I ) (final concentration 
lpg/ ml) was added to the cells before analysis . Dead cells were detected 
by their ability to take up PI and fluoresce in the far red channel. Cells 
which gave PI fluorescence were then gated out so that the data in the green 
(FITC) channel was only obtained from live cells. In each batch of cells 
analysed a control was included which had no antibodies added to correct 
for autofluorescence of the cells. Where a two step reaction was involved a 
control with second antibody was included to account for non specific 
binding .
2.3.10. Isoelectric focusing
Materials
Anode solution
IM H 3PO4
Cathode solution 
lMNaOH
Dialysis buffer
3 M urea
0.05 % ( w/v) glycine
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Fixing solution (500 ml)
11.5 % ( w/v) trichloroacetic acid 
3.45 % ( w/v) sulphosalicylic acid
Staining solution ( 400 m l)
1.15 % ( w/v) coomassie blue -R 250
Destaining solution (2  litres)
25 % ( v/v) ethanol 
8 % ( v/v) acetic acid
Preserving solution ( 400 m l)
1 0  % glycerol in destain solution
74
pi standards
The standards markers ( Pharmacia ) comprise of the following
proteins.
Protein_____________________________ pL_
Amyloglucosidase 3.5
Soyabean trypsin 4.55
lactoglobulin A 5.2
Bovine carbonic anhydrase B 5.85
Human carbonic anhydrase 6.55
Myoglobin-acidic band 6.85
Myoglobin-basic band 7.35
Lentil lectin-acidic band 8.15
Lentil lectin middle band 8.45
Trypsinogen 9.3
0 .1  ml of distilled water was added to the lyophilysed markers , 
2 0 |xl sample was used.
LKB Ampholine
PAG plates are ready made polyacrylamide gels containing 
Ampholine carrier ampholites pH range , 3.5 - 9.5
Sample preparation
Prior to isoelectric focusing the concentration of the samples were 
adjusted to lmg / ml and these were then dialysed against urea overnight.
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Isoelectric focusing conditions
The isoelectric focusing was electrophoresed at 10 - 15 °C for 1.5 
hours at
£=1500 V 7=50 mA £=30 W
The Multiphor ( LKB ) was connected to a water supply at flow rate
of 6  -10 I / min , and allowed to cool. The gel was placed on the cooling
plate, with some insulating fluid ( paraffin o il) in between and centered in
the middle of the plate . The electrode strips were soaked with the
appropriate electrode solutions and the excess solution was removed with
filter paper. The electrode strips were applied close to the g e l. Dry sample
application pieces were applied to the surface of the gel and 2 0 }il of the
sample was applied on the anodic side of the gel. After approximately half
the focusing time , the sample application pieces were removed and the
focusing continued . After isoelectric focusing the gel was removed and
fixed for 0.5 -1 hour to precipitate the protein and allowed the Ampholine
%
to diffuse out. The gel was washed in the staining solution for 5 minutes 
and stained for 10  minutes in staining solution which has been preheated to 
60 °C , Finally the PAG plate was destained in several changes of the 
destaining solution until the background was clear and preserved in the 
glycerol preserving solution.
2J.11. Protein estimation by Bradford’s assay 
Materials
85 % ( w/v) phosphoric acid 
95 % alcohol
100 mg coomassie blue G in 50 ml ethanol 
Dilution solution 
0.01 % ( w/v) SDS
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Bradford reagent ( Bradford, 1976 ) was prepared fresh before use 
by dissolving lOOmg of coomassie briliant blue G -250 in 50ml of 95 % 
ethanol . 100 ml of 85 % ( w/v ) phosphoric acid were added and the 
volume was made up to one litre. The solution was filtered before use.
A duplicate series of tubes containing 1 -100 jig BSA per 100|il 
(from a stock solution of lmg / ml) were set up . The volume in the tubes 
were kept constant at lOOjil with the dilution solution. 2ml of Bradford 
reagent was added to each tube, mixed well and incubated for 2  minutes at 
room temperature . The optical density of the content of the tubes were 
measured at 595 nm and a standard curve was drawn (fig 2.1).
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Bradford's assay
A595
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RESULTS
AND
DISCUSSION
CHAPTER 3
THE OPTIMAL GROWTH 
AND
SECRETION CONDITIONS 
OF IIA1 AND 04A6
3.1. The Effect of Foetal Calf Serum ( FCS ) concentration 
on cell growth and synthesis of antibody.
Two cell lines were used throughout this study. IIA 1 is a rat 
hybridoma cell line secreting antibody which reacts preferentially on ELISA 
with V.cholerae Inaba. 04A6 is a different rat hybridoma secreting 
antibody with specificity for V. cholerae Ogawa. (Ghosh and Campbell, 
1986 a) .The culture media were prepared with different concentrations of 
FCS in order to determine both the optimal growth of hybridoma cells and 
maximal MCAb secretion in the cell culture supernatant.
3.1.1. Cell number and growth kinetics
10^ cells / ml of IIA 1 or 04A6 were seeded in 25 cm^ cell culture 
flasks in 1 0  ml complete medium and the cells were counted by 
haemocytometer every 24 hours for the first 3 days and subsequently every 
12  hours.
Fig 3.1 shows the growth of IIA 1 and Fig 3.2 the growth of 
04A6 in RPM I1640 containing 20 % , 10 % and 5 % FCS over a period of 
106 hours (4 days 10 hours). IIA 1 grew slightly faster than 04A6 at all 
three different FCS concentrations, and this is seen most clearly at the 
lowest one. A decrease in cell doubling time was observed at lower FCS 
percentages in the media for both cell lines I1A1 and 04A6. The cells 
doubled in 8-10 hours in 20% FCS, 22-24 hours in 10% FCS and 40-50 
hours in 5% FCS.
3.1.2. MCAb secretion
The effect of FCS concentration on antibody secretion by the two 
hybridomas was determined by ELISA using Ogawa or Inaba Vibrios and a
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Figure 3.1 Growth curve of I1A1 in different FCS
concentrations
104 11A1 cells were seeded in 25 cm  3 cell culture flasks in 10ml RPMI 
with different concentrations of FCS 20%, 10% and 5%, the cells were 
counted by means of a haemocytometer over a period of 106 hours. The 
values plotted are a mean of three determinations.
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Figure 3.2 Growth curve of 04A6 in different FCS
concentrations
1()4 04A6 cells were seeded in 25 cm^ cen culture flasks in 10ml RPMI 
with different concentrations of FCS 20%, 10% and 5%. The cells were 
counted by means of a haemocytometer over a period of 106 hours. The 
values plotted are a mean of 3 determinations.
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2nd anti rat IgG antibody conjugated to peroxidase (Section 2.3.4.1) .
The IgG secretion was greater from cells cultured in medium 
supplemented with 20 % FCS followed by 10 % FCS then 5 % FCS. It is 
clear that antibody secretion was highly dependent on increasing FCS 
concentration in the medium (Figs 3.3 and 3.4). Possibly in part due to the 
fact that IIA 1 grew faster in the three different concentrations of FCS than 
04A6, the IIA 1 antibody titre was greater in the three media than the titre 
of 04A6.While antibody secretion rose sharply over the last part of the 24 
hour period, this is to be expected from the growth in cell number, but the 
actual amount of antibody secreted per cell fell. Thus, for example, in Fig 
3.4 at 106 hours, cells grown in 20% FCS produced only 1.25 fold more 
antibody than cells grown in 10%, despite the fact that the cell number was 
an order of magnitude greater (Fig 3.2).
There have been numerous attempts to establish the best conditions 
for growing hybridomas in cell culture. The effects of amino acids reported 
to extend cell longevity and to increase MCAb secretion (Luan et a/,1987), 
and vitamins for survival and growth (Orikasa et al, 1985), antioxidant 
substances, such as glutathione and ascorbic acid (O'Donnell et al, 1987) 
reported to protect cells against H2 O2  toxicity and the role of albumin in 
detoxifying the culture medium (Halliwell, 1988) have all been documented.
Most cells are unable to grow in a medium containing amino acids, 
vitamins, and glucose unless serum is added, in the case of fibroblast 
cultures, when the concentration of the serum is reduced to a low level 
(i.e.0.25-0.5%), cell multiplication ceases and the population is arrested in 
the Go phase of the cell cycle . Growth may be reinitiated at any time by
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Figure 3.3 IgG secretion of IIA l in different concentrations
of FCS
The secretion of IgG from II Al cells grown in different concentrations 
of FCS was determined by reactiion of the IIA1 supernatant with Inaba 
vibrios on ELISA.
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Figure 3.4 IgG secretion of 04A6 in different concentrations
of FCS
The secretion of IgG from 04A6 cells grown in different concentrations 
of FCS was determined by reaction of the 04A6 supernatant with Ogawa 
vibrios on ELISA.
0.8 -l
A492
H 04A6 cells grown in 5% FCS 
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adding back fresh serum when DNA synthesis begins after a well defined 
lag period (Brooks, 1975). Such low concentrations were not employed in 
this study.
The data show that both cell growth rate and total antibody secretion 
(although not antibody secretion / cell) were reduced in 5 % FCS in 
comparison with values obtained at the higher concentration of 20 % FCS. 
It is likely that the addition of more FCS stimulated growth of the cells 
probably by stimulation of DNA synthesis. This agrees with the results of 
Avola et al (1988) who reported that EGF and FCS significantly stimulated 
[ methyl-^H ] thymidine incorporation into DNA , and that DNA synthesis 
was markedly reduced during incubation with serum free medium (Tanaka 
et a l , 1988).
Damerdji et al (1988) observed the stimulation by FCS of DNA 
synthesis in a concentration dependent manner and noted that cells grown in 
medium supplemented with whey fractions exhibited a slower rate of DNA 
synthesis. Immunoglobulin, secretion was greater when cells were cultured 
with medium supplemented with FCS. The interleukin, IL- 6  (BSF-2) has 
also been shown to be a powerful stimulant for growth and development 
into active secretion of hybridoma cells (Kishimoto and Hirano, 1988).
Attempts have been made to fractionate FCS in order to obtain the 
stimulatory component and it has been suggested that this component is 
highly acidic (Pullen and Munro, 1988). However, it is possible to cultivate 
hybridoma cells over long period of time in an entirely chemically defined 
culture medium in the absence of serum (Schneider, 1989) in spinner 
flasks, permitting MCAb secretion to be increased, or in dialysis tubing 
containing medium with low levels of protein for large scale production of
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antibodies (Jansson and Jeansson, 1985).
Ascitic fluid gives a high yield of monoclonal antibodies but these 
are contaminated with irrelevant mouse or rat immunoglobulins. 
Consequently, ascitic fluid is seldom employed in large scale commercial 
work. In vitro culture of hybridomas using classical methods such as 
spinner flasks and roller bottles gives a much lower yield of antibody, 
usually in the range 10-100jig/ml. In addition, most culture media contain 
horse or bovine serum which are complex mixtures of poorly defined 
constituents. These proteins are usually present at 500 to 7000jig/ml several 
times the concentration of the actual monoclonal antibody (Schneider, 1989). 
In consequence, the ideal methods for large scale culture of hybridoma cells 
are probably in completely defined medium, devoid of animal serum and 
indeed perferably of any exogenous protein. However, to be realistic, a 
balance must be achieved between, on the one hand, good growth of cells 
and antibody yield, and on the other, sufficiently defined medium to make 
subsequent antibody purification a standard procedure.
At the present time, media designed for serum free culture of animal 
cells are complex mixtures of salts, amino acids, vitamins, glucose and 
various compounds such as nucleic acid precursors and lipids or 
antioxidative substances. In addition, they are supplemented with hormones 
(insulin, growth factors, steroids etc), binding proteins (transferrin, 
albumin etc) and trace elements. As the understanding of factors affecting B 
cell growth and secretion is extended, factors such as Interleukin 6  (also 
known as hybridoma growth factor) can be added to this list.
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3.2. The effect of FCS concentration on the expression of
membrane immunoglobulin.
The expression of IgG on the membrane of IIA 1 and 0 4 A6 cells 
cultured in different FCS concentrations was observed by staining the cells 
with antibody against rat IgG conjugated to fluorescein isothiocyanate 
(FITC). The fluorescence intensity of the cells was then determined by flow 
cytometry. To exclude the dead cells, propidium iodide (PI) staining 
followed by gating out of PI positive cells was employed (Fig 3.5). The 
FACScan settings and parameters are shown in Fig 3.5 .
The cells were first tested to see if the FITC conjugated antibody 
bound to them non specifically. Fig 3.6 shows IIA 1 cells cultured in 
different concentration of FCS and incubated with FITC conjugated anti 
goat IgG. All control cells cultured at different FCS concentrations had the 
same low intensity of fluorescence indicating that the antibody did not bind 
non specifically to the cells . These data were then used to set an analysis 
gate above which less than 1% of control cells were positive in the FL1 
(green) axis.
The proportion and intensity of the cells positively stained with anti 
rat IgG FITC were then determined. IIA 1 cells grown in 5 % FCS had a 
higher percentage of cells positive for surface IgG than those grown in 10 
% and 20 % with 83 % of the cells staining above the control ( Fig 3.7A) 
as opposed to 57 % and 56 % in the case of cells grown in 10 % and 20 % 
FCS respectively (Fig 3.7 B and C ). The relative result was confirmed by 
using two antibodies, goat anti rat IgG followed by rabbit anti goat IgG 
conjugated to FITC (Fig 3.8).
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Figure 3.5 FACScan setting and parameters
II Al cells were cultured in 10% complete medium and prepared for 
flow cytometry (Section 2.3.9.2) and subjected to flow cytometry. The 
data showed the autofluroescence of the cells without the addition of any 
antibody.
SSC Side scatter of the cells indicating granuality 
FSC Forward scatter of the cells indicating size of the cells
FL1 Green Channel (autofluroescenceof the cells) fluorescence peak
530nm
FL2 Orange Channel (Near Red) Fluorescence peak 575nm
FL3 Far Red Channel excluding dead cells after the addition of
propidium iodide (PI) Fluorescence peak > 650nm In effect, the 
instrument is set to record the data from cells which have low intensity on 
FL3 i.e. cells which have not taken up propidium iodide and are therefore 
live.
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Figure 3.6 Binding of FITC conjugated irrelevant antibody to
the cells
II Al cells were cultured in different concentrations of foetal calf serum 
(FCS) and prepared for flow cytometry (Section 23.9.2). lOp.1 of 1:60 
dilution of FITC labelled rabbit anti-goat IgG (final dilution 1:300) was 
added to determine non specific binding of the FITC antibody to the cells. 
The results are displayed as fluorescence intensity against cell number. 
Dead cells were gated out by counter staining propidium iodide.
A II Al cells cultured in RPMI medium in the presence of 5% FCS 
B IIA1 cells cultured in RPMI medium in the presence of 10% FCS 
C IIA1 cells cultured in RPMI medium in the presence of 20% FCS 
—  Marker to indicate the upper limit of autofluorescent intensity of IIAl 
control cells.
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Figure 3.7 The expression of I1A1 surface immunoglobulin
using direct antibody staining
II Al cells cultured in three different concentrations of FCS were 
prepared for flow cytometry (Section 23.9.2). The cells were stained with 
10(il of 1:4 dilution of FITC labelled anti rat IgG (final dilution 1:20). The 
results are displayed as fluorescence intensity against cell number. The 
dead cells were gated out by counter staining propipdium iodide.
A II Al cells cultured in RPMI containing 5% FCS 
B IIA 1 cells cultured in RPMI containing 10% FCS 
C II Al cells cultured in RPMI containing 20% FCS 
— Marker to indicate the upper limit of autofluorescence intensity of II Al 
control cells.
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Figure 3.8 The expression of I1A1 surface immunoglobulin
using dual antibody staining
IIA1 cells cultured in different concentrations of FCS were prepared for 
flow cytometry (Section 23.9.2). The cells were stained with lOpl of 1:60 
dilution of goat anti rat IgG (final dilution 1:300) followed by 10}il of 1:60 
dilution of FTTC labelled rabbit anti goat (final dilution 1:300) and then 
subjected to flow cytometry. The dead cells were gated with counter 
staining propidium iodide.
A IIA1 cells cultured in RPMI medium containing 5% FCS 
B IIA 1 cells cultured in RPMI medium containing 10% FCS 
C IIA1 cells cultured in RPMI medium containing 20% FCS
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The fluorescence intensity of 04A6 cells grown in 5 % , 10 % and 
20 % FCS media using both, the single and the double staining methods is 
shown in Fig 3.9 and Fig 3.10 . The results are summarised in Table 3.1
The data show that for both IIA 1 and 04A6 cells, growth in 5 % 
FCS medium led to expression of a higher level of surface IgG than those 
grown in 10 % and 20 %.This is in agreement with the results obtained for 
secreted IgG in the supernatant from cells grown under the same conditions 
(section 3.1 .2). Thus, while the cells grow well at high FCS 
concentrations, they appear to make less surface antibody.
B lymphocytes are known to produce two different mRNA 
molecules for membrane bound and secreted IgG respectively and the 
transcription and processing of these messages are under separate control. 
In normal B cell differentiation, early lineage cells carry largely the message 
for the membrane bound form of receptor immunoglobulin. As a normal B 
cell progresses to a fully secreting plasma cell, the genetic control 
mechanisms switch to the production of message for the secreted antibody 
(Roitt et al, 1989). From this study of I1A1 and 04A6 membrane and 
secreted IgG in different serum concentrations it appears that low FCS 
concentrations in the medium stimulate the production of both RNA 
transcripts relative to higher FCS concentrations.
A major factor affecting both cell surface expression and secretion of 
immunoglobulin is likely to be the proportion of cells at different stages of 
the cell cycle. Evidence from this laboratory has indicated that cell surface 
immunoglobulin expression is decreased in S phase when the cells are 
engaged in DNA synthesis (Alam, Campbell and Cushley, unpublished 
results). Thus rapidly growing and dividing cells may contain a larger
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Figure 3.9 The expression of 04A6 surface immunoglobulin
using direct antibody staining
04A6 cells cultured in different concentrations of FCS were prepared 
for flow cytometry (Section 2.3.9.2). The cells were stained with lOjil 1:4 
dilution of FITC labelled anti rat IgG (final dilution 1:20). The dead cells 
were gated out by counter staining with propidium iodide. The results are 
displayed as fluorescence intensity against cell number.
A autofluroescence of 04A6 cells 
B 04A6 cells cultured in RPMI containing 5% FCS 
C 04A6 cells cultured in RPMI containing 10% FCS 
D 04A6 cells cultured in RPMI containing 20% FCS 
—  marker to indicate the upper limit of fluorescence intensity of 04A6 
control cells.
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Figure 3.10 The expression of 04A6 surface immunoglobulin
CL
using dual antibody stining
04A6 cells cultured in different concentrations of FCS were prepared 
for flow cytometry (Section 2.3.9.2). The cells were stained with 10}il of 
1:60 dilution of goat anti rat IgG (final dilution 1:300) followed by 10|il of 
1:60 dilution of FITC labelled rabbit anti goat IgG (final dilution 1:300) and 
then subjected to flow cytometry. The dead cells were gated with counter 
staining with propidium iodide.
A 04A6 cells cultured in RPMI medium containing 5% FCS 
B 04A6 cells cultured in RPMI medium containing 10% FCS 
C 04A6 cells cultured in RPMI medium containing 20% FCS
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The effects of different growth media on the expression of
surface immunoglobulin.
% of cells expressing membrane immunoglobulin
Control 5%FCS 10% FCS 20% FCS
I1A1 <1 83 57 56
04A6 <1 85 40 33
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population with little or no cell surface or secreted immunoglobulin.
For the rest of this study, the value of 10% FCS was chosen as one 
which gave an acceptable yield of antibody after 4-5 days of culture at 
reasonable cost and with minimal contaminating proteins to interfere with 
the purification of the antibody (Section 4). In practice, the cells were 
grown to exhaustion and the supernatant was then harvested from the 
terminal cells.
If the diagnostic test produced proves suitable for large scale 
commercial development, then it would clearly be advisable to adapt the 
cells to growth in defined serum free medium to standardise procedures, 
minimise cost and facilitate purification.
3.3. Binding of FITC labelled Inaba and Ogawa bacteria to
I1A1 secreting cells
The specificities of I1A1 for the two serotypes of V.cholerae, Inaba 
and Ogawa were also determined by means of flow cytometry . The cells 
were incubated with bacteria labelled with fluorescein isothiocyanate (FITC) 
and the fluorescence intensity of the cells was then determined by flow 
cytometry . The dead cells were gated by counter staining with propidium 
iodide.
Fig 3.11(A) shows IIA1 cells gated before the addition of FITC 
labelled Inaba (A). An analysis gate, above which all cells were considered 
positive was set using this sample. After the addition of FITC labelled Inaba 
a substantial increase in the percentage of positive cells in the FL1 (green) 
channel was seen ( Fig 3.1 l.B ).
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The comparative specificity of IIA1 for Inaba and Ogawa antigens is 
shown in (Fig 3.12 A ,B). 55% of the cells reacted with FITC labelled 
Inaba whereas only 23% reacted with FITC labelled Ogawa indicating that 
I IA1 has a preference for Inaba . The case is similar with 04A6 cells 
which show preference for the Ogawa antigen.
To confirm the binding specificity of Inaba to IIA1 cells, FITC 
labelled Inaba and Ogawa were allowed to react with IIA1 cells separately 
in the presence of unlabelled (cold) Ogawa and Inaba (Figs 3.13 and 3.14). 
The results obtained indicated that the unlabelled serotypes were able to 
compete out the labelled, confirming that the binding is specific, competitive 
and reversible for both serotypes. The overall results for IIA1 are 
summarised in Table 3.2.
The Lipopolysaccharides (LPS) of Inaba and Ogawa serotypes are 
chemically very similar (Section 1.6.12.2.). Biochemical analysis of the 
LPS component of the two serotypes has indicated that the Ogawa serotype 
has an additional component, 4-amino arabinose not present in the Inaba 
serotype (Redmond 1978 ; Kabir 1982) . Physically, however, on SDS- 
PAGE, the two types of LPS band in identical fashion and the two LPS 
structures must therefore have similar O regions repeats (Ghosh and 
Campbell, 1985). In a detailed analysis of the specificities of a group of 
monoclonal antibodies directed against V.cholerae, Ghosh and Campbell 
(1986) showed that while IIA1 had a preference for the Inaba serotype, it 
also had a capacity to bind and agglutinate Ogawa. 04A6 bound well to 
Ogawa but had little affinity for Inaba. The experiments described here 
confirm that both serotypes can bind to the I1A1 hybridoma and that an
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excess of either unlabelled antigen can dislodge the other serotype.The most 
suitable diagnostic test for V.cholerae will clearly be one that detects both 
serotypes.
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Figure 3.11 Binding of FITC labelled Inaba to I1A1 cells
IIA1 cells cultured in RPMI with 10% FCS were prepared for flow 
cytometry (Section 2.3.9.2). 25|il of FITC labelled Inaba were added and 
the increase of fluorescence intensity in FL1 was observed. The dead cells 
were gated out with propidium iodide.
A IIA1 cells before the addition of FITC labelled Inaba 
B IIA1 cells after the addition of FITC labelled Inaba 
FSC forward scattered of the cells indicating the size of the cells 
SSC Side scattered of the cells indicating the granularity of the cells 
FL1 Green Channel (recording FITC)
FL2 Orange (near Red) Channel
FL3 Far Red Channel excluding the dead cells after the addition of 
propidium iodide (PI). In effect, the instrument is set to record data 
from those cells which have low intensity on FI3 i.e. those cells which 
have not taken up propidium iodide and are therefore live.
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Figure 3.12 Binding of I1A1 to FITC labelled Inaba and
Ogawa antigens
IIA1 cells were cultured in RPMI medium containing 10% FCS and 
prepared for flow cytometry as described in Section 23.9.2. 25jil of FITC 
labelled Inaba and Ogawa were added separately. The dead cells were 
excluded by counter staining with propidium iodide. The result is 
displayed as fluorescence intensity against cell number.
A IIA1 cells with FITC labelled Inaba 
B IIA1 cells with FITC labelled Ogawa
—  Marker indicating the upper limit of autofluorescence intensity of IIA1 
control cells.
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Figure 3.13 Binding of IlA lto  a mixture of FITC labelled and
unlabelled Inaba and Ogawa antigens (A)
IIA1 cells were cultured in RPMI medium containing 10% FCS and 
prepared for flow cytometry as described in Section 2.3.9.2. 25|il of FITC 
labelled antigen followed by 25|il of unlabelled antigen were added. The 
dead cells were gated out by counter staining with propidium iodide. The 
result is displayed as fluroescence intensity against cell number.
A IIA1 cells + FITC labelled Inaba + unlabelled Ogawa 
B I1A1 cells + FITC labelled Ogawa + unlabelled Ogawa 
—  Marker indicating the upper limit of autofluorescence intensity of IIA1 
control cells.
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Figure 3.14 Binding of I1A1 to a mixture of labelled and 
unlabelled Inaba and Ogawa antigens (B)
IIA1 cells were cultured in RPMI medium containing 10% FCS and 
prepared for flow cytometry as described in Section 2.3.9.2. 25jxl of FITC 
labelled antigen followed by unlabelled antigen were added. The dead cells 
were gated out by counter staining propidium iodide. The result is 
displayed as fluorescence intensity against cell number.
A 11A1 cells + FITC labelled Ogawa + unlabelled Inaba 
B IIA1 cells + FITC labelled Inaba + unlabelled Inaba.
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Table 3.2
A summary of binding and competition studies with hvbridoma 
IIA1 and serotypes Inaba and Ogawa.
% of I1A1 cells binding fluorescent antigen
FITC labelled Inaba 55
FITC labelled Inaba competed 10
with unlabelled Inaba
Fl'IC labelled Inaba competed 21
with unlabelled Ogawa
FITC labelled Ogawa 23
FITC labelled Ogawa competed 8
with unlabelled Ogawa
FITC labelled Ogawa competed 6
with unlabelled Inaba
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CHAPTER 4 
PURIFICATION &LABELLING 
OF MONOCLONAL ANTIBODIES
4.1. Purification and labelling of monoclonal antibodies
4.1.1. Introduction
For the majority of applications of monoclonal antibodies it is 
desirable to have highly purified preparations free from the extraneous 
proteins present in ascitic fluid or FCS in tissue culture media. In 10% FCS 
there are approximately 7mg/ml of contaminating protein of which around 
half is bovine serum albumin while the monoclonal antibody concentration 
is usually under lOOpg/ml. The purification method chosen should be rapid 
to minimise the processing time and should result in a homogeneous 
antibody preparation in high yield. MCAbs have been separated from other 
proteins by a variety of chromatographic methods including affinity 
chromatography on Protein A (Ledbetter and Herzenberg,1979;Ey et 
a/,1978;Goding 1978;Nilson et a/,1982) which is frequently not suitable 
for rat monoclonal antibodies of the IgG2b subclass(Ghosh,1985). Other 
methods include ion exchange chromatography (Goding,1980;Bruck et 
a/,1982) and immunoaffinity chromatography, which has been proposed as 
a method suitable for IgA or IgM (Cripps et a/,1983). Size fractionation 
methods such as sepharose can be used particularly where high molecular 
weight IgM antibodies are involved. However, each method gives 
characteristic values for processing, yield, and purity which depend on the 
individual properties of the monoclonal antibody involved and for each 
MCAb, the optimum purification schedule must therefore be established.
4.1.2. Purification of I1A1 on QAE- sephadex A50
IIA 1 was first concentrated by precipitation with ammonium 
sulphate and dialysed into PBS, pH 7.2. BSA has a strong negative charge 
at this pH and is retarded on the positively charged beads. Figs 4.1 and 4.2 
show the elution pattern of I1A1 after first and second purification
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Figure 4.1 First purification of I1A1 on QAE-Sephadex A50
IIA1 was purified on QAE-Sephadex A50 as described in Section 
2.3.3.2. The protein content of each fraction was measured at A280nm 
and antigen binding activity was determined by ELISA at 492nnx 
The background absorbance value was less than 0.1 O.D.
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Figure 4.2 Second purification of I1A1 on QAE-Sephadex 
A50
The fractions obtained from the first purification were concentrated and 
purified again on QAE-Sephadex A50 as described in Section 2.3.3.2. The 
protein content of each fraction was measured A280nm and antigen binding 
activity was determined by ELISA A492nm. The background absorbance 
value less than 0 .1 .
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1(Section 2.3.3).
The activity profile obtained against Inaba bacteria did not 
correspond with the protein content of the fractions. The assymetric IgG 
peak and the elution of IIA 1 activity over a wide range of fractions are 
probably due to charge microheterogeneity leading to partial binding of 
some antibody molecules to the column. Contamination with IgG is unlikely 
since the antibody was obtained from tissue culture medium which is 
generally free of IgG when FCS is used.
SDS-PAGE patterns of the corresponding pooled fractions obtained 
from the second purification on QAE sephadex are shown in Fig 4.3 with 
the protein stained by coomassie blue and in Fig 4.4 with the more sensitive 
silver stain. Both gels were run with the same sample at the same time. The 
purified MCAb was free from most of the FCS proteins with the silver stain 
detecting trace contamination with albumin. The reducing gels clearly show 
the heavy (H) and light (L) chains of the IgG together with some high 
molecular weight bands ,visible only in the coomassie blue stain which may 
represent aggregated forms of the antibody during electrophoresis. The level 
of purity of antibody from these two steps is comparable to that obtained in 
most other published methods.
QAE- sephadex purification involves mild conditions with 
physiological buffer pH values. In contrast, immunoaffinity 
chromatography desorption procedures tend to use extreme conditions such 
as low pH which can denature antibodies (Bazin et al, 1986). Protein A 
shows poor binding to several classes of mouse and rat monoclonal 
antibodies (Akerstrom and Bjorck,1986) and has already been shown
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Figure 4.3 Coomassie blue stain of SDS-PAGE of purified
I1A1 in QAE-Sephadex
IIA1 purified on QAE Sephadex was analysed on 12.5% SDS-PAGE to 
detect any contaminating proteins.
Lane 1 Protein molecular weight markers 
Lane 2 30jil of pooled fractions 1-10 Fig. 4.2 
Lane 3 30pl of pooled fractions 11-20 Fig. 4.2 
Lane 4 30|il of pooled fractions 21-30 Fig. 4.2 
Lane 5 30pl of pooled fractions 31-40 Fig. 4.2 
Lane 6  30p! of pooled fractions 41-50 Fig. 4.2
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Figure 4.4 Silver stain of SDS-PAGE of purified I1A1 in
QAE-Sephadex
I1A1 purified on QAE Sephadex was analysed on 12.5% SDS-PAGE to 
detect any contaminating proteins.
Lane 1 30|il of pooled fractions 41-50 Fig. 4.2 
Lane 2 30jil of pooled fraction 31-40 Fig. 4.2 
Lane 3 30}il of pooled fraction 21-30 Fig. 4.2 
Lane 4 30jil of pooled fraction 11-20 Fig. 4.1 
Lane 5 30jil of pooled fraction 1-10 Fig. 4.2 
Lane 6  Protein molecular weight markers
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unsuitable for IIA 1 (Ghosh, 1985). Other problems with protein A can 
relate to protein A contamination of the affinity purified monoclonal 
antibody (Dertzbaugh et a/,1985) and leakage which can occur even with 
different coupling chemistries (Bloom et a/,1989).
4.1.3. Purification of I1A1 by FPLC gel filtration
FPLC offers advantages of speed and resolution over conventional 
chromatographic systems and has been extensively used to purify 
monoclonal and polyclonal antibodies. FPLC techniques permit accurate 
control of all the operating conditions and give a higher degree of 
reproducibility over a wide range of volumes and concentrations than is 
possible with conventional chromatography. Moreover, the direct and 
continuous detection system provides considerable control over sample 
collection. The easy programming and the automation that can be introduced 
both for the injection and the collection steps, greatly reduces the time and 
manual work required. These advantages can be combined with gel filtration 
using a commercially available column, Superose 12, and the FPLC 
apparatus.
For routine purification of MCAb this system was suitable as a 
substitute for the second purification on QAE-sephadex and gave a higher 
yield of IgG within a shorter period of time. The difference in molecular 
weight between IgG and the main contaminant, bovine serum albumin from 
the FCS means that gel filtration can be used to resolve the two and, in 
addition, remove any low molecular weight contaminating proteins.
Fig 4.5 shows the chromatogram trace of I1A1 which has been 
purified once on QAE-sephadex. The activity profile of the fractions (Fig 
4 .6 ) shows a high reading after fraction 12 which corresponds to the second
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Figure 4.5 Purification of I1A1 on FPLC. Method A
Elution profile of IIA1 IgG from FPLC gel filtration superose 12 using 
Method A for sample preparation (Section 2.3.3.3). 500jil of the sample 
was injected using PBS pH7.2 buffer for column calibration and sample 
elution. The flow rate was adjusted to lml/min, the speed chart to 
lcm/min, and the absorbance at 280nm was adjusted to a maximum of 1.0 . 
Fractions 13-16 represent the pure IIA 1.
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Figure 4.6 I1A1 activity from FPLC fractions
Fractions from the FPLC chromatogram (Fig. 4.5) were reacted with 
Inaba vibrios in an ELISA assay to determine the antigen binding activity. 
The absorbance was below 0.12 O.D
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peak indicating that the antibody elutes after some high molecular weight 
inactive protein. The activity profile and protein profile correspond well for 
this peak and activity appears in only four fractions in contrast to the QAE- 
sephadex elution pattern so that the yield is considerably improved.
The technique was adapted to further increase the resolution of this 
peak by using different conditions of separation (Fig 4.7). These further 
separated the IgG from the high molecular weight aggregates and the low 
molecular weight proteins including BSA. The purity of the antibody was 
assessed by SDS-PAGE with Coomassie Blue (Fig 4.8) and silver staining 
(Fig 4.9). These show the analysis of the peaks in Figure 4.7. The first 
peak corresponds to high molecular weight aggregates, the second shows 
pure IIA 1 with a dominant heavy chain and no detectable impurities and the 
third shows BSA. The speed and good resolution and yield obtained by 
FPLC in comparison to the second QAE-sephadex column make it the more 
suitable method, especially taking into account that it was not necessary to 
concentrate the samples at the end of the run. However purification by 
FPLC without the first QAE-sephadex column was not satisfactory.
Others have used FPLC with a combination of other techniques to 
try to achieve one step purification of monoclonal antibodies, for example 
combining affinity chromatography with immobilised ligand on FPLC 
(Santucci et al, 1988), using protein G instead of protein A (Ohlson et 
al,7988) or anion and cation exchange chromatography to purify all 
subclasses from mouse ascites (Danielsson et al, 1988). Below et al (1987) 
purified antibodies using a single step method involving T-gel (thiophillic 
adsorbent). It is possible that single step purification of IIA 1 might be 
achieved by some of these methods but the two step procedure described
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Figure 4. 7 Purification of I1A1 on FPLC. Method B
Elutinon profile of II Al IgG from FPLC gel filtration superose 12 
using Method B for sample preparation (Section 2.3.3.3).
200}il of the sample was injected using PBS pH 7.2 buffer for column 
calibration and sample elution. The flow rate was adjusted to 0.25ml/min, 
the speed chart to lcm/min, and the maximum absorbance at 280 was 
adjusted to 2 .0 .
Fractions 10-13 Represent the pure I1A1.
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Figure 4.8 Coomassie blue stain of I1A1 purified by FPLC
Fractions of purified I1A1 from FPLC (Fig. 4.7) were analysed on SDS 
PAGE 12.5%.
Lane A IOjjI bovine serum albumin (BSA)
Lane B 20|il IIA1 before purification in FPLC 
Lane 6-9 Protein contaminants from the culture medium 
(20jil each fraction)
Lane 10-15 Pure II Al (20jxl each fraction)
Lane 16 Protein contaminant (BSA) from the culture medium (20jLil)
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Figure 4.9 Silver stain of I1A1 purified by FPLC
Fractions of purified II Al from FPLC (Fig. 4.7) were analysed by 
SDS-PAGE 12.5%.
Lane A lOp.1 bovine serum albumin (BSA)
Lane B lOjil II Al before purification on FPLC
Lane 6-9 Protein contaminants from culture medium lOjil each fraction
Lane 10-15 Pure II Al lOjil each fraction
Lane 16 lOpl protein contaminant (BSA) from culture medium.
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was adopted for the work reported in this thesis.
4.1.4. Purification of 04A6 on QAE-sephadex A50
04A6 culture supernatant was concentrated by ammonium sulphate 
precipitation and applied to QAE-sephadex A50 (Section 2.3.3). Fig 4.10 
shows profiles of protein content and ELISA activity against Ogawa bacteria 
at 492nm. The antibody elutes early in the fractionation process in 
comparison to IIA 1 and there is considerable activity before the main 
protein peak is eluted giving good purification. When the column was 
loaded with more protein, the two profiles were less satisfactory due to the 
presence of contaminating BSA.
Figure 4.11 shows the SDS-PAGE profile of the various fractions 
from Fig 4.10. The early fractions contain pure antibody and the later ones 
antibody have heavy BSA contamination. The secondary FPLC step was 
not therefore necessary for 04A6 as pure antibody could be obtained from 
the early fractions on QAE-sephadex.
It is interesting to note the different behaviour of IIA 1 and 04A6 on 
QAE-sephadex. Both are rat monoclonal antibodies of the same (IgG2b) 
subclass and both were purified at the same pH (7.2). Nonetheless, 04A6 
came through the column more readily than I1A1 which was definitely 
retarded. The difference between the two must reflect differences in the 
charged amino acids in the variable region.
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Figure 4.10 Purification of 04A6 by QAE-Sephadex A50
The protein content for each fraction of QAE- Sephadex column was 
measured at 280nm and antigen binding was determined by ELISA.
The background absorbance for ELISA was below 0.13 O.D.
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Figure 4.11 SDS-PAGE of purified 04A6
04A6 purified on QAE- Sephadex was analysed by 10% SDS PAGE. 
The gel was stained with coomassie blue.
Lane A Molecular weight marker
Lane B lOjil bovine serum albumin (BSA)
Lane 1-13 QAE-Sephadex fractions (Fig. 4.10) 20jil each fraction
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Table 4.1
Yields of I1A1 and 04A6 during purification
Before purification After purification
Sample Volume Total proteins QAE-sephadex
I1A1 8ml 57.1mg
04A6 8 ml 55.1mg
1st 2nd
5.6mg 1.7mg
4.2mg
FPLC
5.1mg
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4.2. Labelling of monoclonal antibodies with enzymes
4.2.1. Introduction
Many different enzymes have been used for enzyme immunoassay 
(Chandler and Harrel,1982) ; among these, peroxidase, P-galactosidase, 
urease, alkaline phosphatase and glucose oxidase have been the most 
frequently used in diagnostic medicine. Horseradish peroxidase (HRP) and 
alkaline phosphatase (AP) are the two most commonly used enzymes 
(Blacke and Barry, 1984). Enzymes can be covalently linked to antibodies 
by a number of techniques (Avrameas,1969; Goodfriend et al, 1964; 
Rajkowski and Cittanova,1981; Wilson and Nakane,1978). The availability 
of methods for the conjugation of enzymes to antibodies with high 
efficiency expands the use of enzyme-antibody conjugates as markers not 
only for immunoglobulins but for proteins in general. The use of EIA as 
opposed to RIA avoids the hazards and complications of handling 
radioisotopes and also the inconveniences of radioisotope decay since the 
enzyme labelled compound can be stored without loss of activity. The 
sensitivity of an EIA system should be comparable to to RIA.
4.2.2. Conjugation of IgG to horseradish peroxidase
IIA l and 04A6 were purified (Section 4.1) and the pure antibody 
was concentrated and conjugated to HRP with a molar ratio of 1:5 IgG to 
HRP using glutaraldehyde as a bifunctional crosslinker. The excess 
glutaraldehyde was removed by separation on a sephadex G25 column. The 
efficiency of the conjugate was then tested in ELISA against the appropriate 
serotype.
The elution profile of IIA l and 04A6 with respect to both protein 
concentration and ELISA activity are shown in Figs 4.12 and 4.13. The 
fractions giving colour on ELISA were then subjected to SDS-PAGE to
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determine the molecular weight of the conjugate (Figs 4.14 and 4.15). This 
showed a large amount of free enzyme indicating that a low yield of 
conjugate and poor coupling efficiency had been obtained. A possible 
reason for this low coupling efficiency is the blockage of the majority of a- 
and e- amino groups and some hydroxy groups of the commercial HRP by 
allylisothiocyanate (Omstein,1966). These groups are therefore not 
available for the coupling reaction. Furthermore, it is likely that the 
carbohydrate moiety on the periphery of HRP interferes sterically with 
reactions involving the protein core (Nakane and Kawaoi,1974). The 
periodate method, which uses this carbohydrate, might therefore be a more 
suitable method to employ with HRP.
Experiments carried out by other groups in order to determine the 
nature and molecular weight of the complex after coupling suggested that a 
1:1 complex of IgG to HRP of molecular weight 200 kDa. However, any 
conjugate formed between IIA 1 and 04A6 obviously possessed a high 
molecular weight. This would agree more with the study of Boorsma and 
Streefkerk (1976) who found a polymerised conjugate of molecular weight 
400 kDa. Avrameas (1969) showed no distinct electrophoretic bands but 
rather a continuous pattern of protein having a wide range of electrophoretic 
mobility and possessing enzymatic activity. It is also likely that the different 
antibody preparations used in each study contributed to the different patterns 
obtained.
A further disadvantage of the HRP method is the fact that several of 
the most convenient substrates have carcinogenic properties. Thus, although 
HRP is widely used in many laboratories, alkaline phosphatase was 
considered as a potentially more suitable enzyme if cross linking with good
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Figure 4.12 Conjugation of I1A1 to HRP
IIA1 was purified and conjugated to HRP as described in Section
2.3.7.1. The elution profile of the conjugate from a Sephadex G25 
column, the protein content of the fraction being measured at 280nm and the 
ELISA activity being determined against Inaba vibrios (Section 2.3.4.2). 
Background absorbance was less than 0.14 O.D.
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Figure 4.13 Conjugation of 04A6 to horse radish peroxidase 
(HRP)
Protein content and ELISA activity of the 04A6 conjugate from a 
Sephadex G25 column.
Background absorbance was less than 0.15.
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Figure 4.14 SDS-PAGE of I1A1-HRP conjugate
Fractions from a Sephadex G25 column (Fig. 4.12) were analysed 
12.5% SDS-PAGE and stained with silver stain.
Lane A 20|il horse radish peroxidase 
Lanes 4-7 Sephadex G25 fractions (20|il)
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Figure 4.15 SDS-PAGE of 04A6-HRP conjugate.
Fractions from a Sephadex G25 column (Fig. 4.13) were analysed 
10% SDS-PAGE and stained with coomassie blue.
Lane A 20|il horse raddish peroxidase enzyme 
Lanes 1-10 Sephadex G25 fractions (40jll1)
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activity could be achieved.
4.2.3. Conjugation of IgG to alkaline phosphatase
IIA1 and 04 A6 were coupled to alkaline phosphatase by the method 
recommended by Johnstone and Thorpe (1986) using glutaraldehyde as 
cross linker. While enzymes have been conjugated to proteins by a variety 
of methods such as direct condensation (e.g with carbodiimide) (Nakane 
and Pierce, 1967), by periodate oxidised carbohydrate (Nakane and 
Kawaoi,1974) or through chemical bridging by bifunctional reagents (e.g 
dimethylsuberimidate) (Dower etal, 1981).
It is obviously important to obtain a protein-enzyme complex which 
retains a significant amount of both immunological and enzymatic activity. 
In this context, gluataldehyde was used since it had been reported that 
antibody activity was at least partially preserved by this method (Avrameas 
and Temynck,1969).
4.2.4. Purification of the enzyme-antibody conjugate
Clearly the congugate used in any diagnostic kit must be as sensitive 
as possible. It has been shown that even a small amount of free antibody 
will considerably decrease the sensitivity of enzyme immunoassay (Tijssen 
et al, 1982). Moreover, the presence of free enzyme increases the 
background colour of the assay. The difference between the native 
molecular weights of the conjugate, the free antibody (150kDa), and the 
enzyme (140kDa (Fosset et al 1974)) makes it possible to separate the 
conjugate by gel filtration.
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Fig 4.16 shows the elution profile of IIA 1 conjugated to alkaline 
phosphatase on FPLC Superose 12 gel filtration. The fractions were 
pooled, run in SDS-PAGE and visualised with silver stain (Fig 4.17). The 
first peak represented protein which could not penetrate the gel and was 
presumably high molecular weight conjugate. The second represented a 
peak of above 200kDa which was presumed to contain dimerised enzyme or 
antibody and the third showed free enzyme. The activity of the conjugate 
against Inaba bacteria on ELISA is shown in Fig 4.18.
Similar data showing the FPLC trace and ELISA activity for the 
04A6 alkaline phosphatase conjugate are shown in Figs 4.19 and 4.20. 
Again there is a high titre from the first peak and no ELISA activity in the 
other peaks.
Various attempts at precise definition of the reaction between 
alkaline phosphatase and other antibodies have been made. Cordell et al 
(1984) described a complex of molecular weight 800kDa which differed 
markedly from the predicted value of 560kDa for a complex of one antibody 
and two enzyme molecules. The latter molecular weight is at variance with 
the known molecular weight of the components (150 kDa + 2 x 140kDa = 
430 kDa ). Hohmann et al (1988) estimated a complex of monoclonal 
antibody conjugated to alkaline phosphate to be 600kDa and suggested that 
this could be composed of complexes of two enzyme and two antibody 
molecules or one enzyme and three antibody molecules. However, complex 
polymers will arise if more than one active group is present in each 
macromolecule and it is generally observed that large polymers cause high 
background staining levels (Kurstak, 1985). The size of the conjugate in a 
diagnostic kit has been suggested to be less important than when it is used 
in tissue sections in immunohistochemistry where deeper penetration into
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Figure 4.16 Separation of I1A1-AP by FPLC
Elution profile of II Al conjugated to alkaline phosphatase. II Al was 
conjugated to alkaline phosphatase as described in Section 2.3.7.2. lOOjil 
was injected onto a Superose 12 column and the conjugate was eluted with 
0.05 M Tris-HCl pH 8.0. The flow rate was lml/min, the speed chart 
lcm/min, fractions of 0.5ml were collected, and the maximum O.D. was 
adjusted to 2.0.
Peak 1 Represent the conjugated IIAl
Peak 2 Represumed dimer form of enzyme or antibody
Peak 3 Represent the free alkaline phosphatase.
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Figure 4.17 SDS-PAGE of IlA l-alkaline phosphatase (AP) 
conjugate
Each peak from FPLC chromatogram (Fig. 4.16) was pooled and 
analysed by 7.5%. SDS-PAGE and stained with silver stain to detect the 
conjugate.
Lane A Free alkaline phosphatase
LaneB Dimeric form of enzyme or antibody
LaneC Conjugated I1A1
Lane D Alkaline phosphatase
LaneE 200 kDa protein
Lane F Low molecular weight markers
Lane G 200kDa protein and low molecular weight marker
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Figure 4.18 ELISA activity of purified I1A1-AP conjugate
Peak 1 from FPLC chromatogram (Fig. 4.16) was pooled and a series 
of doubling dilution were prepared. The conjugate was reacted against 
Inaba vibrios in a direct ELISA assay. Background absorbance was below 
0.12 O.D.
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Figure 4.19 Separation of 04A6-AP in FPLC
Elution profile of 04A6 conjugated to alkaline phosphatase. 100|il was 
injected and the conjugate was eluted with -0.05M Tris-HCl pH 8.0. The 
flow rate was lml/min, speed chart to lcm/min, fractions of 0.5ml were 
collected and the maximum O.D. was adjusted to 0.5.
The first peak represents the conjugated antibody.
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Figure 4.20 ELISA activity of purified 04A6-AP conjugate
Fractions from the FPLC chromatogram (Fig. 4.19) were reacted with 
Ogawa in a direct ELISA assay.
Background absorbance was below 0.04 O.D.
ELISA activity at A405
A405
4 020 3 01 00
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the sections is required (Nygren,1982).
4.2.5. Comparison between the glutaraldehyde and periodate methods
The data in Figs 4.21 and 4.22 show a comparison between alkaline 
phosphatase conjugates of both I1A1 and 04A6 prepared by either the 
periodate or the glutaraldehyde method using and enzyme/antibody ratio of 
1 :1 .
The periodate method was not as efficient as the glutaraldehyde 
method for the conjugation of alkaline phosphate to both antibodies. 
Alkaline phosphatase activity was better maintained in the glutaraldehyde 
method, possibly since the conjugation did not require subsequent 
manipulations which were required in the periodate method. The conditions 
of treatment with sodium periodate may have been too severe for the 
antibodies, resulting in the destruction of the sugar residues (Jeanson et al, 
1988). The central problem in the use of the periodate method is the 
sensitivity of the carbohydrate moiety to oxidation. Too little oxidation will 
not activate the enzyme satisfactorily and excessive oxidation can cause 
damage (Kurstak,1985). However, Beyzavi et al (1987) suggested that the 
size of the carbohydrate moiety of alkaline phosphatase is not sufficient to 
make the periodate method an efficient conjugation technique for alkaline- 
phosphatase-antibody preparation.
In this study, the antigen binding activity of the conjugate increased 
with both V.cholerae concentration and conjugate concentration. The 
minimum detectable concentration for these conjugates is between 1(P and 
104 bacteria/well.
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Figure 4.21 Comparison between the periodate and
glutaraldehyde methods for conjugation of I1A1 to 
alkaline phosphatase
II Al was conjugated to alkaline phosphatase using the periodate 
method (Section 23.13) and the glutaraldehyde method (Section 23.1.2). 
Three dilutions from each method were prepared 1/50,1/100 and 1/500.
The various conjugate dilutions were reacted with increasing numbers of 
Inaba vibrios.
Background absorbance was below 0.1.
A405
1.2 I  1/50 dil periodate method 
□  1/100 dil periodate method 
1/500 dil periodat method 
EJ 1/50 dil glutaraldehyde
1/100 dil glutaraldehyde method 
1/500 dil glutaralgehyde method
10000 100000 1000000 10000000 100000000
Concentration of Inaba/well
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Figure 4.22 Comparison between the periodate
andglutaraldehyde methods for conjugation of 
04A6 to alkaline phosphatase
Three dilutions from glutaraldehyde and periodate methods respectively 
were prepared (1/50,1/100 and 1/500). The various conjugate dilution 
were reacted with increasing numbers of Ogawa vibrios.
Background absorbance was below 0.1 O.D.
A405
1/50 dil periodate method 
1/100 dil periodate method 
H  1/500 dil periodate method 
0  1/50 dil glutaraldehyde method 
□  1/100 dil glutaraldehyde method 
1/500 dil gutaraldehyde method
10000 100000 1000000 10000000 100000000
Concentration of Ogawa/well
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The best conjugation methods are, however, not universally 
applicable. For example, the periodate method is eminently suitable for 
perxidase but not for alkaline phosphatase and some of the recommended 
procedures such as the two step glutaraldehyde procedure (Avrameas and 
Temunck,1971) are widely used but yield, at best, poor results (1-10% 
conjugation).
4,2.6. The optimum molar ratio for conjugation of antibody to enzyme.
Pure 04A6 was conjugated to different amounts of alkaline 
phosphatase using the one step glutaraldehyde method. The amount of 
glutaraldehyde was the same for the different ratios of antibody/enzyme.
To prepare the conjugate with reasonably active enzyme activity 
using the glutaraldehyde method, it was necessary to use a molar ratio of 
antibody to enzyme of approximately 1:1. The use of smaller amounts of 
enzyme than antibody resulted in a conjugate with low antigenic binding 
capacity. Fig 4.23 shows 04A6-alkaline phosphatase conjugate at different 
molar ratios tested against 10^ Ogawa vibrios. The higher ratios of enzyme: 
antibody resulted in conjugates with high relative background and with little 
improvement in activity or sensitivity of conjugate.
The amount of antibody and enzyme used depends in general on the 
procedure, and different investigators have used different molar ratios 
varying between 1:1 (Johnstone and Thorpe, 1986) for 1:4 alkaline 
phosphatase:antibody(Williams,1984) for 5:1 alkaline phosphatase:antibody 
(Beyzavi et a/,1987).
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Figure 4.23 Conjugation of 04A6 to different ratios of AP 
(AB:Enzyme)
04A6 was conjugated to different molar ratios of alkaline phosphatase. 
A series of doubling dilutions of the conjugates were prepared and reacted 
with Ogawa vibrios.
The values plotted are a mean of three assays. The background 
absorbance was below 0.1 O.D.
Ratio 1:1 lmg 04A6: lmg AP 
Ratio 1:2 lmg 04A6 : 0.5mg AP 
Ratio 1:4 lmg 04A6 : 0.25mg AP 
Ratio 1:8 lmg 04A6 :0.125 mg AP
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Ratio 1:1
Ratio 1:2A405
Ratio 1:4
Ratio 1:8
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In summary therefore, the efficiency of conjugation depends on 
many factors and among these are the nature of both the antibody and 
enzyme used, the method used and concentration of reagents, and the ratio 
of antibody to enzyme used in the conjugation process.
4.3. Monoclonal antibody cross reactivity
Cross reactions among polyclonal antisera raised against bacterial 
antigens are commonly observed. They are, however, difficult to evaluate in 
terms of fine specificity because of the heterogeneity of the antibody 
population. With the use of hybridoma technology, cross reactions may be 
expected to be simplified. Where the antibody reacts with identical epitopes 
on two populations of antigen, the cross reaction is likely to be more 
extensive than with conventional serum. Where the antibody reacts with a 
unique epitope, cross reaction may be expected to be negligible. 
Conversely, however, when whole antigen rather than single epitope is 
considered, all the antibodies in polyclonal antisera have this in common 
and a natural immune response should statistically favour the major 
immunising antigen. A homogeneous population of a single monoclonal 
antibody may actually be more able to make significant contact with antigens 
other than the immunising one and lead to equally complex cross reactions. 
The situation is further complicated in cases like this where the cross 
reacting antigens have strong structural similarities.
Multispecific polyreactive MCAbs are reported in the literature with 
increasing frequency, and are particularly common where highly repeated 
structures such as bacterial LPS represent one or both of the cross reacting 
antigens (Ghosh and Campbell, 1986b). They are also frequently observed 
with antibodies of the IgM isotype and have been suggested to originate 
from a particular subtype of B lymphocytes (Casali and Notkins,1989).
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4.3.1. Cross reaction of anti-Inaba and anti-Ogawa conjugates
with increasing concentration
The IIA 1 conjugate cross reacted with Ogawa vibrios in the direct 
ELISA assay only within a restricted range of antigen concentration. At the 
maximum level of antigen coating on the plate, 10  ^vibrios/well, no binding 
was observed. A positive reaction was, however observed in the range 10^ 
to 1 0 8  vibrios/well with a maximum at 107/well (Fig 4.24). When the 
04A6 conjugate was reacted with different amounts of Inaba vibrios, again 
no reaction was observed at 10  ^vibrios/well and a positive reaction peaking 
at 10? vibrios/well was evident (Fig 4.25). The reaction of the IIA 1 
conjugate with the Ogawa vibrios appeared stronger than that of 04A6 to 
Inaba vibrios confirming the data of Ghosh and Campbell (1988).
Chemical analysis has indicated that the LPS of the two serotypes 
are very similar with the possible exception of 4-amino-2-deoxy arabinose 
(Redmond, 1978; See Section 1) in their O chains and that they share a 
common core (Hisatsune and Kondo,1980; Brade,1985). In addition, the 
outer membrane proteins of the two serotypes have been shown to be 
similar (Kabir,1980; Manning,1982; Manning and Haynes,1984). Hence, 
although both antibodies are known to react with the LPS (Ghosh and 
Campbell, 1986b), the common epitopes recognised by the conjugate could 
possibly involve additional interactions with core and/or membrane protein 
antigens.
The skewed distribution of activity of I1A1 and04A6 conjugates on 
ELISA against heterologous vibrios is not observed when conjugate,
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Figure 4.24 Reaction of the I1A1-AP conjugate with different 
concentrations of Ogawa vibrios
Conjugated IIA1 was reacted with increasing amounts of Ogawa vibrios 
in a direct ELISA assay.
the control was 0.05M Tris buffer saline pH 8.
I1A1-AP conjugate
A405
control
0.8
0.6 -
0.4
0.2 -
0.0
1 0 1 0 1 01 0 1 01 0 1 01 0
Concentration of Ogawa/well
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Figure 4.25 Reaction of the 04A6-AP conjugate with different 
concentrations of Inaba vibrios
Conjugated 04A6 was reacted with increasing amounts of Inaba vibrios 
in a direct ELISA assay.
the control was 0.05M Tris buffer saline pH 8.
04A6-AP conjugate
A405
control
0.3
0.2
0.1
Concentration of Inaba/well
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prepared by a different method, is reacted with homologous vibrios (Figs 
4.21 and 4.22). Thus, any explanation involving either leaching (Frankel 
and Gerhard, 1979) or zone effects offering limited access which may be 
invoked to explain this skewing have to take into account the fact that it does 
not occur where high affinity contact with autologous antigen is made. 
Ghosh (1985) noted an almost identical dependence on heterologous but 
not homologous ELISA using the classical second antibody system and 
consequently the shape of the curve is unlikely to relate to the fact that the 
monoclonal antibodies are directly labelled in this case.
4.3.2. Cross reaction of anti-Inaba and anti-Ogawa conjugates
with other bacteria.
The reaction of IIA 1 and 04A6 conjugates with other bacteria was 
monitored by direct ELISA using plates coated with logarithmically 
increasing amounts of antigen. Very weak cross reactions were detected 
between both conjugates and E. coli (Figs 4.26 and 4.27), Brucella spp., 
and both spore and vegetative forms of B.anthracis (Figs 4.28 and 4.29). 
These are probably attributable to non specific binding of the conjugate to 
the cross reactive bacteria as the level is very little above the background 
control. Nonetheless, unusual cross reactions with antisera and MCAbs and 
also unexpected structural homologies among bacterial antigens in this 
group have been observed. Thus similarities between the LPS on 
V.cholerae , Y.enterocolitica and Br.abortus have been reported 
(Feeley,1969; Caroff etal, 1984a,b). Since the reaction with B.anthracis 
spores is one of the stronger, the involvement of LPS core is unlikely, 
B.anthracis being a gram positive organism. Common antigenic features 
among proteins within this group have also been described. Lang and 
Pavala (1987) decribed the presence in El Tor Inaba of a maltose inducible
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Figure 4.26 Reaction of the I1A1-AP conjugate with various 
strains of E. coli.
The IIA1 conjugate was reacted with increasing concentrations of three 
species of E. coli. K l, K12 and B the values plotted are a mean obtained 
from the assays.
The control was 0.05M Tris HC1 pH 8.
A405
0.5 n
E.coli K
E.coli K12
E.coli.B
control
0.4
0.3
0.2
0.1
Concentration of bacteria/well
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Figure 4.27 Reaction of the 04A6-AP conjugate with various 
strains of E. coli.
04A6 conjugate was reacted with increasing concentration of three 
species of E. coli, K, K12, and B. The values plotted are a mean 
obtained from three assays.
The control was 0.05M Tris-HCl pH 8.
0.5 -I
E.coli K12
A405 ■
E.coli B
control
0.4
0.3
0.2
0.1
Concentration of bacteria/well
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Figure 4.28 Reaction of the IlAl-alkaline phosphatase
conjugate with Brucella and B. anthracis species
IIA1 conjugate was reacted with increasing concentration of Brucella, 
suis, Br. melitensis, Br. abortus, B. anthracis Ames spores and B. 
anthracis form values plotted are a mean obtained from three assays.
The control was 0.05M Tris-HCl pH 8.
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Figure 4.29 Reaction of the 04A6-AP conjugate with 
Brucella and B. anthracis species 
04A6 conjugate was reacted with increasing concentration of Brucella, 
suis, Br. melitensis, Br. abortus, B. anthracis Ames spores and vegetative 
form. The values plotted are a mean obtained from three assays . 
the control was 0.05M Tris-HCl pH 8.
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outer membrane protein in the range 43kDa which resembled Lam B of 
E.coli and a 44kDa protein of Sal.typhimurium in its induction properties. 
In addition, all three proteins appeared to be associated with the 
peptidoglycan layer (Pavala,1978; Enderman et a/,1978; Pavala and 
Randall, 1978; Osborn and Wu,1980). It was found that the LPS in 
Enterobacteriaceae, Pseudomonas aeruginosa, and V.cholerae were 
immunologically related to Campylobacter spp. and the lipid A component 
was suggested to be responsible. However, the activity of IgG and IgM 
antibodies to V.cholerae was also shown to be significantly reduced by 
absorption with Sal. enteritidis and E.coli (Cooper et al, 1983). The 
results of Hunt et al (1988) confirm an association between an increased 
level of vibriocidal antibody and Brucellosis infection. The similarity 
between V.cholerae antigens and those of other bacteria is not restricted to 
the cell wall. Partial antigenic similarities between the toxins of V.cholerae 
01 and E.coli have been established (Ruiz-Palacios et al, 1983; Klipstein 
and Engert, 1984,1985; McCardell et al, 1984; Clemens et a/,1988). The 
enterotoxin of Campylobacter jejuni produced by chicken isolates has been 
reported to be completely neutralised by a 1 in 60 dilution of anti-cholera 
toxin antiserum indicating immunological homology between the two toxins 
(Saha era/, 1988).
4.4. The avidin-biotin complex
The first reported application of the avidin biotin complex in an 
immunological system was its use in an immunohistochemical study in 
which biotin labelled antibody in conjunction with ferritin-avidin conjugates 
were employed to localise erythrocyte surface antigens (Bayer et al, 1976). 
The binding of biotin to egg white avidin is one of the highest affinity 
biological interactions yet characterised (Green, 1963). The strength of this 
association, added to the ease and relative gentleness of biotinylation
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reactions and the wide availability of active biotin derivatives have led to the 
widespread use of the avidin-biotin system as a reporter in both 
immunological and molecular biological studies. Furthermore, the use of the 
avidin-biotin probe is extremely flexible. Biotinylated antibodies can be 
utilised on either side of a heterogeneous immunoassay and with a number 
of radioactively labelled and enzyme labelled avidins (Kendall et a/,1983). 
Biotin-avidin technology has been used in screening and defining the 
immunochemical specificity of monoclonal antibodies (Watt and Watt, 1983) 
and in sensitive immunoassays (Watt et a/,1986). In addition, uses as 
diverse as the detection of viruses in soyabean seeds (Diaco et a/,1985) and 
high resolution mapping of DNA with biotin labelled probes (Manuelidis et 
a/,1982) have been reported. More recently biotin-avidin complexes have 
been used in combination with other immunoenzyme techniques for double 
and triple staining protocols in immunohistochemistry (Van der Loos et 
al, 1987; Van der Loos et al, 1988).
The four binding sites of biotin together with the high affinity 
(Kd=10“^  M‘ l) of avidin for biotin serve as an aid in amplifying the 
sensitivity of the immunoassay techniques which have become so 
widespread as a general diagnostic tool in all fields of biology ( Wilchek and 
Bayer, 1984).
4.4.1. Biotinylation of I1A1 and 04A6
I1A1 and 04A6 were biotinylated with N-hydroxy- 
succinimidobiotin using dimethylsulphoxide and dimethylformamide as a 
solvent (Section 2.3.7.4). When the biotinylated antibodies were tested on 
nitrocellulose paper, there was no significant difference between the two 
methods, which use both different organic solvents and different pH values.
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The application of biotinylated I1A1 and 0 4 A6 in the detection of 
V.cholerae on nitrocellulose paper are further described in Section 5.
4.4.2. Sensitivity studies of biotinylated 04A6 with increasing
amounts of Ogawa using the ABC kit
A dilution of 1:50 of biotinylated 04A6 was used to detect different 
concentrations of Ogawa in conjunction with the ABC kit (biotinylated 
alkaline phosphatase- avidin complex) and the results are shown in Fig 
4.30. In this assay, the biotinylated antibody was optimal at 10^ vibrios 
/well and insensitive above 10  ^ and below 10^ vibrios/well. The fall off at 
high values is probably due to a limit in the capacity of the ELISA plate to 
bind vibrios with the excess being washed off together with the detecting 
reagents.
Although the biotin-avidin complex immunoassay offers enhanced 
sensitivity over the conventional system (Alevy and Blynn,1986) it showed 
limited sensitivity in this assay. Cassano (1989) overcame this problem by 
developing several murine monoclonal antibodies to egg white avidin which 
enhanced the sensitivity of the avidin-biotin immunoassay by selectively 
enlarging the avidin-biotin-enzyme complex through bridging avidin to a 
second layer of avidin-biotin-enzyme complex, thus increasing the signal 
for substrate conversion to product antigen binding site .
O'Shannessy and Quarles (1985) described a general procedure for 
the biotinylation of both polyclonal and monoclonal antibodies in high 
yields with no detectable loss of immunological activity. The method relies 
on the generation of active aldehydes on the oligosaccharide moiety of the 
immunoglobulin and subsequent reaction with biotin hydrazin. Another
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Figure 4.30 Reaction of biotinylated 04A6 with different 
concentration of Ogawa
04A6 was biotinylated as described in Section 2.3.7.4. 1:50 dilution 
of the biotinylated antibody was reacted with increasing concentrations of 
Ogawa vibrios. The values plotted are a mean of two assays.
The control was 0.1M carbonate buffer pH 9.5.
2.0 n
 A ™ "  biotinylated 04A6
~ control
A405
0.5-
0.0
Concentration of Ogawa/well
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possible reason for the comparatively poor sensitivity of the biotin labelled 
antibody is incomplete reaction between antibody and biotin leading to free 
antibody molecules competing with the biotin labelled ones to bind to 
antigen. Stemberger and Stemberger (1986) compared the peroxidase- 
antiperoxidase (PAP) method with the avidin-biotin complex (ABC) method 
and showed that at the usual antibody dilution, the PAP method was much 
more sensitive than the ABC method.
4.5. Streptavidin
Streptavidin is a biotin binding protein with an apparent molecular 
weight of 600kDa consisting of four identical subunits, each with a biotin 
binding site (Chaiet and Wolf, 1964). Recently, the gene encoding 
streptavidin has been cloned and the amino acid sequence has been deduced 
from the nucelotide sequence (Argarana et al, 1986). The affinity of biotin 
for stretavidin has been estimated to be similar to that for avidin 
(Green, 1975).
4.5.1. Comparison between streptavidin and avidin (ABC) for
the detection of biotinylated antibody.
Biotinylated 04A6 was reacted with 10^ Ogawa vibrios and detected 
by the avidin (ABC) kit according to the instructions and by streptavidin, 
according to the dilution recommended for ELISA (1:5000). Avidin was 
observed to give a threefold stronger reaction than streptavidin. However, 
when the dilution of streptavidin was lowered to 1:1000, the reaction was 
comparable to that with avidin (Fig 4.31).
Streptavidin is commercially available but the current cost is very 
high. Avidin is widely available and comparatively inexpensive. A simple 
procedure to obtain avidin directly from homogenised egg white (yield
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Figure 4.31 Comparison between avidin and streptavidin
The relative sensitivities of streptavidin and avidin (ABC) kit were 
compared for the detection of biotinylated antibody in an ELISA assay. 
Biotinylated 04A6 was reacted with 10^ Ogawa vibrios.
The values plotted are a mean of two assays.
The control was 0.1M carbonate buffer pH 9.5.
Background absorbance was below 0.125 O.D.
1/5000 dilution streptavidin 
1/1000 dilution streptavidin 
■  Avidin
A405
tMp
illpiil:
Treatment
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about lmg/egg white) has been reported by Heney and Orr (1981). The 
high affinity and stability of the biotin-streptavidin complex has led to many 
applications of the system in solid phase assay, affinity purification, cell 
labelling and estimation of receptor densities on cell surfaces (Wilchek and 
Bayer, 1984; Updyke and Nicolson,1986).
4.6. The effect of biodnyladon on antibody isoelectric point
Fig 4.32 shows a stained isoelectric focusing gel. The typical 
microheterogeneous banding pattern generally seen with isoelectric focusing 
of monoclonal antibodies (Williamson, 1974; Lowe et a/,1982; Suzan et al, 
1982) is evident. The origin of the microheterogeneity is generally unknown 
but differential loss of amido groups, fine differences in glycosylation and 
interaction of antibodies with the carrier ampholytes have all been put 
forward as possible explanations. With rat hybridomas generated from the 
Y3.Ag 1.2.3 cell line there is the additional explanation that the parent cell 
line is itself a kappa light chain secretor and thus ,if the hybridoma light 
chain and parent light chain differ in isoelectric point, at least three species 
of antibody can be generated.
04A6 and I1A1 exhibit pis in the range 6.8-7.2 and 8.5-9.0 
respectively, while after biotinylation, there is an acidic shift in these values 
to 4.5 and 5.9. The reactivity of neutral NHS-biotin (N- 
hydroxysuccinimide biotin) with positively charged amino groups on the 
antibodies probably explains such shifts. While the biotinylated IIA l 
appears to have only a single band, this probably only reflects the 
comparatively small amount of protein available for staining on the gel so 
that only the major band is visible.
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Figure 4.32 Isoelectric focusing of I1A1 and 04A6
Pure IIAl, 04A6 and biotinylated 04A6 and IIAl were isoelectric 
focusing as described in Section 2.3.10, the gel was stained with coomassie 
blue.
Lane 1 Protein isoelectric focusing markers (pi)
Lane 2 20jil pure 04A6 
Lane 3 20jil biotinylated 04A6 
Lane if 20jil pure I1A1 
Lane 4- 20pl biotinylated IIA1
Dve
f r o n t
4.7 Summary
Conditions for the purification of the two antibodies, for optimal 
labelling of them with enzyme or biotin, and for purification of the 
appropriate conjugates were thus established. While these experiments gave 
an indication of what experimental procedures might prove most suitable for 
the construction of a solid phase based "dipstick” type kit, there are 
obviously several differences. The major ones relate to the difference in 
solid support and the use of a capture antibody for antigen in a dipstick kit 
in contrast to the experiments described which were all performed on 
antigen directly bound to an ELISA plate. In addition, the detecting system 
involved a soluble product for the enzyme where a solid phase kit requires 
an insoluble product. Clearly there are several areas where signal strength, 
background binding, and signal/noise ratio may vary between the two 
systems. The application of this information to the construction of a portable 
diagnostic kit is described in Section 5.
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CHAPTER 5 
CONSTRUCTION OF 
A DIAGNOSTIC KIT FOR THE 
DETECTION OFV.CHOLERAE
5 . Construction of a diagnostic kit for the detection of
V.cholerae
Chapter 4 showed the results obtained by various methods of 
conjugation of the monoclonal antibodies to enzymes followed by assay on 
a microtitre plate. In this chapter the construction of a solid phase based 
colourimetric diagnostic kit is described. Several variables which influence 
the sensitivity, specificity, and quantitative aspects have been investigated. 
Although a universal protocol for all monoclonal antibodies would be 
desirable, differences in the physical properties of the antibodies and 
antigens make such an aim impracticable. For the optimisation of this type 
of immunoassay, specific conditions have to be determine for each pair of 
antibody and antigen of interest. In this chapter, ways of improving the 
qualitative and quantitative aspects of kit technique were examined.
Nitrocellulose paper frequently used as the solid support for 
enzyme dot blot assays and immunoblots to assess protein antigen 
concentrations. In this study nitrocellulose has been used as the main 
supporting matrix for the kit
5 .1 . Blocking conditions
Traditionally, blocking and/or inactivation of unoccupied binding 
sites of the matrix have been used to eliminate background staining. 
Blocking with Tris (hydroxymethyl)aminomethane and gelatin have been 
shown to be effective in reducing or eliminating non-specific reactions 
(Renart et al, 1979; Lin and Kasamatsu, 1983). Other blocking agents used 
include BSA (Towbin et al, 1979; Aubertin et al, 1983), foetal bovine 
serum (De Bias and Cherwinski,1983; Ramirez etal, 1983), haemoglobin
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(Gershoni and Palade,1982), Tween 20 (Batteiger et a/,1982; Muilerman 
et al, 1982; Wedege and Svenneby,1986) and milk (Vogt et a/,1987).
Different concentrations of four different blocking reagents were 
prepared - skimmed milk (Blotto), BSA, gelatin and normal goat serum - 
and all four were tested for their ability to block the nitrocellulose paper in 
the absence of both capture antibody and antigen i.e. testing for "noise" 
alone rather than the more complex parameter of signal/noise. The 
membrane was blocked at room temperature for 3 hours, incubated with the 
biotinylated II Al, washed, and then treated with the ABC kit (biotinylated 
alkaline phosphatase-avidin complex) followed by substrate to detect any 
biotinylated antibody bound to the membrane. The results are shown in 
Figure 5.1. When the Blotto was used to block (A), only the lowest 
concentration of the milk gave a completely white background (A4) and 
higher concentrations (Al-3) appeared less satisfactory. In the case of BSA, 
higher concentrations (B1 and B2) were clearly more effective than lower 
ones (B3 and B4). Where gelatin was used (C) the result was clearly 
unsatisfactory with strong background colour and normal goat serum (D) 
was also ineffective. The finding that blocking by smaller rather than larger 
amounts is more effective in the case of Blotto can be explained by the fact 
that in any complex mixture such as this, components may selectively 
absorb to the membrane and if these components can bind to the biotinylated 
antibody or the ABC complex, such as reverse concentration effect may be 
expected. Milk, even skimmed, may have the additional problem of lipid 
involvement affecting the ability of the blocker to bind to the membrane.
It is clear that gelatin and normal goat serum are unsuitable in this 
system and give non-specific binding to either the antibody or ABC
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Figure 5.1 The effects of different blocking reagents
Four different blocking reagents were tested for blocking of the 
nitrocellulose paper in the absence of antigen. The strips were blocked, 
incubated with biotinylated IIAl, washed, and then treated with the ABC 
kit (avidin-biotinylated alkaline phosphatase) finally the substrate was 
added.
A Dried skimmed milk (Blotto)
B Bovine serum albumin (BSA)
C Gelatin
D Normal goat serum
1 10% Blocker concentration
2 5% Blocker concentration
3 2.5% Blocker concentration
4 1.25% Blocker concentration
5 0.625% Blocker concentration
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complex. From this data, BSA would appear to be the most effective 
blocking reagent at values above 5% (w/v) while low levels of milk give the 
most satisfactory overall result
Many other investigators, using different antibodies and varying 
detection systems, have also evaluated BSA as a blocking reagent. The 
conclusion above is similar to that of Gershoni and Palade (1982) who 
showed that lower concentrations of BSA resulted in unacceptable high 
results. Esen et al (1983) found that values as low as 0.2 -0.5% BSA were 
sufficient to block non-specific binding sites. Vogt et al (1987) compared 
different blockers and found that non-fat dry milk was as effective as BSA 
in the blocking of both ELISA plates and nitrocellulose membranes. In this 
context, it is worth noting that milk at the lowest concentration (1.25%) was 
actually more effective than BSA at 10% and 5%. Consequently, low levels 
of milk would appear to be a more effective (and indeed less expensive) 
blocking reagent than any level of BSA in this, and many other 
immunological assays.
The incubation temperature was found by Thean and Toh (1989) to 
be an important factor with respect to background staining, who found that, 
at 4 °C there was little difference between any of the blocking reagents, 
whereas at 22 °C the background was higher in strips blocked with Blotto 
and Tween 20 and at 37 °C all strips had high background including 
negative controls. They also suggested that background staining related 
more to blocking reagent and temperature than to non-specific binding.
The interaction of macromolecules with nitrocellulose paper remains 
poorly understood but hydrophobic effects are believed to play a role. 
Electrophoretic transfer of proteins to nitrocellulose membranes generally
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takes place at a pH of 8 where both proteins and membranes are generally 
negatively charged indicating that hydrophobic rather than electrostatic 
effects may influence the binding (Gershoni and Palade,1983). In addition, 
non-ionic detergents are very effective in eluting proteins from nitrocellulose 
membranes (Schneider,1980;Farrah etal, 1981).
5 .1 .1  The effect of Tween 20
Tween 20 was tested not on the membrane alone but on the 
completed I1A1 kit i.e. with the pure unlabelled antibody first bound to the 
nitrocellulose, blocked with 1.25% milk, incubated with the V.cholerae 
antigen, and then sequentially with the biotinylated antibody, the ABC kit 
and the substrate (see later in this Section). All washes between steps were 
performed with PBS containing 0.5% Tween 20. Fig 5.2 shows the result 
in which it is clear that Tween 20 has been too harsh a reagent and has 
obliterated the positive control (1) by washing off one or more of the 
necessary components.
Non-ionic detergents are commonly used to reduce non-specific 
binding of antibody and Tween 20 can also be used to block unoccupied 
binding sites. The study of Smith et al (1989) showed that non-ionic 
detergents lead to loss of the sample from the paper, making accurate 
quantitation impossible. They also showed that the detergents NP-40 and 
Tween-20 washed 90% of a native human serum albumin sample off a 
paper within one hour. Hawkes (1986) observed that detergents such as 
Triton X-100, NP-40, sodium deoxycholate and sodium dodecyl sulphate 
(SDS) all interfere with protein binding to the paper. Similar observations 
were reported by Lin and Kasamatsu (1983). However, Tween 20 was 
reported to be effective alone to incubate non-specific interactions,
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Figure 5.2 The effect of Tween 20 on the kit
The effect of Tween 20 was determined by using biotinylated IIA1 in 
the complete kit. Steps were as described in Section 2.3.8.2 except all the 
washes were in 0.5% PBS Tween.
1 Positive control (kit)
2 No Inaba vibrios
3 No capture antibody (I1A1)
4 No biotinylated IIA1
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eliminating the need for a blocking step (Mohammed and Esen,1989). In 
addition, De Bias (1983) suggested that it increased sensitivity of 
immunoblotting in comparison to foetal calf serum. However, Bird et al 
(1988) found that the use of Tween 20 alone led to false positive results due 
to non-specific binding and inefficient blocking. All these systems used 
different antigens and different antibodies, some polyclonal and some 
monoclonal, and it appears that the conclusion derived is heavily dependent 
on the particular antigen-antibody system under test. In addition, the 
percentage of Tween may be important. Reid et al (1987) found no binding 
of polyclonal antiserum at 0.5 % Tween 20 in a weak interaction, but 
specific binding at 0.1 %.
5.1.2. The effect of the blocking reagents on the full 
diagnostic I1A1 kit.
The results obtained in Section 5.1 clearly suggest that >5% BSA or 
+/< 1.25% milk are the best blocking reagents to be used in the current 
study with respect to backround ’’noise". These two blockers were therefore 
tested in the full reagent system, this time inclusive of purified nitrocellulose 
bound capture antibody, blocker, antigen and conjugated antibody in order 
to evaluate their effects ion signal strength and the crucial signal/noise 
parameter. In addition. Tween 20 at levels below those shown to be 
ineffective in Section 5.2 were evaluated. The data are shown in Fig 5.3. 
While BSA and Blotto both perform well in this system, BSA gave a better 
and more even colour intensity. However, it was noted during this study 
that blocking with milk seemed to lower slightly the sensitivity of the 
reaction, reducing the accessibility of the antigen to the antibody. This may 
be due to the steric hindrance caused by proteins present in milk that bind
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Figure 5.3 Signal/noise ratio of blocking reagents
Three blocking reagents were used to study the signal/noise ratio of the 
complete kit nitrocellulose paper background. Conjugated II Al-AP was 
used. Steps as described in Section 2.3.8.1.
A 5% BSA in PBS 
B 1.25% Blotto in PBS 
C 0.1% Tween T20 in PBS
1 Positive control (kit)
2 No antigen (Inaba)
3 No capture antibody.
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close to the site occupied by the antigen on the matrix. Alternatively, some 
milk proteins may bind to the antibody. Similar observations have been 
made by Esen et al (1983) and Vogt et al (1987). If, however, the negative 
control (2) is compared between the two blocking reagents, it is clear that 
milk gives a clearer background than BSA and appears to be the more 
effective. The reduction of Tween 20 concentration from 0.5% (Section 
5.1.1) to 0.1% as shown in C gave a signal, on the positive sample, but the 
signal/noise ratio between sample 1 and samples 2 and 3 was less 
satisfactory than when milk or BSA were used.
5.1.3.The effect of blocking time on the signal and 
background
Blocking of the nitrocellulose strips is the most important step in the 
development of the diagnostic kit since this step decreases the background 
staining or noise and thus facilitates the detection of the antigen. As any kit 
used in the field would be supplied already blocked, it is possible to use 
long blocking times which will not affect the speed of the actual assay.
In this experiment I1A1-AP complete system was used. In Fig 5.4 
the IIA l strips were blocked with 1:25% Blotto and incubated for 3 hours 
(A), 24 hours (B), at room temperature, and for 2 days (C) and 3 days (D) 
at 4 °C. All four sets of conditions showed very similar results indicating 
that the 3 hour room temperature blocking step was sufficient and no 
improvement is obtained with longer blocking times.
5 .2 .  Background reaction of the 04A6 biotin and 0 4 A6 
alkaline phosphatase conjugates
Background noise of the biotin and alkaline phosphatase conjugates 
were compared with two different blocking reagents, BSA and milk. The
165
Figure 5.4 Blocking time of the kit
The time required to block the nitrocellulose paper was estimated using 
conjugated I1A1-AP with 1.25% Blotto as a blocker.
A Incubation of the blocker for 3 hours at room temperature 
B Incubation of the blocker for 24 hours at room temperature 
C Incubation of the blocker for 2 days at 4° C 
D Incubation of the blocker for 3 days at 4° C
1 Positive control (kit)
2 No antigen (Inaba vibrios)
3 No capture antibody IIA1
4 No conjugated II Al-AP
LnJ
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strips were blocked for 3 hours at room temperature, and then treated with 
biotinylated or conjugated antibody. The strips were washed and the 
biotinylated kit was then treated with the ABC kit. Both strips were then 
developed with substrate.The results are shown in Fig 5.5. The conjugated 
antibody gives a stronger background colour than the biotinylated antibody 
at all levels of blocking agent. The data also confirm the observation in 
Section 5.1 that low concentrations of BSA (B3 and B4) and high 
concentrations of milk (A1,A2 and A3) are less efficient using 04A6 
biotinylated antibody, the experiment also shows that Blotto is a suitable 
blocker for 04A6 -AP conjugate.
The biotin system thus gives a clearer background than the 
conjugated antibody system.
5.2.1.The working dilution of conjugated antibody
This experiment was designed to optimise the working dilution of 
04A6 conjugated to alkaline phosphatase. Three working dilutions of 
1:100, 1:50 and 1:10 are shown in Fig 5.6. The most suitable dilution is 
clearly 1:100 where the signal/noise of the test (1) to the controls is the 
highest and the signal is of acceptable strength. High concentrations of 
conjugate show non-specific binding to other components of the kit. As a 
result of this experiment, the dilution of 1:100 was used for the further 
development of the kit.
5.2.2.Incubation time for the ABC kit.
Since the aim was to produce a kit with an optimal signal/noise ratio 
and in particular with a clear background, the effect of incubation time of the 
ABC reagent on the nitrocellulose kit was determined. Three strips were
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Figure 5.5 Background noise of biotinylated and conjugated 
antibody
The strips were blocked with BSA and milk for 3 hours at room 
temperature, followed by the addition of either biotinylated 04A6 or 
conjugated 04A6, (ABC kit in the case of the biotinylated antibody) and 
finally developed.
I Biotinylated antibody (04A6)
II Conjugated antibody (04A6).
A, C Strips blocked with Blotto
B, D Strips blocked with BSA
1 10% Blocker concentration
2 5% Blocker concentration
3 2.5% Blocker concentration
4 1.25% Blocker concentration
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Figure 5.6 The optimum working dilution of the conjugate
Different dilutions of 04A6-AP were prepared to determine the working 
dilution of the conjugate.
A Dilution 1/100 of conjugated 04A6-AP 
B Dilution 1/10 of conjugated 04A6-AP 
C Dilution 1/50 of conjugated 04A6-AP
1 Positive control (kit)
2 No antigen (Ogawa vibrios)
3 No capture antibody 04A6
4 No conjugated 04A6-AP
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blocked at room temperature and then the ABC kit was applied and 
incubated also at room temperature for 20,40 and 60 minutes respectively 
(Fig 5.7). While 20 minutes (A) gave the desired clear background, 40min 
and 60 min gave an unacceptably high colour. The recommendation for the 
ABC kit is 30min incubation, the positive samples with I1A1 and 04A6 give 
good intensity in 20 minutes without an increase in background.
5.2.3. The effect of prolonging the development of colour by
the enzyme
In order to visualise the bound alkaline phosphatase on the 
nitrocellulose paper the substrate is added with colour subsequently 
appearing within 3-5 minutes. The reaction is usually stopped after 10 
minutes by washing the strips under the tap. In Fig 5.8, the strips were left 
for more than one hour and this resulted in colour development of not only 
the positive control (1) but also the negative controls (2 and 3). Thus, 
prolonged development of colour may lead to a false positive result. It is 
therefore likely that even in the negative controls, a small amount of the 
enzyme is bound to the paper.
Alkaline phosphatase removes the phosphate group from the 
substrate 5-bromo-4-chloro-3-indolyl phosphate followed by a progressive 
oxidation reaction which results in the formation of the coloured insoluble 
complex 5,5 dibromo-4,4’-dichloro-indigo. The reaction can be facilitated 
by the addition of oxidation catalysts such as nitroblue tetrazolium or ferric 
and feirocyanide. The addition of copper sulphate as an oxidation catalyst 
results in a significant improvement in both the rate and intensity of colour 
development (Turner, 1986). In this study for the development of alkaline 
phosphatase, the substrate was used with the addition of ImM magnesium
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Figure 5.7 ABC (kit) incubation time
The strips were blocked with 1.25% Blotto for 3 hours at room 
temperature, then ABC (kit) was added, incubated for 3 different times, the 
strips were washed and developed.
A Incubation of ABC (kit) for 20 minutes 
B Incubation of ABC (kit) for 40 minutes 
C Incubation of ABC (kit) for 60 minutes
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Figure 5.8 Prolonged colour development of the enzyme 
substrate
The steps of conjugated antibody (04A6) for kit development were used 
Section 2.3.8.1 except the development time was for 1 1/2 hours.
1 Positive control (kit)
2 No antigen (Ogawa vibrios)
3 No capture antibody (04A6)
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chloride in an alkaline pH of 9.8.
5 . 3 .  The washing solution
The washing solution between each step was determined by 
washing the kits and the control after each step in four different buffer 
solutions:- PBS,TBS, carbonate buffer and tap water. The result shown in 
Fig 5.9 indicates that tap water was the most efficient (D) while the three 
buffers were all less effective as shown by the colour in the negative 
controls (A,B and C).
However, this result is probably due to physical rather than chemical 
factors as the force of tap water was much stronger than the force of the 
buffer expelled from a polythene washing bottle. Clearly in any field kit, 
water is the most useful washing reagent but the pressure of water used may 
be a factor to be taken into account in order to achieve standard results.
5.3.1.Washing time
In Fig 5.10 the strips have been washed with tap water for times of 
5,10,20 and 30 seconds for each side of the kit. The best time appeared to 
be 20 seconds (C) per side a total of 40 seconds, since a short washing time 
(A and B) gave a high background and a long washing time (D) resulted in a 
poor foreground. Cartwright et al (1985) compared different types of 
commercially available pregnancy testing kits on the market and found that 
incomplete washing produced false positive results while over vigorous 
washing removed the bound conjugate giving false negative results. The 
data obtained depended on the temperature and the pressure of the tap water 
used.
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Figure 5.9 Washing solutions for the kit
Four different solutions were employed for washing the strips after 
addition of antigen, biotinylated 04A6 and ABC (kit).
A Phosphate buffered saline (PBS)
B Tris buffered saline (TBS)
C Carbonate buffer 
D Tap water
1 Positive control (kit)
2 No antigen (Ogawa vibrios)
3 No capture antibody 04A6
4 No biotinylated 04A6
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Figure 5.10 kit washing time
Four different times were tested for washing the kit.
A Washing for 5 second/side; total of 10 sec 
B Washing for 10 second/side; total of 20 sec 
C Washing for 20 second/side; total of 40 sec 
D Washing for 30 second/side; total of 60 sec
1 Positive control (kit)
2 No antigen (Ogawa vibrios)
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5.3.2.The effect of pH of the solution
The effect of pH on the conjugate was determined by washing the 
conjugate with PBS buffer at pH values ranging from 2 to 10. Washing 
with tap water was included as a control. The result (Fig 5.11) suggests that 
alkaline phosphatase was completely inactivated at low pH(E). The negative 
controls of samples A,B,C and D give a higher background than those in F 
(tap water). The pH of the tap water used was 6. Alkaline phosphatase is 
known to be activated at high pH values and inhibited by low ones. Clearly 
the PBS will not buffer well at extremes of pH, the pK of phosphate being 
in the region of 7. However, the results do give an indication that the pH of 
any solution used for washing in the field will affect the result.
5 .4 .  Comparison of the conjugate prepared by cross linking
with glutaraldehyde and periodate.
IIA 1 and 04A6 conjugated to alkaline phosphatase by these two 
different methods and compared in the kit. Each conjugate was reacted with 
homologous serotype which had been bound to the appropriate antibody on 
the nitrocellulose paper and blocked with 1.25% Blotto (milk). The results 
(Fig 5.12) confirm the ELISA results (Figs 4.21 and 4.22) indicating that 
the glutaraldehyde method is much more suitable for the conjugation of both 
I1A1 and 04A6 and, if conjugation rather than biotin is the method of 
choice, glutaraldehyde should be used to cross link. The probable reason 
for the low coupling efficiency with periodate is the low amount of 
carbohydrate present on alkaline phosphatase. In consequence, all of the 
data presented with alkaline phosphatase conjugates of I1A1 and 04A6 in 
this section is with antibody coupled using the glutaraldehyde method.
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Figure 5.11 The effect of pH on the conjugate
Conjugated II Al-AP was washed with different pHs of PBS buffer and 
tap water to determine the effect of pH on the conjugate.
A Strips washes with PBS pH 10 
B Strips washed with PBS pH 8 
C Strips washed with PBS pH 6 
D Strips washed with PBS pH 4 
E Strips washed with PBS pH 2 
F Strips washed with tap water.
1 Positive control (kit)
2 No antigen Inaba vibrios
3 No capture antibody (I1A1)
8177
Figure 5.12 A comparison of the glutaraldehyde and periodate 
methods for conjugation of alkaline phosphatase 
to I1A1 and 04A6
A 04A6 - AP conjugated by the glutaraldehyde method 
B 04A6 - AP conjugated by the periodate method 
C IIA1 - AP conjugated by the glutaraldehyde method 
D IIA1 - AP conjugated by the periodate method
1 Positive control (kit)
2 No antigen (Ogawa or Inaba vibrios)
o
N3 r o
Us!o
178
5.4.1.The detection of the conjugate peak from FPLC
04A6 was purified and conjugated to alkaline phosphatase and the 
conjugated enzyme was then separated from the free enzyme and antibody 
by FPLC Superose 12 gel filtration. The three peaks obtained (see Fig 4.19 
for chromatogram profile) were then tested on nitrocellulose paper against 
Ogawa vibrios. Fig 5.13 shows that the first peak (A) represents the 
conjugated enzyme and the later peaks (B and C) representing the free 
antibody and enzyme give no reaction.
5.4.2.The optimum conditions for the 04A6 and I1A1 kits
The conditions established in earlier parts of Section 5 were then 
employed to develop the full diagnostic kits for IIA1 and 04A6. Figs 5.14 
and 5.15 show the IIA1 and 04A6 kits respectively with 1.25% Blotto 
(milk) as blocking reagent, for 3 hours, conjugate dilution at 1:100 washing 
between each step with tap water for total of 40 seconds, then developing of 
the alkaline phosphatase substrate for not more than 10 minutes . The data 
show a strong colour with the positive sample (1) and a reasonable 
signal/noise ratio with respect to the controls, in particular the control 
lacking cholera vibrios (2) in both kits.
5.5.  Comparison of avidin and streptavidin
Streptavidin has been reported by several laboratories to be superior 
to avidin and consequently the two were compared for the kits under 
construction. Streptavidin was prepared using dilutions of 1:250, 1:500, 
1:1000 and 1:2000 to detect the most suitable working dilution. Avidin was 
prepared according to the instructions for the use of the ABC kit. Fig 5.16 
shows the results. 1:500 appears to be the best working dilution of
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Figure 5.13 Detection of the conjugate in the various FPLC 
peaks
The three peaks obtained from the separation of 04A6 conjugate from 
the free enzyme and antibody (Fig. 4.19) were pooled separately and 
reacted against Ogawa vibrios on nitrocellulose paper.
A Represents the first peak (1)
B Represents the second peak (2)
C Represents the third peak (3)
1 Positive control (kit)
2 No antrigen (Ogawa vibrios)
3 No capture antibody (04A6)
4 No conjugated 04A6-AP
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Figure 5.14 The I1A1 kit using conjugated antibody
The method of construction of the kit described in Section 2.3.8.1 was 
used.
1 Positive control (kit)
2 No antigen (Inaba vibrios)
3 No capture antibody (II Al)
4 No conjugated II Al-AP

Figure 5.15 The 04A6 kit using conjugated antibody
The method of construction of the kit described in Section 2.3.8.1 was 
used.
1 Positive control (kit)
2 No antigen (Ogawa vibrios).
4 No capture antigen (04A6)
4 No conjugated 04A6-AP
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Figure 5.16 The use of avidin and streptavidin in the kit
Different concentrations of streptavidin were compared with avidin for 
the binding to biotinylated 04A6.
A 1/250 Dilution of streptavidin conjugated to alkaline phosphatase 
B 1/500 Dilution of streptavidin conjugated to alkaline phosphatase 
C 1/1000 Dilution of streptavidin conjugated to alkaline phosphatase 
D 1/2000 Dilution of streptavidin conjugated to alkaline phosphatase 
E (ABC kit) avidin - biotinylated alkaline phosphatase.
1 Positive control (kit)
2 No antigen (Ogawa vibrios)

streptavidin (B) since higher concentrations increase the background 
staining although the positive control is stronger (A). The lower 
concentrations of streptavidin were clearly unsuitable (C and D). Avidin (E) 
gave very similar results to streptavidin at 1:500 (B). However, the 
recommended dilution of stretavidin for immunoblots was in fact 1:3000 
which would have yielded no colour on this kit. Streptavidin is very much 
more expensive than avidin and in any diagnostic kit, cost is a factor to be 
taken into account. In this case therefore, avidin appears to be the more 
suitable reagent
5.5.1.04A6 and I1A1 kits using the avidin biotin system
Figs 5.17 and 5.18 show the 04A6 and IIA1 kits using the avidin 
biotin system using all the conditions earlier established as optimal. The 
avidin biotin system does not give as strong positive reaction as the 
conjugate but the background is very much clearer and almost white.
5.5.2.Time reduction in the I1A1 and 04A6 biotin kits
The time employed in the previous section for incubation of 
biotinylated antibody and avidin with biotinylated alkaline phosphatase was 
one hour in each case. For use in the field, a shorter time would clearly be 
very much more convenient. IIA 1 and 04A6 biotinylated antibodies were 
therefore incubated for only 15-20 min with the homologous serotype and 
the time of incubation with the ABC kit was also reduced to 15 minutes. Fig 
5.19 shows the results for 04A6 (A) and IIA1 (B). The positive control (1) 
remains of the same intensity as that in the longer incubation time.
5.5.3.The use of tissue culture supernatant as capture antibody
In view of the fact that blocking is routinely required in the 
construction of the kits, it is clearly possible that extensive antibody
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Figure 5.17 The 04A6 kit using biotinylated antibody
The method described in Section 2.3.8.2 was used for construction of 
the biotinylated 04A6 kit with the incubation time for biotinylated 04A6 and 
ABC (kit) being altered to 1 hour.
1 Positive control (kit)
2 No antigen (Ogawa vibrios)
3 No capture antibody (04A6)
4 No biotinylated 04A6
A 1/10 Dilution of biotinylated 04A6 
B 1/50 Dilution of biotinylated 04A6
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Figure 5.18 The I1A1 kit using biotinylated antibody
The method of Section 2.3.8.2 was used for construction of the 
biotinylated IIA1 kit with the incubation time for biotinylated IIA1 and 
ABC (kit) being altered to 1 hour.
1 Positive control (kit)
2 No antigen (Inaba vibrios)
3 No capture antibody IIA 1
4 No biotinylated IIA1
A 1/10 Dilution of biotinylated IIA1 
B 1/50 Dilution of biotinylated 11A1
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Figure 5.19 The I1A1 and 04A6 biotin kits (time reduction)
IIA1 and 04A6 biotin kits were constructed according to the method 
described in Section 2.3.8.2.
A 04A6 - biotin strips 
B IIA 1 - biotin strips
1 Positive control (kit)
2 No antigen (Inaba or Ogawa vibrios)
3 No capture antibody (IIA1 or 04A6)
4 No biotinylated antibody (IIA1 or 04A6)
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Figure 5.20 The use of tissue culture supernatant in the I1A1 
and 04A6 biotin kits
04A6 and I1A1 tissue culture supernatants were used as a capture 
antibody for the biotin kit
A 04A6 - biotin strips 
B I1A1 - biotin strips
1 Positive control (kit)
2 No antigen (Inaba or Ogawa vibrios)
3 No capture antibody (IIA1 or 04 A6)
4 No biotinylated antibody (IIA1 or 04A6)
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purification might not be necessary for the capture antibody on the first part 
of the kit. To test this, the I1A1 and 04A6 cell culture supernatants were 
bound to the nitrocellulose paper followed by blocker, antigen, biotinylated 
second antibody and the avidin-alkaline phosphatase detection system. Fig 
5.20 shows the result. A strong positive colour was obtained but the 
background "noise" of non specific binding was increased (2,3 and 4). 
Tissue culture supernatant can therefore be used but it gives a poorer kit. In 
addition, the level of antibody in tissue culture supernatant can vary and a 
very important feature of any kit is that it must be standard. This is more 
likely to be achieved with precise amounts of highly purified antibody.
5 .6 .  Cross reactions between the I1A1 and 0 4 A6 kits and
other bacteria
The two diagnostic kits were then tested for cross reactions with 
other bacteria. Three different gram negative bacteria:- E.coli K,K12 and 
B, Brucella abortus Strain 544, and m elitensis ,the heterologous 
V.cholerae serotype together with both the spore and vegetative forms of 
B.anthracis, a gram positive bacterium were tested. The 04A6 kit (Fig 
5.21) showed no cross reaction although the background was generally 
raised and in particular, no reaction with the Inaba serotype. The I1A1 kit 
(Fig 5.22) also showed no cross reaction with other bacteria but did, as 
expected, show cross reaction with Ogawa which is an inherent property of 
this antibody (Ghosh and Campbell 1986a; 1988). There was, however, an 
increase in the background, particularly with E.coli. Any kit designed to 
detect V.cholerae should detect both serotypes. While the I1A1 kit can 
detect Ogawa, the 04A6 kit does it better. Thus the final kit should involve 
a combination of the two described here with both antibodies being 
incorporated in the capture and detection stages. Alternatively, a double
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Figure 5.21 The reaction of the 0 4 A6 conjugate kit with other
bacteria
Different bacteria at the same density (10^ bacteria/ml) were reacted with 
the 04A6 conjugate kit to detect any cross-reaction.
1 E coli K12
2 E. coli K
3 E. coli B
4 Inaba vibrios
5 Control (no antigen)
6 Br. abortus
I  Br. suis
8 Br. melitensis
9 B. anthracis Ames spores
10 B. anthracis vegetative form
II Ogawa vibrios kit
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Figure 5.22 The reaction of I1A1 conjugate kit with other
bacteria
Different b  acteria at the same density (10$ bacteria/ml) were reacted 
with the IIA1 conjugate kit to detect any cross reaction.
1 E.coliK12
2 E. coli K
3 E.coliB
4 Ogawa vibrios
5. Control (no antigen)
6 Br. abortus
I  Br. suis
8 B r . melitensis
9 B. anthracis Ames spores
10 B. anthracis vegetative form
II Inaba vibrios kit
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wand containing both antibodies would be constructed. A far wider range 
of potentially cross reactive bacteria will also have to be assessed. These 
results to date are, however, encouraging.
The cross reaction of antibodies and antisera to V.cholerae with 
other bacteria has been reported (see Section 1). Many of these tests involve 
agglutination where such antibodies behave in a totally different fashion (for 
example IIA 1 agglutinates Ogawa where 04A6 does not) due to low 
affinity contacts which can be maintained in non-washing type assays 
(Ghosh and Campbell, 1986). Other cross reactions have been shown by 
ELISA which is generally more sensitive than nitrocellulose.
However, Holm and Gustafsson (1985), using mouse monoclonal 
antibodies also directed against the LPS of V.cholerae,tested ten different 
serotypes of E.coli, nine strains of Salmonella, Citrobacter freundii, and 
Shigella sonnei in both slide agglutination and sandwich ELISA with no 
positive results.
5 .7 . The sensitivity of the I1A1 and 04A6 kits
Both kits were tested for sensitivity over the range 10^ vibrios/ml to 
lvibrios/ml. Figure 5.23 shows the data for the conjugated 04A6 The 
highest colour intensity was at the highest concentration of vibrios, 10^ /  ml 
followed by 10& /  ml. The intensities at 10?, 10^ and 10^ /  ml were very 
similar and clearly above background. At 10^ /  ml, however, the intensity 
fell to control levels. The sensitivity of I1A1 kit is shown in Fig 5.24. Thus 
the sensitivity of both kits is in the range 10^ vibrios /  ml. The inoculum 
sufficient to cause the disease is believed to be 10^ as described by Smith 
(1985).
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Figure 5.23 The sensitivity of the 04A6 conjugate kit
The sensitivity of 04A6 kit using conjugated 04A6-AP for the detection 
of V. cholerae was estimated by reaction of the 04A6-AP conjugate with 
decreasing amounts of Ogawa vibrios
1 1()9 Ogawa/ml/strip
2 1C)8 Ogawa/ml/strip
3 107 Ogawa/ml/strip
4 1C)6 Ogawa/ml/strip
5 105 Ogawa/ml/strip
6 1()4 Ogawa/mlstrip
7 1()3 Ogawa/ml/strip
8 1C)2 Ogawa/ml/strip
9 10 Ogawa/ml/strip
10 1 Ogawa/ml/strip
11 no Ogawa bivrios
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Figure 5.24 The sensitivity of the I1A1 conjugate kit
The sensitivity of II Alkit using conjugated II Al-AP for the detection of 
V. cholerae was estimated by reaction of the IIA1 conjugate with 
decreasing amounts of Inaba vibrios.
1 1()9 Inaba/ml/strip
2 10$ Inaba/ml/strip
3 107 Inaba/ml/strip
4 10^ Inaba/ml/strip
5 105 Inaba/ml/strip
6 104 Inaba/ml/strip
7 10^ Inaba/ml/strip
8 10^ Inaba/ml/strip
9 10 Inaba/ml/strip
10 1 Inaba/ml/strip
11 no Inaba vibrios
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Figure 5.25 The sensitivity of the biotin kit
The sensitivity of the 04A6 biotin kit for the detection of V. cholerae 
was estimated by reaction of the biotinylate 04A6 with decreasing amount 
of Ogawa vibrios.
1 1()9 Ogawa/ml/strip
2 108 Ogawa/ml/strip
3 107 Ogawa/ml/strip
4 106 Ogawa/ml/strip
5 10  ^Ogawa/ml/strip
6 10^ Ogawa/ml/strip
7 103 Ogawa/ml/strip
8 10^ Ogawa/ml/strip
9 10 Ogawa/ml/strip
10 1 Ogawa/ml/strip
11 No Ogawa vibrios

The sensitivity of the biotinylated 04A6 kit was also estimated by 
the same procedure (Fig 5.25) and shown to be 10 fold less i.e. 10^ 
vibrios/ml. Thus, despite the more satisfactory background, the biotin- 
avidin system is probably less suitable for kit construction, at least from this 
antibody.
5 .8 .  The use of plastic as an alternative solid matrix
The majority of commercial kits use as a solid matrix, more 
substantial solid matrices based on plastic or beads. In the mid-1980s, the 
company Bioscot developed a series of kits for detection of fish viruses 
using as the solid base, commercially available plastic knives from a firm 
called Sweetheart plastic. It was on this basis, that attempts were made to 
transfer the kit to knives from the same source.
In order to ascertain the appropriate blocking conditions, different 
blocking reagents were tested as for the nitrocellulose paper in Section 5.1. 
Knives without first antibody or antigen were blocked with Blotto, BSA, 
gelatin and normal goat serum and biotinylated 04A6 antibody followed by 
the ABC kit were then reacted with the blocked knives. Fig 5.26 shows the 
result together with a knife which has no blocking reagent and only the 
ABC kit (E). Thus it would appear that all types of blocking reagent were 
suitable for the plastic knives.
5.8.1.DeveIopment of the plastic based kits using variable 
concentrations of blocking reagent
As all the blocking reagents proved effective, it was obviously 
possible that they might be too effective and reduce the positive signal in the 
full kit using biotinylated 04A6. The kit was therefore tested with and
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Figure 5.26 The effect of different blocking reagents on the 
plastic matrix
Different blockers were tests on plastic matrix in the absence of antigen. 
The knives were blocked, incubated with biotinylated 04A6, washed and 
then treated with ABC kit (avidin-biotinylated alkaline phosphatase) and 
finally the substrate was added.
A Dried skimmed milk (Blotto)
B Bovine serum albumin (BSA)
C Gelatin
D Normal goat serum 
E No blocker only enzyme added
1 10% Blocker concentration
2 5% Blocker concentration
3 2.5% Blocker concentration
4 1.25% blocker concentration
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Figure 5.27 Development of the plastic matrix kit using high
concentrations of blocking reagent.
The kit was constructed using high concentration of different blockers 
using biotinylate 04A6.
A 10% Blotto 
B 5% Blotto 
C 10% BSA 
D 5% BSA
E 10% Normal goat serum 
F 5% Normal goat serum 
G 10% Gelatin 
H 5% Gelatin
1 Kit
2 No Ogawa vibrios

Figure 5.28 Development of the plastic matrix kit using low
concentrations of blocking reagent
The kit was constructed using low concentration of blocking agents 
using biotinylated 04A6.
A 2.5% Dried skimmed milk (Blotto)
B 1.25% M ed skimmed milk (Blotto)
C 2.5% Bovine serum albumin (BSA)
E 1.25% Bovine serum albumin (BSA)
E 2.5% Gelatin 
F 1.25% Gelatin 
G Only (ABC kit) applied.
1 Kit
2 No Ogawa vibrios
23
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without antigen using both a high (Fig 5.27) and a low (Fig 5.28) 
concentration of blocking reagents. In general, the colour development in 
the positive controls (1) in all cases was faint and patchy even at the lower 
concentration of blocking reagent.. In addition, at the lower concentration, 
gelatin yielded a false positive (Fig 5.28, F2). In all other cases, the reagent 
controls remained clear.
5.8.2.Factors affecting the plastic based kit
In general for the investigations on the plastic based kit, identical 
conditions to those which had been shown to be optimal for the 
nitrocellulose based kit were used. However, since the plastic yielded such 
weak positive colour an attempt was made to increase this by increasing the 
amounts of the constituent parts of the nitrocellulose kit.. Thus the amount 
of first antibody, antigen, biotinylated second antibody and alkaline 
phosphatase were increased (Fig 5.29). This did not improve the colour 
strength on the positive control and indeed led to a false positive when the 
amount of first antibody was increased (D2). It was considered that the low 
intensity might be related to the limited surface area available, the plastic 
having been treated to produce a smooth surface.
Commercially available kits tend to have a rough or grooved surface 
in order to increase first antibody binding. The plastic wands from the 
Clearblue Pregnancy test (Unipath) were therefore used at the end which did 
not have the Clearblue reagents, and which was smooth. As the Clearblue 
test recommended at least 10 minutes between each step, two different times 
of 10 minutes and 30 minutes were used between each step and the results 
are shown in Fig 5.30. There was no colour at 10 minutes, and little at 30 
minutes. In (C) where there is no blocking reagent and only conjugated
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04A6 to alkaline phosphatase, non-specific colour was evident after 30 
minutes. From this it is concluded either that the commercial kit had 
additional different methodology involved in the binding of the anti-hCG 
antibody, or that the roughening of the plastic is an important feature of 
the kit.
In this chapter, the optimal conditions for the nitrocellulose kits has 
been established. Only a small number of experiments have been performed 
with plastic as a solid matrix as it appeared, in our hands to provide a less 
satisfactory kit. While nitrocellulose paper is brittle, it can readily be held in 
a plastic wand, and this would appear to be the most satisfactory method for 
the kit constructed to date.
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Figure 5.29 The effect of increasing the amounts of Ag, Ab, 
biotinylated Ab and AP on the plastic matrix kit
The amounts which were generally used as described in Section 2.3.8.2 
were increased.
A More avidin-AP added 500}il/strip 
B More biotinylated 04A6 added 500|il/strip 
C More Ogawa vibrios added lO^ml/strip .
D More capture 04A6 added lml/strip
1 Positive control (kit)
2 No antigen (Ogawa vibrios)
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Figure 5.30 The use of the Clearblue kit plastic
The 04A6 conjugated antibody kit was constructed using Clearblue 
pregnancy test sticks as a solid matrix. The incubation between each step 
was for 10 and 30 minutes.
A Incubation for 10 minutes between each step 
B Incubation for 30 minutes between each step 
A1 Positive control (kit)
A2 No Ogawa vibrios 
B1 Positive control (kit)
B2 No Ogawa vibrios
Cl Only 04A6 conjugate applied for 10 minutes 
C2 Only 04A6 conjugate applied for 30 minutes
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6.C0NCLUSI0N
6 . CONCLUSION
This thesis has been concerned with the development of inexpensive 
and readily operated immunodiagnostic monoclonal antibodies. While there 
are many others working actively in the field, there are few published 
reports and indeed, severe constraints on disclosure of information are 
placed on speakers at scientific meetings. To some extent, the research has 
therefore been performed in a scientific vac /uum.
i) Main summary of work in thesis
The first section analysed optimal growth conditions and the second 
sought optimal purification conditions and suitable methods of conjugation 
of antibody to enzyme. Later sections concentrated on optimal conditions 
for kit establishment.
The results obtained showed that for both IIA 1 and 04A6 the cell 
growth rate and total antibody secretion were higher in 20% FCS than at 
the lower levels of FCS, much as might be expected. In contrast, however, 
the cell surface immunoglobulin level and antibody production per cell was 
higher in hybridoma cells grown in the lower percentages of FCS. The 
overall picture is that the cells tend to divide and mutliply in rich medium 
and only when the medium is exhausted, or the cells are transferred to a less 
rich medium, is the expression of the membrane and secretory 
immunoglobulin genes fully activated.
From the FPLC elution pattern of the antibody conjugated to alkaline 
phosphatase, it appears that polymeric and dimeric forms of alkaline 
phosphatase and antibody can readily be formed by the treatment with 
glutaraldehyde. The glutaraldehyde method was much more efficient than
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the periodate method for conjugation of alkaline phosphatase to both IIA1 
and 04A6 IgGs. However, the size of the carbohydrate moiety of alkaline 
phosphatase might not be sufficient to make the periodate method an 
efficient conjugation technique for alkaline phosphatase-antibody 
preparation.
Non fat dried milk is the most efficient blocking agent, effectively 
preventing background staining of nitrocellulose paper. Since it dissolves 
easily and is inexpensive, it offers certain advantages over other blockers. 
The data obtained from comparison of antibody directly conjugatedto 
enzyme with the biotin-avidin system, indicated that the former is more 
sensitive by 10 fold and, as it involves one less step, it is consequently the 
method of choice. In spite of the fact that a similarity in the structure of the 
O antigen of Brucella and V. cholerae has been demonstrated (Garoff et 
alt 1984a; 1984b), no significant cross reaction was obtained between Inaba 
and Ogawa kits and a number of gram negative and gram positive bacteria. 
None the less, a wider range of bacteria should be tested in further 
development of the kit. The fact that the Inaba kit reacts with Ogawa vibrios 
is expected, since it is an inherent property of the anti- Inaba antibody.
A solid support is more convenient for a hand held kit. The 
nitrocellulose paper shows the best result of the limited number of matrices. 
Both IIA1 and 04A6 could be held in a double plastic wand for the 
detection of both Inaba and Ogawa. This thesis did not extend to testing in 
body fluid or more solid samples and these should clearly be investigated 
before the kit could be marketed.
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ii) Immunodiagnostics in general
Analytical technology for immunoassays has recently been 
revolutionized by the advent both of biosensor technology and monoclonal 
antibody production. New probes such as optical and electrochemical cells 
are sensitive devices but still depend primarily on antibody affinity. 
However sophisticated the electronic detection may be, it will fail with a low 
affinity antibody since the key factor for these assays is signal/noise ratio. 
Another factor is the long-term stability of immobilized reagents subjected to 
the different operating parameters of the sensors such as temperature, light 
and storage conditions.
iii) Field kits for non-trained personnel in general
Clearblue 2 is the ideal kit which has led many in the field to 
extrapolate perhaps beyond what is practicable. hCG is a small soluble 
protein tested in urine which is low in contaminating proteins. With such a 
kit it is possible to have a diffusible Ab-Ag complex, but this is not the case 
with bacteria. It remains to be seen whether Clearblue 2 can be extrapolated 
to other proteins from more complex biological fluids, and with the more 
usual multisubunit structure (e.g. cholera toxin). A relevant factor is that, 
prior to their development, pregnancy diagnosis was already a 
comparatively sophisticated technique. The MCAb kits in fact give slightly 
earlier detection which, in the case of pregnancy, is almost unnecessary.
iv) Immunodiagnostic field kits for whole bacteria as
opposed to soluble proteins
These present different problems but earlier detection is much more 
important. The antigen is multivalent and of limited diffusible capacity. It 
is also larger up to (3 orders of magnitude greater than the antibody 
molecule which captures a part of its surface), and readily detached from its
206
antibody bound to a solid support by fluid flow. It carries repetitive surface 
structure which are naturally "sticky" targets for non specific binding of 
detecting systems.There is no published data, but informal contact with 
other groups (Dr. W. Melvin, University of Aberdeen (Listeria) personal 
communcation, Dr Qadri, India Institute of Immunology {salmonella) 
indicate that they have kits with similar sensitivity limits. There are many 
possible ways to further improve this. For example, growing a clinical 
sample in culture for 6 hours to increase sensitivity gives "same day" 
diagnosis (Qadri and Ghosh, 1989, Hybridoma, in press).
v) The future for immunodiagnostic field kits
The polymerase chain reaction (PCR) which amplifies DNA 
sequences of interest may in the future make possible sensitive detection of 
pathogens that would be difficult to identify with conventional culturing 
techniques. Detection of fastidious pathogens such as chlamydia or 
mycobacteria with this approach and also viral pathogens human 
immunodeficiency virus (HIV) is though to be particularly appropriate. 
However, the same was true for MCAbs ten years ago and in that ca^se, the 
full anticipitated potential has yet to be realised. PCR error rate associated 
with Taq polymerase is a critical factor in determining its general use, and 
high level of amplification possible with PCR and Taq polymerase creates a 
significant problem of contaminanting sequences and consequently 
unexpected results (Bell, 1989). Even in PCR the signal/noise ratio is what 
counts. In the context of this thesis, it is perhaps worth noting that a DNA 
probe which distinguished Inaba from Ogawa would be difficult to 
construct in comparison to antibody technology, the antigens being 
carbohydrate in nature.
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vi) The potential utilities of a V. Cholerae kit
There are a variety of situations where a kit for V.cholerae may be 
of value. In case of the detection of infection, it may well be irrelevant in 
primary patients since oral rehydration therapy should ideally be applied to 
the majority of diarrheal patients, but useful information for field workers if 
an epidemic is developing.
With respect to prevention, water supplies can be routinely tested by 
untrained individuals. In many respects, the cost alternative comes down 
to using a kit versus boiling. The main application of such testing is that 
one cannot routinely boil an entire village pond.
As with many third world problems, education would probably be 
better than science.
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